,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes,Direction,Dataset
0,Lysosome,3/121,0.003249208365999697,1.0,0,0,10.11975037949064,57.9795300253322,GGA1;AP3M1;SGSH,up,BioPlanet
1,"Fatty acid, triacylglycerol, and ketone body metabolism",3/173,0.008755652530847998,1.0,0,0,7.0779756989501,33.535843696998356,AGPAT5;MED13;CPT2,up,BioPlanet
2,Axonal growth stimulation,1/5,0.012191219830698688,1.0,0,0,81.6326530612245,359.7583079469002,ARHGDIA,up,BioPlanet
3,Import of palmitoyl-CoA into the mitochondrial matrix,1/8,0.019435974184612268,1.0,0,0,51.020408163265316,201.05253013595427,CPT2,up,BioPlanet
4,SREBP control of lipid biosynthesis,1/8,0.019435974184612268,1.0,0,0,51.020408163265316,201.05253013595427,SCAP,up,BioPlanet
5,Axonogenesis regulation by p75 neurotrophin receptor,1/9,0.021839307484116888,1.0,0,0,45.351473922902485,173.42602436330466,ARHGDIA,up,BioPlanet
6,Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha),2/112,0.030807709687087226,1.0,0,0,7.288629737609329,25.364360829520702,MED13;CPT2,up,BioPlanet
7,p27 phosphorylation regulation during cell cycle progression,1/13,0.03139507576319159,1.0,0,0,31.39717425431711,108.66889234518707,CKS1B,up,BioPlanet
8,Polyamine metabolism,1/14,0.033769693865094014,1.0,0,0,29.15451895043732,98.7810935836037,AMD1,up,BioPlanet
9,ABCA transporters in lipid homeostasis,1/17,0.04085938516720612,1.0,0,0,24.009603841536613,76.77355911185376,ABCA7,up,BioPlanet
10,Activated AMPK stimulation of fatty-acid oxidation in muscle,1/18,0.04321127244441888,1.0,0,0,22.67573696145125,71.23931704209987,CPT2,up,BioPlanet
11,Glycosaminoglycan degradation,1/19,0.045557510321821836,1.0,0,0,21.482277121374864,66.35402337351628,SGSH,up,BioPlanet
12,Heparan sulfate/heparin glycosaminoglycan (HS-GAG) degradation,1/20,0.04789811206941787,1.0,0,0,20.40816326530613,62.01386100697238,SGSH,up,BioPlanet
13,RNA polymerase II promoter escape,1/22,0.052562460131218174,1.0,0,0,18.55287569573284,54.652191090011996,TAF1,up,BioPlanet
14,Mitochondrial fatty acid beta-oxidation,1/23,0.054886232846338284,1.0,0,0,17.74622892635315,51.50830043904919,CPT2,up,BioPlanet
15,Hypoxia and p53 in the cardiovascular system,1/23,0.054886232846338284,1.0,0,0,17.74622892635315,51.50830043904919,TAF1,up,BioPlanet
16,Triacylglyceride biosynthesis,1/24,0.057204422219257416,1.0,0,0,17.006802721088437,48.658572654069516,AGPAT5,up,BioPlanet
17,SREBP signaling,1/24,0.057204422219257416,1.0,0,0,17.006802721088437,48.658572654069516,SCAP,up,BioPlanet
18,Metal ion solute carrier family (SLC) transporters,1/25,0.059517041402020875,1.0,0,0,16.3265306122449,46.06518526236904,SLC31A1,up,BioPlanet
19,Alpha-9 beta-1 integrin pathway,1/25,0.059517041402020875,1.0,0,0,16.3265306122449,46.06518526236904,ADAM15,up,BioPlanet
20,Interaction between L1-type proteins and ankyrins,1/26,0.06182410346022105,1.0,0,0,15.698587127158554,43.69642020297904,SCN9A,up,BioPlanet
21,Phosphatidic acid biosynthesis,1/28,0.06642160851252993,1.0,0,0,14.57725947521866,39.529633324123054,AGPAT5,up,BioPlanet
22,Skeletal myogenesis control by HDAC and calcium/calmodulin-dependent kinase (CaMK),1/29,0.06871207754428547,1.0,0,0,14.074595355383533,37.68937781813083,CABIN1,up,BioPlanet
23,T cell receptor calcium pathway,1/29,0.06871207754428547,1.0,0,0,14.074595355383533,37.68937781813083,CABIN1,up,BioPlanet
24,Association of TriC/CCT with target proteins during biosynthesis,1/29,0.06871207754428547,1.0,0,0,14.074595355383533,37.68937781813083,AP3M1,up,BioPlanet
25,CDC42 activity regulation,1/30,0.07099704156206503,1.0,0,0,13.60544217687075,35.987987359848866,ARHGDIA,up,BioPlanet
26,Cysteine and methionine metabolism,1/34,0.08008210609353099,1.0,0,0,12.004801920768307,30.308557556443446,AMD1,up,BioPlanet
27,Fatty acid beta oxidation,1/34,0.08008210609353099,1.0,0,0,12.004801920768307,30.308557556443446,CPT2,up,BioPlanet
28,MEF2D role in T cell apoptosis,1/35,0.08233973871315534,1.0,0,0,11.661807580174925,29.118384092278692,CABIN1,up,BioPlanet
29,Basal transcription factors,1/35,0.08233973871315534,1.0,0,0,11.661807580174925,29.118384092278692,TAF1,up,BioPlanet
30,Cyclin D-associated events in G1,1/38,0.08908012117667435,1.0,0,0,10.741138560687432,25.97442616843159,CKS1B,up,BioPlanet
31,RAC1 activity regulation,1/38,0.08908012117667435,1.0,0,0,10.741138560687432,25.97442616843159,ARHGDIA,up,BioPlanet
32,Triglyceride biosynthesis,1/38,0.08908012117667435,1.0,0,0,10.741138560687432,25.97442616843159,AGPAT5,up,BioPlanet
33,HIV-1 transcription initiation,1/39,0.09131611933080344,1.0,0,0,10.465724751439037,25.048958173793586,TAF1,up,BioPlanet
34,FOXM1 transcription factor network,1/41,0.09577199782508727,1.0,0,0,9.955201592832255,23.352761921448888,CKS1B,up,BioPlanet
35,Fatty acid metabolism,1/42,0.09799190344985674,1.0,0,0,9.718172983479104,22.574056575152703,CPT2,up,BioPlanet
36,Porphyrin and chlorophyll metabolism,1/43,0.10020647014004594,1.0,0,0,9.4921689606075,21.836948459042464,COX15,up,BioPlanet
37,Lysine degradation,1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,SETD8,up,BioPlanet
38,Vasopressin-regulated water reabsorption,1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,ARHGDIA,up,BioPlanet
39,RhoA activity regulation,1/46,0.10681826213767642,1.0,0,0,8.873114463176575,19.845841821431655,ARHGDIA,up,BioPlanet
40,ABC transporters,1/47,0.10901159849285977,1.0,0,0,8.684324793747287,19.247077674533823,ABCA7,up,BioPlanet
41,Lipid and lipoprotein metabolism,3/489,0.11769334413382815,1.0,0,0,2.5040691123075,5.357888608313781,AGPAT5;MED13;CPT2,up,BioPlanet
42,Type I interferon (interferon-alpha/beta) pathway,1/51,0.11773230434297198,1.0,0,0,8.003201280512204,17.12158334507697,PTPRD,up,BioPlanet
43,Heparan sulfate/heparin glycosaminoglycan (HS-GAG) metabolism,1/52,0.11989938284584432,1.0,0,0,7.849293563579278,16.649155135028106,SGSH,up,BioPlanet
44,Protein folding,1/53,0.122061246826909,1.0,0,0,7.7011936850211775,16.197399592213856,AP3M1,up,BioPlanet
45,Arginine and proline metabolism,1/54,0.12421790857292912,1.0,0,0,7.558578987150415,15.765063707247872,AMD1,up,BioPlanet
46,Calcineurin-dependent NFAT signaling role in lymphocytes,1/55,0.12636938033824105,1.0,0,0,7.421150278293135,15.350991248791996,CABIN1,up,BioPlanet
47,RAGE pathway,1/60,0.13704931664792866,1.0,0,0,6.802721088435375,13.519826138757372,SCAP,up,BioPlanet
48,HIV genome transcription,1/61,0.13916990440240695,1.0,0,0,6.691201070592173,13.195448367099164,TAF1,up,BioPlanet
49,Ubiquitin-mediated degradation of phosphorylated Cdc25A,1/64,0.145501086009976,1.0,0,0,6.3775510204081645,12.293187043446148,CKS1B,up,BioPlanet
50,Retinoblastoma protein regulation,1/66,0.1496965090156283,1.0,0,0,6.184291898577612,11.744868940614404,TAF1,up,BioPlanet
51,PPAR signaling pathway,1/69,0.1559518351617717,1.0,0,0,5.915409642117718,10.992061924687226,CPT2,up,BioPlanet
52,CDC42 signaling events,1/70,0.1580269091413692,1.0,0,0,5.830903790087462,10.757958888834528,ARHGDIA,up,BioPlanet
53,Rac1 cell motility signaling pathway,1/71,0.16009698547444592,1.0,0,0,5.748778384593273,10.531621087515461,ARHGDIA,up,BioPlanet
54,Cyclin A-Cdk2-associated events at S phase entry,1/72,0.1621620759393262,1.0,0,0,5.6689342403628125,10.312692602742626,CKS1B,up,BioPlanet
55,Cap-dependent translation initiation,1/73,0.16422219226923945,1.0,0,0,5.5912776069331835,10.100838340526812,RPL7,up,BioPlanet
56,Chronic myeloid leukemia,1/73,0.16422219226923945,1.0,0,0,5.5912776069331835,10.100838340526812,CTBP2,up,BioPlanet
57,Transcriptional regulation of white adipocyte differentiation,1/77,0.17241315077194586,1.0,0,0,5.30082162735224,9.318111015542156,MED13,up,BioPlanet
58,Small cell lung cancer,1/84,0.1865585167269208,1.0,0,0,4.859086491739553,8.158456396990406,CKS1B,up,BioPlanet
59,Pathways in cancer,2/325,0.18915017683326385,1.0,0,0,2.5117739403453694,4.18264111276552,CTBP2;CKS1B,up,BioPlanet
60,Glycerophospholipid biosynthesis,1/86,0.19055636178365606,1.0,0,0,4.7460844803037485,7.868093335513186,AGPAT5,up,BioPlanet
61,Neural crest differentiation,1/91,0.20046695733149195,1.0,0,0,4.485310607759588,7.208368904040989,CTBP2,up,BioPlanet
62,Metabolism,6/1615,0.20090820345388208,1.0,0,0,1.516396032097049,2.4336748712600045,AGPAT5;MED13;CPT2;COX15;AMD1;SGSH,up,BioPlanet
63,L1CAM interactions,1/94,0.20635615488224895,1.0,0,0,4.3421623968736425,6.852590950224973,SCN9A,up,BioPlanet
64,"Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds",1/96,0.21025865699508986,1.0,0,0,4.2517006802721085,6.630173495783064,SLC31A1,up,BioPlanet
65,Wnt signaling pathway and pluripotency,1/98,0.21414235950352406,1.0,0,0,4.164931278633904,6.418634959615513,CTBP2,up,BioPlanet
66,RNA polymerase II transcription,1/101,0.21993285781620825,1.0,0,0,4.04122044857547,6.120157490219282,TAF1,up,BioPlanet
67,Electron transport chain,1/105,0.22758854778675144,1.0,0,0,3.887269193391643,5.7539976492801825,COX15,up,BioPlanet
68,Cytoplasmic ribosomal proteins,1/108,0.2332819671059828,1.0,0,0,3.779289493575208,5.500783816386177,RPL7,up,BioPlanet
69,Glycosaminoglycan metabolism,1/110,0.2370547198597219,1.0,0,0,3.710575139146568,5.3412403673948,SGSH,up,BioPlanet
70,S phase,1/112,0.24080928525036116,1.0,0,0,3.6443148688046647,5.188593317350888,CKS1B,up,BioPlanet
71,HIV life cycle,1/118,0.2519647137871081,1.0,0,0,3.4590107229332414,4.768129456691159,TAF1,up,BioPlanet
72,p53 activity regulation,1/118,0.2519647137871081,1.0,0,0,3.4590107229332414,4.768129456691159,SETD8,up,BioPlanet
73,Notch signaling pathway,1/121,0.257482053509444,1.0,0,0,3.37325012649688,4.576843502837304,CTBP2,up,BioPlanet
74,Rho GTPase cycle,1/123,0.2611381124361412,1.0,0,0,3.3184005309440856,4.4556357896022085,ARHGDIA,up,BioPlanet
75,p75 neurotrophin receptor-mediated signaling,1/124,0.26295952305137155,1.0,0,0,3.2916392363396967,4.3968241059794595,ARHGDIA,up,BioPlanet
76,Influenza viral RNA transcription and replication,1/125,0.26477653500882337,1.0,0,0,3.26530612244898,4.339164319545324,RPL7,up,BioPlanet
77,Neurotrophin signaling pathway,1/126,0.2665891587198105,1.0,0,0,3.2393909944930352,4.282625646359972,ARHGDIA,up,BioPlanet
78,Spliceosome,1/127,0.2683974045277928,1.0,0,0,3.2138839787883664,4.227178351586288,THOC3,up,BioPlanet
79,PDGFB signaling pathway,1/129,0.27200080396294063,1.0,0,0,3.1640563202025,4.1194439390742055,ARHGDIA,up,BioPlanet
80,Developmental biology,2/420,0.2750113012279262,1.0,0,0,1.9436345966958213,2.5091216458419447,MED13;SCN9A,up,BioPlanet
81,"TNF-alpha effects on cytokine activity, cell motility, and apoptosis",1/135,0.2827070050205103,1.0,0,0,3.0234315948601664,3.8196348770958566,ABCA7,up,BioPlanet
82,Mitotic G1-G1/S phases,1/135,0.2827070050205103,1.0,0,0,3.0234315948601664,3.8196348770958566,CKS1B,up,BioPlanet
83,Ubiquitin-mediated proteolysis,1/136,0.2844763130304335,1.0,0,0,3.0012004801920766,3.772824991365301,UBE2NL,up,BioPlanet
84,Oxidative phosphorylation,1/136,0.2844763130304335,1.0,0,0,3.0012004801920766,3.772824991365301,COX15,up,BioPlanet
85,Transmembrane transport of small molecules,2/432,0.2859509985799256,1.0,0,0,1.889644746787604,2.3657120492785197,SLC31A1;ABCA7,up,BioPlanet
86,Influenza infection,1/142,0.2950027306318848,1.0,0,0,2.8743891922966367,3.5089700095024057,RPL7,up,BioPlanet
87,Protein metabolism,2/442,0.29505905866274895,1.0,0,0,1.8468926031951245,2.2542797004758666,AP3M1;RPL7,up,BioPlanet
88,Translation,1/151,0.31050850642228905,1.0,0,0,2.703067982159751,3.161356891739086,RPL7,up,BioPlanet
89,EGFR1 pathway,1/152,0.3122106087631069,1.0,0,0,2.685284640171858,3.125878868997733,AMD1,up,BioPlanet
90,Transcription,1/181,0.35981993847876154,1.0,0,0,2.255045664674709,2.3049984069263645,TAF1,up,BioPlanet
91,Amino acid metabolism,1/195,0.3816330514858885,1.0,0,0,2.093144950287808,2.0163175934069586,AMD1,up,BioPlanet
92,Jak-STAT signaling pathway,1/199,0.3877304897677703,1.0,0,0,2.051071684955389,1.9432771914994016,PTPRD,up,BioPlanet
93,HIV infection,1/200,0.3892456229672477,1.0,0,0,2.0408163265306123,1.9256014553402925,TAF1,up,BioPlanet
94,Phospholipid metabolism,1/205,0.3967663670987994,1.0,0,0,1.9910403185664511,1.8405329367834082,AGPAT5,up,BioPlanet
95,Signaling by NGF,1/221,0.4202282253075736,1.0,0,0,1.8468926031951245,1.6011770647337644,ARHGDIA,up,BioPlanet
96,Gene expression,3/968,0.4253608961359217,1.0,0,0,1.26496879743633,1.0813172158260946,MED13;RPL7;TAF1,up,BioPlanet
97,Wnt signaling pathway,1/231,0.4344354459053535,1.0,0,0,1.7669405424507465,1.4731123178784038,CTBP2,up,BioPlanet
98,Carbohydrate metabolism,1/235,0.44002234091415104,1.0,0,0,1.7368649587494571,1.4258441659642869,SGSH,up,BioPlanet
99,SLC-mediated transmembrane transport,1/251,0.4618342775032575,1.0,0,0,1.6261484673550697,1.2562796307894015,SLC31A1,up,BioPlanet
100,Interleukin-4 regulation of apoptosis,1/267,0.4828132801326793,1.0,0,0,1.5287013681877246,1.1130861173255246,CPT2,up,BioPlanet
101,Disease,2/674,0.4952588985247591,1.0,0,0,1.211166959365349,0.8510562899797944,RPL7;TAF1,up,BioPlanet
102,Oncostatin M,1/311,0.5364611326204128,1.0,0,0,1.3124220749393003,0.8173255013100904,CKS1B,up,BioPlanet
103,Axon guidance,1/325,0.5523581028823527,1.0,0,0,1.2558869701726845,0.7454426448204481,SCN9A,up,BioPlanet
104,Generic transcription pathway,1/377,0.606862501496103,1.0,0,0,1.0826611811833486,0.5407384128248963,MED13,up,BioPlanet
105,Interleukin-2 signaling pathway,2/847,0.6203469895997396,1.0,0,0,0.96378575042768,0.460184851070881,ARHGDIA;TAF1,up,BioPlanet
106,Cell cycle,1/453,0.6750143721437236,1.0,0,0,0.9010226607199172,0.3541210940861416,CKS1B,up,BioPlanet
107,Signal transduction,1/1020,0.9233206555520648,1.0,0,0,0.4001600640256103,0.03192424930458323,ARHGDIA,up,BioPlanet
0,Disease,3/674,0.0051342304007430005,1.0,0,0,8.09279741030483,42.663814298139464,IGFBP2;EPN1;HIST2H2BE,down,BioPlanet
1,Ghrelin-mediated regulation of food intake and energy homeostasis,1/13,0.007128500182420091,1.0,0,0,139.86013986013987,691.4201985706308,IGFBP2,down,BioPlanet
2,Insulin-like growth factor (IGF) activity regulation by insulin-like growth factor binding proteins (IGFBPs),1/17,0.009312583434128836,1.0,0,0,106.951871657754,500.1485279087759,IGFBP2,down,BioPlanet
3,"Endocytotic role of NDK, phosphins and dynamin",1/17,0.009312583434128836,1.0,0,0,106.951871657754,500.1485279087759,EPN1,down,BioPlanet
4,EGFR downregulation,1/27,0.014753702756032041,1.0,0,0,67.34006734006735,283.92331268638986,EPN1,down,BioPlanet
5,RNA polymerase I promoter opening,1/31,0.016922534733463997,1.0,0,0,58.65102639296187,239.24393718954147,HIST2H2BE,down,BioPlanet
6,Packaging of telomere ends,1/32,0.017464064240814415,1.0,0,0,56.81818181818181,229.97783984491127,HIST2H2BE,down,BioPlanet
7,Integrated cancer pathway,1/35,0.01908702632439229,1.0,0,0,51.94805194805194,205.64916492239948,NOXA1,down,BioPlanet
8,ERBB1 internalization pathway,1/41,0.022325642342211446,1.0,0,0,44.345898004434595,168.603963649933,EPN1,down,BioPlanet
9,Deposition of new CENP-A-containing nucleosomes at the centromere,1/45,0.02447931669919003,1.0,0,0,40.4040404040404,149.89602967039846,HIST2H2BE,down,BioPlanet
10,Amyloids,1/51,0.027701743059261864,1.0,0,0,35.650623885918,127.85240432946449,HIST2H2BE,down,BioPlanet
11,Meiotic recombination,1/54,0.029309324971107782,1.0,0,0,33.670033670033675,118.85015337350148,HIST2H2BE,down,BioPlanet
12,Meiotic synapsis,1/55,0.029844648447595826,1.0,0,0,33.057851239669425,116.09090038690742,HIST2H2BE,down,BioPlanet
13,RNA polymerase I transcription,1/55,0.029844648447595826,1.0,0,0,33.057851239669425,116.09090038690742,HIST2H2BE,down,BioPlanet
14,Telomere maintenance,1/59,0.031983259760384464,1.0,0,0,30.816640986132512,106.08760078742485,HIST2H2BE,down,BioPlanet
15,Rac1 cell motility signaling pathway,1/71,0.03837340635379309,1.0,0,0,25.60819462227913,83.49271708519889,NOXA1,down,BioPlanet
16,Meiosis,1/83,0.044725183473176736,1.0,0,0,21.90580503833516,68.0661237096331,HIST2H2BE,down,BioPlanet
17,"RNA polymerase I, RNA polymerase III, and mitochondrial transcription",1/95,0.051038798139041684,1.0,0,0,19.13875598086124,56.94103708431418,HIST2H2BE,down,BioPlanet
18,Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family,1/97,0.052087371500602615,1.0,0,0,18.74414245548266,55.385805983649085,NOXA1,down,BioPlanet
19,Chromosome maintenance,1/103,0.05522677507896637,1.0,0,0,17.652250661959396,51.12634399862731,HIST2H2BE,down,BioPlanet
20,Signaling by EGFR in cancer,1/111,0.05939794346176081,1.0,0,0,16.380016380016382,46.24890540653181,EPN1,down,BioPlanet
21,Prolactin regulation of apoptosis,1/118,0.06303397522541687,1.0,0,0,15.408320493066256,42.58985221359758,MATN2,down,BioPlanet
22,Interleukin-1 regulation of extracellular matrix,1/120,0.06407049195104964,1.0,0,0,15.15151515151515,41.63289947005629,MATN2,down,BioPlanet
23,Integration of energy metabolism,1/125,0.06665722494334128,1.0,0,0,14.545454545454545,39.391881265192424,SYT5,down,BioPlanet
24,Spliceosome,1/127,0.0676900970783306,1.0,0,0,14.316392269148176,38.551401378698,PRPF19,down,BioPlanet
25,"TNF-alpha effects on cytokine activity, cell motility, and apoptosis",1/135,0.07181120313483334,1.0,0,0,13.468013468013467,35.4709061627097,IGFBP2,down,BioPlanet
26,Ubiquitin-mediated proteolysis,1/136,0.07232517529799498,1.0,0,0,13.36898395721925,35.11474604771465,PRPF19,down,BioPlanet
27,Diabetes pathways,1/137,0.07283888870776588,1.0,0,0,13.271400132714,34.76450273204473,IGFBP2,down,BioPlanet
28,Systemic lupus erythematosus,1/139,0.07386553979752421,1.0,0,0,13.080444735120993,34.0812147592173,HIST2H2BE,down,BioPlanet
29,EGF/EGFR signaling pathway,1/141,0.0748911573283546,1.0,0,0,12.894906511927788,33.41998007904706,EPN1,down,BioPlanet
30,Integrated breast cancer pathway,1/152,0.08051362066732018,1.0,0,0,11.961722488038275,30.135513253997498,NOXA1,down,BioPlanet
31,Myometrial relaxation and contraction pathways,1/155,0.08204161892727208,1.0,0,0,11.730205278592374,29.33171393059459,IGFBP2,down,BioPlanet
32,Transcription,1/181,0.09518789678290693,1.0,0,0,10.04520341536916,23.625338823711104,HIST2H2BE,down,BioPlanet
33,Endocytosis,1/201,0.10518369495092053,1.0,0,0,9.045680687471732,20.37129788920578,EPN1,down,BioPlanet
34,BDNF signaling pathway,1/261,0.1345717890784102,1.0,0,0,6.966213862765587,13.971838903086455,PRPF19,down,BioPlanet
35,Interleukin-4 regulation of apoptosis,1/267,0.1374617975671696,1.0,0,0,6.8096697310180465,13.513171510753686,HIST2H2BE,down,BioPlanet
36,Oncostatin M,1/311,0.15838857498040515,1.0,0,0,5.846243788365975,10.772896403695366,IGFBP2,down,BioPlanet
37,Cell cycle,1/453,0.22281600681861152,1.0,0,0,4.013646397752358,6.0261245419226075,HIST2H2BE,down,BioPlanet
38,Gene expression,1/968,0.4206534295830525,1.0,0,0,1.8782870022539444,1.6264951013569515,HIST2H2BE,down,BioPlanet
39,Signal transduction,1/1020,0.4378339765177089,1.0,0,0,1.7825311942959,1.4722201239024355,EPN1,down,BioPlanet
0,MAX ENCODE,13/2073,0.001124700635438692,0.11696886608562394,0,0,2.5596345629423984,17.38052884952346,AGPAT5;AMD1;SDR39U1;GPATCH4;CABIN1;RPL7;CKS1B;GGA1;AP3M1;ADAM15;SCFD2;ARHGDIA;SCAP,up,Encode/ChEA TFs
1,NRF1 ENCODE,12/1882,0.0015828857844187153,0.08231006078977321,0,0,2.6025287904747447,16.782421614954096,AGPAT5;COX15;ARHGDIA;RBM12B;ZC3H8;SDR39U1;SCAP;TCTA;CCDC93;RPL7;CKS1B;OTUD3,up,Encode/ChEA TFs
2,SPI1 ENCODE,10/1540,0.0036514547487217454,0.1265837646223538,0,0,2.65041081367612,14.875774263181984,PURB;GGA1;TPPP3;SCFD2;ZDHHC6;ZC3H8;UBAP1;GPATCH4;ABCA7;RPL7,up,Encode/ChEA TFs
3,ERG CHEA,3/144,0.005286650609673479,0.13745291585151045,0,0,8.503401360544219,44.57968017610904,PURB;SETD8;CCDC93,up,Encode/ChEA TFs
4,UBTF ENCODE,10/1631,0.005487583049570186,0.11414172743105985,0,0,2.5025338154881815,13.026357603016407,AGPAT5;PURB;MED13;ADAM15;AMD1;SCAP;TCTA;AFF1;RPL7;OTUD3,up,Encode/ChEA TFs
5,GABPA ENCODE,11/2082,0.010610462330359541,0.18391468039289868,0,0,2.1564821894175537,9.803184198036913,PURB;GGA1;SETD8;CPT2;COX15;AMD1;ZDHHC6;SDR39U1;GPATCH4;CKS1B;DIS3L2,up,Encode/ChEA TFs
6,MYC CHEA,5/573,0.012815720016023876,0.19040498309521187,0,0,3.561634077714856,15.518334349591678,SETD8;ZC3H8;GPATCH4;RPL7;CKS1B,up,Encode/ChEA TFs
7,ELF1 ENCODE,12/2483,0.014732875540272843,0.19152738202354694,0,0,1.972597335349766,8.319772199810668,PURB;GGA1;KBTBD6;CPT2;COX15;SCFD2;ARHGDIA;ZDHHC6;GPATCH4;CKS1B;DIS3L2;TAF1,up,Encode/ChEA TFs
8,NFYA ENCODE,11/2250,0.01827758042420892,0.2112075960130808,0,0,1.9954648526077097,7.986010144206818,AGPAT5;MED13;SETD8;SCFD2;AMD1;ABCA7;TCTA;CCDC66;CABIN1;CKS1B;TAF1,up,Encode/ChEA TFs
9,CHD1 ENCODE,5/655,0.021603330103300244,0.2246746330743225,0,0,3.1157501168406294,11.948614440648475,MED13;SDR39U1;TCTA;AFF1;CKS1B,up,Encode/ChEA TFs
10,NFYB ENCODE,15/3715,0.02872740014633288,0.27160451047442,0,0,1.6480347185980717,5.850364879385536,AGPAT5;SETD8;SLC31A1;AMD1;SDR39U1;ABCA7;CABIN1;CKS1B;AP3M1;MED13;SCFD2;UBAP1;TCTA;CCDC66;TAF1,up,Encode/ChEA TFs
11,USF2 ENCODE,6/965,0.02966539122832108,0.25710005731211605,0,0,2.537802685841176,8.927416790473305,MED13;ARHGDIA;SCAP;TCTA;SGSH;OTUD3,up,Encode/ChEA TFs
12,MYC ENCODE,8/1515,0.02968363556553245,0.2374690845242596,0,0,2.155317572573584,7.5805954088165475,AGPAT5;PURB;AP3M1;SCFD2;ARHGDIA;SCAP;GPATCH4;RPL7,up,Encode/ChEA TFs
13,STAT3 ENCODE,5/725,0.0316681882015831,0.23524939806890305,0,0,2.8149190710767065,9.718346597418584,UBAP1;AFF1;CABIN1;CKS1B;TAF1,up,Encode/ChEA TFs
14,PPARD CHEA,3/285,0.03260220262576699,0.2260419382053178,0,0,4.296455424274973,14.708379925603971,SLC31A1;SCN9A;MTUS1,up,Encode/ChEA TFs
15,CEBPD ENCODE,5/734,0.03314530453805993,0.21544447949738954,0,0,2.7804037146193634,9.472430115321936,GGA1;AMD1;SCN9A;UBAP1;AFF1,up,Encode/ChEA TFs
16,SP2 ENCODE,6/994,0.03361169756909447,0.20562450277563676,0,0,2.4637621648256887,8.359252159478467,GGA1;SETD8;AMD1;GPATCH4;ABCA7;CKS1B,up,Encode/ChEA TFs
17,E2F6 ENCODE,13/3245,0.04499523990360688,0.25997249722083976,0,0,1.635168705386623,5.070982858582788,AGPAT5;ZC3H8;MLF1;CKS1B;GGA1;ADAM15;ARHGDIA;RBM12B;SCAP;CCDC66;MEST;DIS3L2;OTUD3,up,Encode/ChEA TFs
18,BHLHE40 ENCODE,3/348,0.05349384897448202,0.2928084364919016,0,0,3.518648838845883,10.303267431842373,AGPAT5;ARHGDIA;SCAP,up,Encode/ChEA TFs
19,NR2C2 ENCODE,3/350,0.05424214265482268,0.2820591418050779,0,0,3.4985422740524785,10.195791718625411,SDR39U1;SCAP;DIS3L2,up,Encode/ChEA TFs
20,USF1 ENCODE,7/1423,0.056954387140544474,0.28205982202936314,0,0,2.0078305391025,5.753447559689776,MED13;SCFD2;ARHGDIA;SDR39U1;SGSH;TAF1;OTUD3,up,Encode/ChEA TFs
21,MYOD1 ENCODE,2/166,0.062483688640958025,0.29537743721180154,0,0,4.917629702483403,13.635848232338901,PURB;TPPP3,up,Encode/ChEA TFs
22,IRF3 ENCODE,4/663,0.07867477050303724,0.35574678836155976,0,0,2.4625234709268327,6.260800327666296,AGPAT5;SETD8;ABCA7;CKS1B,up,Encode/ChEA TFs
23,ATF2 ENCODE,11/2852,0.0809688902046764,0.3508651908869311,0,0,1.5742622434668117,3.9572076832504175,PURB;GGA1;AP3M1;MED13;KBTBD6;SLC31A1;ZDHHC6;UBAP1;ABCA7;RPL7;CKS1B,up,Encode/ChEA TFs
24,CREB1 ENCODE,9/2238,0.09125703550711478,0.3796292677095975,0,0,1.6414072331345408,3.9296523303231385,ZNF672;PURB;GGA1;KBTBD6;SCFD2;SLC31A1;AMD1;UBAP1;MLF1,up,Encode/ChEA TFs
25,ZNF384 ENCODE,4/730,0.10299047816594016,0.41196191266376064,0,0,2.236511042773274,5.083855163582165,AP3M1;SETD8;CCDC93;CABIN1,up,Encode/ChEA TFs
26,SPI1 CHEA,5/1056,0.11505810689506164,0.4431867821143115,0,0,1.932591218305504,4.178876779684873,PURB;GGA1;ZC3H8;UBAP1;CKS1B,up,Encode/ChEA TFs
27,IRF1 ENCODE,2/263,0.1357495194825122,0.5042125009350453,0,0,3.1039031582214642,6.1983203535284375,SLC31A1;CKS1B,up,Encode/ChEA TFs
28,CTCF ENCODE,7/1790,0.14475677912639165,0.5191277596256804,0,0,1.5961691939345573,3.0849167283044405,GGA1;AP3M1;MED13;COX15;ARHGDIA;SCAP;OTUD3,up,Encode/ChEA TFs
29,BRCA1 ENCODE,11/3218,0.15393375606311574,0.5336370210188013,0,0,1.395213150518131,2.6107687840093736,PURB;GGA1;KBTBD6;COX15;AMD1;RBM12B;ABCA7;TCTA;CCDC93;MEST;CKS1B,up,Encode/ChEA TFs
30,TCF7L2 ENCODE,3/583,0.17110580529814784,0.574032379064754,0,0,2.100325550460321,3.7080684063204616,AP3M1;SCFD2;CKS1B,up,Encode/ChEA TFs
31,ZMIZ1 ENCODE,4/914,0.18459816945223134,0.5999440507197521,0,0,1.7862724958692449,3.0180393395364438,CPT2;AMD1;TCTA;AFF1,up,Encode/ChEA TFs
32,YY1 CHEA,2/332,0.19536524260765809,0.6156965221574681,0,0,2.4588148512417014,4.014960495094728,GPATCH4;KLHL41,up,Encode/ChEA TFs
33,REST CHEA,5/1280,0.20272347650534006,0.6200953398986874,0,0,1.5943877551020411,2.5445032099172264,ZNF672;PTPRD;CTBP2;SCAP;AFF1,up,Encode/ChEA TFs
34,RUNX1 CHEA,5/1294,0.2088602618784944,0.620613349581812,0,0,1.5771378103018645,2.469939523206752,AGPAT5;PURB;KBTBD6;SCFD2;TCTA,up,Encode/ChEA TFs
35,ZEB1 ENCODE,1/106,0.2294909406653387,0.6629738285887562,0,0,3.8505968425105888,5.667661626822366,GGA1,up,Encode/ChEA TFs
36,REST ENCODE,2/383,0.24130650218646166,0.6782669250646489,0,0,2.1314008632173502,3.030185666820973,AGPAT5;SCAP,up,Encode/ChEA TFs
37,SP1 ENCODE,3/707,0.24986172391789604,0.6838320865121365,0,0,1.7319516208180583,2.401952980631467,SETD8;ABCA7;CABIN1,up,Encode/ChEA TFs
38,CREB1 CHEA,5/1444,0.2781327034135631,0.7416872091028349,0,0,1.4133077053536096,1.8085489976517355,PURB;GGA1;SLC31A1;UBAP1;MLF1,up,Encode/ChEA TFs
39,ZBTB7A ENCODE,7/2184,0.2843828307603589,0.7393953599769331,0,0,1.3082155939298796,1.6449947055420302,AGPAT5;ZNF672;GGA1;AP3M1;SCN9A;CKS1B;SGSH,up,Encode/ChEA TFs
40,SOX2 CHEA,3/775,0.295311399610284,0.7490825746212083,0,0,1.579986833443055,1.927149262654508,AGPAT5;ARHGDIA;MTUS1,up,Encode/ChEA TFs
41,TAF1 ENCODE,10/3346,0.2979012969945936,0.7376603544628032,0,0,1.2198543493906828,1.4772351580083722,ZNF672;PURB;COX15;ARHGDIA;AMD1;RBM12B;ZDHHC6;UBAP1;TCTA;RPL7,up,Encode/ChEA TFs
42,SIN3A ENCODE,4/1131,0.2999557156087426,0.7254742889141682,0,0,1.4435482415777985,1.73820592917169,SETD8;SCFD2;AMD1;GPATCH4,up,Encode/ChEA TFs
43,SMC3 ENCODE,4/1181,0.3280559634217473,0.7754050044514027,0,0,1.3824327360071886,1.5408195268122251,MED13;SETD8;ARHGDIA;SCAP,up,Encode/ChEA TFs
44,HDAC2 ENCODE,1/175,0.35024234803788656,0.8094489821320046,0,0,2.332361516034985,2.4469503000523978,ARHGDIA,up,Encode/ChEA TFs
45,FOSL2 ENCODE,1/196,0.3831629644986655,0.8662814849535047,0,0,2.0824656393169514,1.9976986370765084,KLHL41,up,Encode/ChEA TFs
46,RFX5 ENCODE,2/559,0.3995745396069892,0.8841649387048273,0,0,1.4603336862473075,1.3396443341752111,AMD1;CABIN1,up,Encode/ChEA TFs
47,SMAD4 CHEA,2/584,0.421102643134444,0.9123890601246284,0,0,1.3978194017332959,1.2089441810117167,PTPRD;TAF1,up,Encode/ChEA TFs
48,NANOG CHEA,2/595,0.4304571409327214,0.9136233195306741,0,0,1.371977362373521,1.1564500312900794,MTUS1;CKS1B,up,Encode/ChEA TFs
49,KLF4 CHEA,3/987,0.4378868669661632,0.9108046832896192,0,0,1.2406178276781838,1.0244956225634725,AGPAT5;TPPP3;DIS3L2,up,Encode/ChEA TFs
50,NELFE ENCODE,1/234,0.43863070679511895,0.8944626177782821,0,0,1.7442874585731731,1.4374628196689632,AMD1,up,Encode/ChEA TFs
51,TP63 CHEA,4/1399,0.4511046538263692,0.9022093076527382,0,0,1.167014339688699,0.9290086715035828,CPT2;SCN9A;MTUS1;SCAP,up,Encode/ChEA TFs
52,FOS ENCODE,2/637,0.4654522690357789,0.91334030150417,0,0,1.2815173165027394,0.9800348886712046,SETD8;CKS1B,up,Encode/ChEA TFs
53,BCL3 ENCODE,1/273,0.490472063958325,0.9446128639197372,0,0,1.4951035359198626,1.0650922565778227,ABCA7,up,Encode/ChEA TFs
54,RCOR1 ENCODE,2/702,0.5171344569754411,0.9778542459171978,0,0,1.162858305715449,0.7668496619189659,SCAP;ABCA7,up,Encode/ChEA TFs
55,ZBTB33 ENCODE,2/702,0.5171344569754411,0.9603925629543908,0,0,1.162858305715449,0.7668496619189659,GGA1;KBTBD6,up,Encode/ChEA TFs
56,YY1 ENCODE,7/2753,0.5202668849249587,0.9492588777578194,0,0,1.0378288620206528,0.6781312426226801,MED13;ARHGDIA;AMD1;RBM12B;UBAP1;GPATCH4;OTUD3,up,Encode/ChEA TFs
57,EGR1 CHEA,1/315,0.5410587077323515,0.9701742345545614,0,0,1.2957563977972142,0.7958891985200668,AFF1,up,Encode/ChEA TFs
58,PML ENCODE,4/1596,0.5565839462828961,0.9810971256512068,0,0,1.0229655772083268,0.5993936604503582,ZNF672;MED13;CPT2;AMD1,up,Encode/ChEA TFs
59,RAD21 ENCODE,3/1265,0.6067456956884828,1.0,0,0,0.9679761232556264,0.483644941626313,GGA1;MED13;SCAP,up,Encode/ChEA TFs
60,PBX3 ENCODE,3/1269,0.6089329951158075,1.0,0,0,0.9649249770830318,0.4786481804079266,SETD8;AMD1;ABCA7,up,Encode/ChEA TFs
61,HNF4A ENCODE,3/1276,0.6127422302372879,1.0,0,0,0.9596315015034228,0.4700380047395691,COX15;SLC31A1;MTUS1,up,Encode/ChEA TFs
62,BCLAF1 ENCODE,2/851,0.6229481474130114,1.0,0,0,0.9592556176407108,0.4540080041586028,GGA1;AMD1,up,Encode/ChEA TFs
63,TCF3 CHEA,2/1006,0.7136454463848407,1.0,0,0,0.8114577839087921,0.27376071218955506,SCFD2;TAF1,up,Encode/ChEA TFs
64,EGR1 ENCODE,1/537,0.7369093268854613,1.0,0,0,0.7600805685402653,0.2320453193233541,KBTBD6,up,Encode/ChEA TFs
65,SIX5 ENCODE,2/1094,0.7567447765409439,1.0,0,0,0.7461851285303884,0.2079836089943657,KBTBD6;RPL7,up,Encode/ChEA TFs
66,AR CHEA,2/1095,0.7572016453742739,1.0,0,0,0.7455036809244245,0.20734372317770536,UBAP1;RPL7,up,Encode/ChEA TFs
67,TAF7 ENCODE,1/640,0.7972087141369496,1.0,0,0,0.6377551020408164,0.1445400253659436,AMD1,up,Encode/ChEA TFs
68,FLI1 ENCODE,1/650,0.8022844074250245,1.0,0,0,0.6279434850863422,0.13833099607844895,AMD1,up,Encode/ChEA TFs
69,E2F4 ENCODE,1/710,0.8302261031836171,1.0,0,0,0.5748778384593275,0.1069601620092379,CKS1B,up,Encode/ChEA TFs
70,GATA1 CHEA,1/807,0.8674257333373279,1.0,0,0,0.5057785195862732,0.07193454255451331,AFF1,up,Encode/ChEA TFs
71,TCF3 ENCODE,1/840,0.8781590552698343,1.0,0,0,0.4859086491739554,0.06313291808069707,PURB,up,Encode/ChEA TFs
72,E2F1 CHEA,1/859,0.8839476671146219,1.0,0,0,0.4751609607754627,0.05861462934758978,KBTBD6,up,Encode/ChEA TFs
73,NFE2L2 CHEA,1/1022,0.92371606561232,1.0,0,0,0.3993769719237989,0.031690779528547965,SCFD2,up,Encode/ChEA TFs
74,SUZ12 CHEA,1/1684,0.9866356227845148,1.0,0,0,0.24237723593000146,0.0032610606963974303,DNAJA4,up,Encode/ChEA TFs
0,FOXP2 ENCODE,2/178,0.004109370718411461,0.4273745547147919,0,0,20.42900919305413,112.2468921771617,UBALD1;EPN1,down,Encode/ChEA TFs
1,BCL3 ENCODE,2/273,0.009413187820526948,0.4894857666674012,0,0,13.320013320013318,62.146435075644376,EPN1;HIST2H2BE,down,Encode/ChEA TFs
2,SIX5 ENCODE,3/1094,0.01934823833515328,0.6707389289519803,0,0,4.9858733588166855,19.670037755169712,SYT5;UBALD1;PRPF19,down,Encode/ChEA TFs
3,GABPA ENCODE,4/2082,0.02120855893765033,0.5514225323789087,0,0,3.4931447035193433,13.460310733750731,NOXA1;UBALD1;PRPF19;EPN1,down,Encode/ChEA TFs
4,FLI1 ENCODE,2/650,0.04776050318731325,0.9934184662961154,0,0,5.594405594405594,17.01569943611483,PRPF19;EPN1,down,Encode/ChEA TFs
5,ZBTB33 ENCODE,2/702,0.054852843457308016,0.9507826199266723,0,0,5.18000518000518,15.03807952860564,UBALD1;HIST2H2BE,down,Encode/ChEA TFs
6,SUZ12 ENCODE,1/105,0.0562711406066492,0.8360283747273595,0,0,17.316017316017316,49.828112129836285,CDK5R2,down,Encode/ChEA TFs
7,SOX2 CHEA,2/775,0.06541687186768153,0.8504193342798598,0,0,4.6920821114369495,12.79519096380926,IGFBP2;HIST2H2BE,down,Encode/ChEA TFs
8,CTCF ENCODE,3/1790,0.06847495843928869,0.7912661864095583,0,0,3.0472320975114267,8.170504329447656,NOXA1;HIST2H2BE;MATN2,down,Encode/ChEA TFs
9,BCLAF1 ENCODE,2/851,0.07711024364853991,0.801946533944815,0,0,4.273047751308622,10.949766671891636,EPN1;HIST2H2BE,down,Encode/ChEA TFs
10,BRCA1 ENCODE,4/3218,0.08595078576076706,0.8126256108290704,0,0,2.2600146900954847,5.54603176479305,UBALD1;PRPF19;EPN1;HIST2H2BE,down,Encode/ChEA TFs
11,FOXA1 ENCODE,1/205,0.10717076670990663,0.9288133114858574,0,0,8.869179600886918,19.80782054222685,UBALD1,down,Encode/ChEA TFs
12,TRIM28 CHEA,1/210,0.10964896506938844,0.8771917205551076,0,0,8.658008658008658,19.138279157181405,IGFBP2,down,Encode/ChEA TFs
13,CREB1 ENCODE,3/2238,0.11648710004693295,0.8653327432057875,0,0,2.4372410431391662,5.2400066812532025,UBALD1;EPN1;HIST2H2BE,down,Encode/ChEA TFs
14,NFYA ENCODE,3/2250,0.11793016662704554,0.8176491552808491,0,0,2.424242424242424,5.182212455635079,UBALD1;CDK5R2;HIST2H2BE,down,Encode/ChEA TFs
15,STAT5A ENCODE,1/233,0.12096833412743813,0.7862941718283478,0,0,7.803355442840421,16.482453913861264,HIST2H2BE,down,Encode/ChEA TFs
16,NELFE ENCODE,1/234,0.1214574995857652,0.7430341151129165,0,0,7.77000777000777,16.38065947974378,HIST2H2BE,down,Encode/ChEA TFs
17,EZH2 CHEA,1/237,0.12292351156490608,0.710224733486124,0,0,7.671653241273494,16.08126562515525,CDK5R2,down,Encode/ChEA TFs
18,SIN3A ENCODE,2/1131,0.12529408898652125,0.6858202765578005,0,0,3.2151756289687317,6.678214269209817,PRPF19;HIST2H2BE,down,Encode/ChEA TFs
19,NFIC ENCODE,1/279,0.14321551004652938,0.7447206522419527,0,0,6.516780710329098,12.66474239126716,HIST2H2BE,down,Encode/ChEA TFs
20,ELF1 ENCODE,3/2483,0.14739914571873608,0.7299767216546931,0,0,2.196756123457694,4.205933646784338,NOXA1;UBALD1;EPN1,down,Encode/ChEA TFs
21,PBX3 ENCODE,2/1269,0.15138059251919286,0.7156173464543663,0,0,2.8655347804283973,5.410009694077539,CDK5R2;HIST2H2BE,down,Encode/ChEA TFs
22,SRF ENCODE,1/299,0.15272754050288706,0.6905940961869675,0,0,6.0808756460930375,11.4265717609731,UBALD1,down,Encode/ChEA TFs
23,FOXA2 ENCODE,1/316,0.16073717384762146,0.696527753339693,0,0,5.7537399309551205,10.517748610397721,UBALD1,down,Encode/ChEA TFs
24,CREB1 CHEA,2/1444,0.1860604963859059,0.7740116649653686,0,0,2.518257365902795,4.234911631237623,UBALD1;EPN1,down,Encode/ChEA TFs
25,REST ENCODE,1/383,0.19163880649556414,0.7665552259822567,0,0,4.747211013529551,7.8430709462746595,SYT5,down,Encode/ChEA TFs
26,EGR1 ENCODE,1/537,0.2587836914508432,0.9967964411439886,0,0,3.385813441679363,4.576816436002288,SYT5,down,Encode/ChEA TFs
27,TAF1 ENCODE,3/3346,0.2752247751659569,1.0,0,0,1.6301689941857305,2.103190486772746,UBALD1;PRPF19;HIST2H2BE,down,Encode/ChEA TFs
28,NANOG CHEA,1/595,0.2827280861193852,1.0,0,0,3.0557677616501144,3.860258730822833,IGFBP2,down,Encode/ChEA TFs
29,FOS ENCODE,1/637,0.2996257802127125,1.0,0,0,2.8542885685742827,3.440048472290516,UBALD1,down,Encode/ChEA TFs
30,TAF7 ENCODE,1/640,0.3008187968356142,1.0,0,0,2.8409090909090913,3.4126340891441425,HIST2H2BE,down,Encode/ChEA TFs
31,CHD1 ENCODE,1/655,0.3067562154281689,0.9969577001415488,0,0,2.7758501040943786,3.280227434842115,HIST2H2BE,down,Encode/ChEA TFs
32,MAX ENCODE,2/2073,0.3181974801847122,1.0,0,0,1.7541551550234618,2.0086533913551183,UBALD1;PRPF19,down,Encode/ChEA TFs
33,SP1 ENCODE,1/707,0.32698614164953194,1.0,0,0,2.571685740002572,2.8747267307692264,SYT5,down,Encode/ChEA TFs
34,STAT3 ENCODE,1/725,0.3338627745037221,0.9920493870967744,0,0,2.5078369905956106,2.751160439394762,HIST2H2BE,down,Encode/ChEA TFs
35,NFYB ENCODE,3/3715,0.3353517202834014,0.9687938585964928,0,0,1.4682491129328277,1.6041728422386743,UBALD1;PRPF19;HIST2H2BE,down,Encode/ChEA TFs
36,ZNF384 ENCODE,1/730,0.3357615808126385,0.943762281203092,0,0,2.4906600249066,2.7181916607855348,UBALD1,down,Encode/ChEA TFs
37,CEBPD ENCODE,1/734,0.3372770816786211,0.9230741182783312,0,0,2.4770869457517954,2.692223149925556,HIST2H2BE,down,Encode/ChEA TFs
38,ZBTB7A ENCODE,2/2184,0.3418001348558801,0.9114670262823468,0,0,1.6650016650016648,1.7874277618290988,C19ORF60;NOXA1,down,Encode/ChEA TFs
39,E2F1 CHEA,1/859,0.3830816620188029,0.9960123212488874,0,0,2.1166260979997884,2.0309177601220814,PRPF19,down,Encode/ChEA TFs
40,ZMIZ1 ENCODE,1/914,0.4023081084240304,1.0,0,0,1.9892580067634766,1.811293107343637,HIST2H2BE,down,Encode/ChEA TFs
41,SP2 ENCODE,1/994,0.4293024745749882,1.0,0,0,1.829156758734224,1.5467231380264952,CDK5R2,down,Encode/ChEA TFs
42,NFE2L2 CHEA,1/1022,0.4384854186235934,1.0,0,0,1.7790428749332856,1.466694041232205,MATN2,down,Encode/ChEA TFs
43,AR CHEA,1/1095,0.4617985732177806,1.0,0,0,1.6604400166044,1.2828999114607071,MATN2,down,Encode/ChEA TFs
44,ATF2 ENCODE,2/2852,0.4791755174263542,1.0,0,0,1.2750223128904754,0.9380190284313128,UBALD1;HIST2H2BE,down,Encode/ChEA TFs
45,SMC3 ENCODE,1/1181,0.4881324734759645,1.0,0,0,1.5395273650989143,1.1041004509694898,NOXA1,down,Encode/ChEA TFs
46,RAD21 ENCODE,1/1265,0.5127176986034785,1.0,0,0,1.4372978799856269,0.9601579308648546,HIST2H2BE,down,Encode/ChEA TFs
47,REST CHEA,1/1280,0.5169932047081399,1.0,0,0,1.4204545454545454,0.9371101537756756,CDK5R2,down,Encode/ChEA TFs
48,E2F6 ENCODE,2/3245,0.5535160855883952,1.0,0,0,1.1206051267684551,0.6627981125297572,C19ORF60;UBALD1,down,Encode/ChEA TFs
49,MYC ENCODE,1/1515,0.5796734000163849,1.0,0,0,1.2001200120012,0.6544139663534009,UBALD1,down,Encode/ChEA TFs
50,PML ENCODE,1/1596,0.5995007483234265,1.0,0,0,1.1392116655274551,0.5828868264632392,HIST2H2BE,down,Encode/ChEA TFs
51,UBTF ENCODE,1/1631,0.6078019355653598,1.0,0,0,1.1147650632629171,0.5550484521055797,UBALD1,down,Encode/ChEA TFs
52,SUZ12 CHEA,1/1684,0.6200748442737805,1.0,0,0,1.0796804145972791,0.5159955643036548,CDK5R2,down,Encode/ChEA TFs
53,YY1 ENCODE,1/2753,0.8039662950400369,1.0,0,0,0.6604365485585972,0.14410588929359644,UBALD1,down,Encode/ChEA TFs
0,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),2/58,0.008906341303457722,1.0,0,0,14.074595355383533,66.44604855664258,PTPRD;ARHGDIA,up,GO BP
1,negative regulation of T cell differentiation in thymus (GO:0033085),1/6,0.014611943812165882,1.0,0,0,68.02721088435375,287.4772799576697,ZC3H8,up,GO BP
2,polyamine biosynthetic process (GO:0006596),1/6,0.014611943812165882,1.0,0,0,68.02721088435375,287.4772799576697,AMD1,up,GO BP
3,white fat cell differentiation (GO:0050872),1/6,0.014611943812165882,1.0,0,0,68.02721088435375,287.4772799576697,CTBP2,up,GO BP
4,positive regulation of amyloid-beta clearance (GO:1900223),1/6,0.014611943812165882,1.0,0,0,68.02721088435375,287.4772799576697,ABCA7,up,GO BP
5,spermine metabolic process (GO:0008215),1/6,0.014611943812165882,1.0,0,0,68.02721088435375,287.4772799576697,AMD1,up,GO BP
6,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/6,0.014611943812165882,1.0,0,0,68.02721088435375,287.4772799576697,PTPRD,up,GO BP
7,regulation of thymocyte apoptotic process (GO:0070243),1/6,0.014611943812165882,1.0,0,0,68.02721088435375,287.4772799576697,ZC3H8,up,GO BP
8,SREBP signaling pathway (GO:0032933),1/6,0.014611943812165882,1.0,0,0,68.02721088435375,287.4772799576697,SCAP,up,GO BP
9,snRNA transcription from RNA polymerase III promoter (GO:0042796),1/6,0.014611943812165882,1.0,0,0,68.02721088435375,287.4772799576697,ZC3H8,up,GO BP
10,positive regulation of phospholipid transport (GO:2001140),1/6,0.014611943812165882,1.0,0,0,68.02721088435375,287.4772799576697,ABCA7,up,GO BP
11,viral process (GO:0016032),3/220,0.016685958195123637,1.0,0,0,5.565862708719852,22.782121001252648,CTBP2;UBAP1;RPL7,up,GO BP
12,spermidine metabolic process (GO:0008216),1/7,0.01702685745129035,1.0,0,0,58.30903790087464,237.4905732653241,AMD1,up,GO BP
13,negative regulation of glycoprotein biosynthetic process (GO:0010561),1/7,0.01702685745129035,1.0,0,0,58.30903790087464,237.4905732653241,ABCA7,up,GO BP
14,positive regulation of apoptotic cell clearance (GO:2000427),1/7,0.01702685745129035,1.0,0,0,58.30903790087464,237.4905732653241,ABCA7,up,GO BP
15,regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),1/7,0.01702685745129035,1.0,0,0,58.30903790087464,237.4905732653241,TAF1,up,GO BP
16,regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714),1/7,0.01702685745129035,1.0,0,0,58.30903790087464,237.4905732653241,SCAP,up,GO BP
17,cellular response to sterol depletion (GO:0071501),1/7,0.01702685745129035,1.0,0,0,58.30903790087464,237.4905732653241,SCAP,up,GO BP
18,regulation of receptor binding (GO:1900120),1/8,0.019435974184612268,1.0,0,0,51.020408163265316,201.05253013595427,ADAM15,up,GO BP
19,viral mRNA export from host cell nucleus (GO:0046784),1/8,0.019435974184612268,1.0,0,0,51.020408163265316,201.05253013595427,THOC3,up,GO BP
20,translocation of molecules into host (GO:0044417),1/8,0.019435974184612268,1.0,0,0,51.020408163265316,201.05253013595427,THOC3,up,GO BP
21,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",1/9,0.021839307484116888,1.0,0,0,45.351473922902485,173.42602436330466,RPL7,up,GO BP
22,regulation of skeletal muscle cell differentiation (GO:2001014),1/9,0.021839307484116888,1.0,0,0,45.351473922902485,173.42602436330466,KLHL41,up,GO BP
23,negative regulation of alcohol biosynthetic process (GO:1902931),1/9,0.021839307484116888,1.0,0,0,45.351473922902485,173.42602436330466,SCAP,up,GO BP
24,negative regulation of amyloid-beta formation (GO:1902430),1/9,0.021839307484116888,1.0,0,0,45.351473922902485,173.42602436330466,ABCA7,up,GO BP
25,regulation of amyloid precursor protein biosynthetic process (GO:0042984),1/9,0.021839307484116888,1.0,0,0,45.351473922902485,173.42602436330466,ABCA7,up,GO BP
26,mRNA metabolic process (GO:0016071),2/97,0.023615958347704524,1.0,0,0,8.415737428992216,31.523943566569788,PABPC3;DIS3L2,up,GO BP
27,cellular biogenic amine metabolic process (GO:0006576),1/10,0.024236870821197704,1.0,0,0,40.81632653061225,151.83184561831845,AMD1,up,GO BP
28,cytochrome complex assembly (GO:0017004),1/10,0.024236870821197704,1.0,0,0,40.81632653061225,151.83184561831845,COX15,up,GO BP
29,cellular response to ATP (GO:0071318),1/10,0.024236870821197704,1.0,0,0,40.81632653061225,151.83184561831845,TAF1,up,GO BP
30,T cell homeostasis (GO:0043029),1/10,0.024236870821197704,1.0,0,0,40.81632653061225,151.83184561831845,ZC3H8,up,GO BP
31,negative regulation of inclusion body assembly (GO:0090084),1/10,0.024236870821197704,1.0,0,0,40.81632653061225,151.83184561831845,DNAJA4,up,GO BP
32,positive regulation of transcription from RNA polymerase III promoter (GO:0045945),1/10,0.024236870821197704,1.0,0,0,40.81632653061225,151.83184561831845,ZC3H8,up,GO BP
33,regulation of amyloid-beta clearance (GO:1900221),1/10,0.024236870821197704,1.0,0,0,40.81632653061225,151.83184561831845,ABCA7,up,GO BP
34,positive regulation of T cell apoptotic process (GO:0070234),1/10,0.024236870821197704,1.0,0,0,40.81632653061225,151.83184561831845,ZC3H8,up,GO BP
35,"regulation of DNA-templated transcription, initiation (GO:2000142)",1/10,0.024236870821197704,1.0,0,0,40.81632653061225,151.83184561831845,TAF1,up,GO BP
36,protein K11-linked deubiquitination (GO:0035871),1/10,0.024236870821197704,1.0,0,0,40.81632653061225,151.83184561831845,OTUD3,up,GO BP
37,positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),1/10,0.024236870821197704,1.0,0,0,40.81632653061225,151.83184561831845,TAF1,up,GO BP
38,presynaptic membrane assembly (GO:0097105),1/10,0.024236870821197704,1.0,0,0,40.81632653061225,151.83184561831845,PTPRD,up,GO BP
39,presynaptic membrane organization (GO:0097090),1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,PTPRD,up,GO BP
40,protein kinase C signaling (GO:0070528),1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,ADAM15,up,GO BP
41,carnitine shuttle (GO:0006853),1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,CPT2,up,GO BP
42,regulation of hemopoiesis (GO:1903706),1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,PURB,up,GO BP
43,positive regulation of receptor biosynthetic process (GO:0010870),1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,SCAP,up,GO BP
44,negative regulation of amyloid precursor protein catabolic process (GO:1902992),1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,ABCA7,up,GO BP
45,fatty acid transmembrane transport (GO:1902001),1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,CPT2,up,GO BP
46,regulation of inclusion body assembly (GO:0090083),1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,DNAJA4,up,GO BP
47,RNA polymerase II transcriptional preinitiation complex assembly (GO:0051123),1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,TAF1,up,GO BP
48,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000059),1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,TAF1,up,GO BP
49,negative regulation of T cell differentiation (GO:0045581),1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,ZC3H8,up,GO BP
50,negative regulation of receptor binding (GO:1900121),1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,ADAM15,up,GO BP
51,viral life cycle (GO:0019058),2/107,0.02832391378045997,1.0,0,0,7.629219912263972,27.1909122353048,CTBP2;UBAP1,up,GO BP
52,modification-dependent macromolecule catabolic process (GO:0043632),1/12,0.029014741507151907,1.0,0,0,34.013605442176875,120.40650511284572,DIS3L2,up,GO BP
53,skeletal muscle cell differentiation (GO:0035914),1/12,0.029014741507151907,1.0,0,0,34.013605442176875,120.40650511284572,KLHL41,up,GO BP
54,regulation of skeletal muscle tissue development (GO:0048641),1/12,0.029014741507151907,1.0,0,0,34.013605442176875,120.40650511284572,KLHL41,up,GO BP
55,regulation of T cell differentiation in thymus (GO:0033081),1/12,0.029014741507151907,1.0,0,0,34.013605442176875,120.40650511284572,ZC3H8,up,GO BP
56,phospholipid efflux (GO:0033700),1/12,0.029014741507151907,1.0,0,0,34.013605442176875,120.40650511284572,ABCA7,up,GO BP
57,skeletal muscle fiber development (GO:0048741),1/12,0.029014741507151907,1.0,0,0,34.013605442176875,120.40650511284572,KLHL41,up,GO BP
58,polyamine metabolic process (GO:0006595),1/12,0.029014741507151907,1.0,0,0,34.013605442176875,120.40650511284572,AMD1,up,GO BP
59,transcription from RNA polymerase II promoter (GO:0006366),4/485,0.030683649963338312,1.0,0,0,3.3662949715968864,11.728256985453374,MED13;ZC3H8;THOC3;TAF1,up,GO BP
60,DNA-templated transcriptional preinitiation complex assembly (GO:0070897),1/13,0.03139507576319159,1.0,0,0,31.39717425431711,108.66889234518707,TAF1,up,GO BP
61,regulation of retinoic acid receptor signaling pathway (GO:0048385),1/13,0.03139507576319159,1.0,0,0,31.39717425431711,108.66889234518707,CTBP2,up,GO BP
62,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/13,0.03139507576319159,1.0,0,0,31.39717425431711,108.66889234518707,TAF1,up,GO BP
63,DNA replication-independent nucleosome organization (GO:0034724),1/13,0.03139507576319159,1.0,0,0,31.39717425431711,108.66889234518707,CABIN1,up,GO BP
64,positive regulation of cholesterol efflux (GO:0010875),1/13,0.03139507576319159,1.0,0,0,31.39717425431711,108.66889234518707,ABCA7,up,GO BP
65,high-density lipoprotein particle assembly (GO:0034380),1/13,0.03139507576319159,1.0,0,0,31.39717425431711,108.66889234518707,ABCA7,up,GO BP
66,copper ion transport (GO:0006825),1/14,0.033769693865094014,1.0,0,0,29.15451895043732,98.7810935836037,SLC31A1,up,GO BP
67,myotube cell development (GO:0014904),1/14,0.033769693865094014,1.0,0,0,29.15451895043732,98.7810935836037,KLHL41,up,GO BP
68,response to ATP (GO:0033198),1/14,0.033769693865094014,1.0,0,0,29.15451895043732,98.7810935836037,TAF1,up,GO BP
69,regulation of cell differentiation (GO:0045595),2/121,0.0354871305334787,1.0,0,0,6.74650025299376,22.523765683324623,PURB;KLHL41,up,GO BP
70,intracellular lipid transport (GO:0032365),1/15,0.03613860922017235,1.0,0,0,27.2108843537415,90.3508429299313,CPT2,up,GO BP
71,presynapse assembly (GO:0099054),1/15,0.03613860922017235,1.0,0,0,27.2108843537415,90.3508429299313,PTPRD,up,GO BP
72,synaptic vesicle transport along microtubule (GO:0099517),1/15,0.03613860922017235,1.0,0,0,27.2108843537415,90.3508429299313,AP3M1,up,GO BP
73,regulation of macrophage chemotaxis (GO:0010758),1/15,0.03613860922017235,1.0,0,0,27.2108843537415,90.3508429299313,MTUS1,up,GO BP
74,anterograde synaptic vesicle transport (GO:0048490),1/15,0.03613860922017235,1.0,0,0,27.2108843537415,90.3508429299313,AP3M1,up,GO BP
75,miRNA metabolic process (GO:0010586),1/16,0.03850183520662026,1.0,0,0,25.510204081632647,83.08799416122565,DIS3L2,up,GO BP
76,heme biosynthetic process (GO:0006783),1/16,0.03850183520662026,1.0,0,0,25.510204081632647,83.08799416122565,COX15,up,GO BP
77,regulation of cell cycle phase transition (GO:1901987),1/16,0.03850183520662026,1.0,0,0,25.510204081632647,83.08799416122565,TAF1,up,GO BP
78,negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,0.03850183520662026,1.0,0,0,25.510204081632647,83.08799416122565,TAF1,up,GO BP
79,positive regulation of dendrite morphogenesis (GO:0050775),1/16,0.03850183520662026,1.0,0,0,25.510204081632647,83.08799416122565,PTPRD,up,GO BP
80,negative regulation of steroid biosynthetic process (GO:0010894),1/16,0.03850183520662026,1.0,0,0,25.510204081632647,83.08799416122565,SCAP,up,GO BP
81,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/16,0.03850183520662026,1.0,0,0,25.510204081632647,83.08799416122565,TAF1,up,GO BP
82,positive regulation of cholesterol transport (GO:0032376),1/17,0.04085938516720612,1.0,0,0,24.009603841536613,76.77355911185376,ABCA7,up,GO BP
83,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/17,0.04085938516720612,1.0,0,0,24.009603841536613,76.77355911185376,TAF1,up,GO BP
84,regulation of transcription from RNA polymerase I promoter (GO:0006356),1/17,0.04085938516720612,1.0,0,0,24.009603841536613,76.77355911185376,TAF1,up,GO BP
85,negative regulation of cellular process (GO:0048523),4/534,0.04141166809076,1.0,0,0,3.057402736375449,9.73535916813776,ADAM15;CTBP2;ARHGDIA;DIS3L2,up,GO BP
86,porphyrin-containing compound biosynthetic process (GO:0006779),1/18,0.04321127244441888,1.0,0,0,22.67573696145125,71.23931704209987,COX15,up,GO BP
87,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),1/18,0.04321127244441888,1.0,0,0,22.67573696145125,71.23931704209987,UBAP1,up,GO BP
88,negative regulation of osteoclast differentiation (GO:0045671),1/18,0.04321127244441888,1.0,0,0,22.67573696145125,71.23931704209987,TCTA,up,GO BP
89,regulation of cholesterol efflux (GO:0010874),1/18,0.04321127244441888,1.0,0,0,22.67573696145125,71.23931704209987,ABCA7,up,GO BP
90,regulation of amyloid-beta formation (GO:1902003),1/18,0.04321127244441888,1.0,0,0,22.67573696145125,71.23931704209987,ABCA7,up,GO BP
91,protein targeting to lysosome (GO:0006622),1/19,0.045557510321821836,1.0,0,0,21.482277121374864,66.35402337351628,AP3M1,up,GO BP
92,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1/19,0.045557510321821836,1.0,0,0,21.482277121374864,66.35402337351628,TAF1,up,GO BP
93,inorganic cation transmembrane transport (GO:0098662),2/140,0.04619354713927469,1.0,0,0,5.830903790087462,17.929534477898546,COX15;SCN9A,up,GO BP
94,striated muscle cell development (GO:0055002),1/20,0.04789811206941787,1.0,0,0,20.40816326530613,62.01386100697238,KLHL41,up,GO BP
95,heparan sulfate proteoglycan metabolic process (GO:0030201),1/20,0.04789811206941787,1.0,0,0,20.40816326530613,62.01386100697238,SGSH,up,GO BP
96,steroid hormone mediated signaling pathway (GO:0043401),1/20,0.04789811206941787,1.0,0,0,20.40816326530613,62.01386100697238,MED13,up,GO BP
97,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),1/21,0.0502330909367498,1.0,0,0,19.43634596695821,58.135690718027526,TAF1,up,GO BP
98,phospholipid translocation (GO:0045332),1/21,0.0502330909367498,1.0,0,0,19.43634596695821,58.135690718027526,ABCA7,up,GO BP
99,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",1/21,0.0502330909367498,1.0,0,0,19.43634596695821,58.135690718027526,COX15,up,GO BP
100,mesoderm development (GO:0007498),1/21,0.0502330909367498,1.0,0,0,19.43634596695821,58.135690718027526,MEST,up,GO BP
101,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),1/22,0.052562460131218174,1.0,0,0,18.55287569573284,54.652191090011996,ZDHHC6,up,GO BP
102,peptidyl-L-cysteine S-palmitoylation (GO:0018230),1/22,0.052562460131218174,1.0,0,0,18.55287569573284,54.652191090011996,ZDHHC6,up,GO BP
103,maturation of LSU-rRNA (GO:0000470),1/22,0.052562460131218174,1.0,0,0,18.55287569573284,54.652191090011996,RPL7,up,GO BP
104,regulation of transcription from RNA polymerase III promoter (GO:0006359),1/22,0.052562460131218174,1.0,0,0,18.55287569573284,54.652191090011996,ZC3H8,up,GO BP
105,lipid translocation (GO:0034204),1/22,0.052562460131218174,1.0,0,0,18.55287569573284,54.652191090011996,ABCA7,up,GO BP
106,ncRNA catabolic process (GO:0034661),1/22,0.052562460131218174,1.0,0,0,18.55287569573284,54.652191090011996,DIS3L2,up,GO BP
107,viral genome replication (GO:0019079),1/22,0.052562460131218174,1.0,0,0,18.55287569573284,54.652191090011996,CTBP2,up,GO BP
108,hematopoietic progenitor cell differentiation (GO:0002244),1/22,0.052562460131218174,1.0,0,0,18.55287569573284,54.652191090011996,MLF1,up,GO BP
109,protein stabilization (GO:0050821),2/152,0.0534910619678653,1.0,0,0,5.370569280343716,15.726319576039028,TAF1;OTUD3,up,GO BP
110,negative regulation of axonogenesis (GO:0050771),1/23,0.054886232846338284,1.0,0,0,17.74622892635315,51.50830043904919,ARHGDIA,up,GO BP
111,membrane assembly (GO:0071709),1/23,0.054886232846338284,1.0,0,0,17.74622892635315,51.50830043904919,PTPRD,up,GO BP
112,protein K48-linked deubiquitination (GO:0071108),1/23,0.054886232846338284,1.0,0,0,17.74622892635315,51.50830043904919,OTUD3,up,GO BP
113,cholesterol efflux (GO:0033344),1/23,0.054886232846338284,1.0,0,0,17.74622892635315,51.50830043904919,ABCA7,up,GO BP
114,neuronal action potential (GO:0019228),1/23,0.054886232846338284,1.0,0,0,17.74622892635315,51.50830043904919,SCN9A,up,GO BP
115,microtubule polymerization or depolymerization (GO:0031109),1/23,0.054886232846338284,1.0,0,0,17.74622892635315,51.50830043904919,TPPP3,up,GO BP
116,sensory perception of pain (GO:0019233),1/24,0.057204422219257416,1.0,0,0,17.006802721088437,48.658572654069516,SCN9A,up,GO BP
117,regulation of cell cycle G1/S phase transition (GO:1902806),1/24,0.057204422219257416,1.0,0,0,17.006802721088437,48.658572654069516,TAF1,up,GO BP
118,transcription initiation from RNA polymerase II promoter (GO:0006367),2/160,0.05856911282011655,1.0,0,0,5.102040816326531,14.47728472621549,MED13;TAF1,up,GO BP
119,respiratory chain complex IV assembly (GO:0008535),1/25,0.059517041402020875,1.0,0,0,16.3265306122449,46.06518526236904,COX15,up,GO BP
120,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),1/25,0.059517041402020875,1.0,0,0,16.3265306122449,46.06518526236904,TAF1,up,GO BP
121,long-chain fatty acid transport (GO:0015909),1/25,0.059517041402020875,1.0,0,0,16.3265306122449,46.06518526236904,CPT2,up,GO BP
122,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/26,0.06182410346022105,1.0,0,0,15.698587127158554,43.69642020297904,CKS1B,up,GO BP
123,RNA biosynthetic process (GO:0032774),1/26,0.06182410346022105,1.0,0,0,15.698587127158554,43.69642020297904,TAF1,up,GO BP
124,positive regulation of synapse assembly (GO:0051965),1/26,0.06182410346022105,1.0,0,0,15.698587127158554,43.69642020297904,PTPRD,up,GO BP
125,microtubule polymerization (GO:0046785),1/27,0.06412562148920224,1.0,0,0,15.11715797430083,41.52549181706361,TPPP3,up,GO BP
126,transition metal ion transport (GO:0000041),1/27,0.06412562148920224,1.0,0,0,15.11715797430083,41.52549181706361,SLC31A1,up,GO BP
127,transcription from RNA polymerase III promoter (GO:0006383),1/27,0.06412562148920224,1.0,0,0,15.11715797430083,41.52549181706361,ZC3H8,up,GO BP
128,negative regulation of cell-matrix adhesion (GO:0001953),1/27,0.06412562148920224,1.0,0,0,15.11715797430083,41.52549181706361,ADAM15,up,GO BP
129,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/27,0.06412562148920224,1.0,0,0,15.11715797430083,41.52549181706361,TCTA,up,GO BP
130,muscle fiber development (GO:0048747),1/27,0.06412562148920224,1.0,0,0,15.11715797430083,41.52549181706361,KLHL41,up,GO BP
131,protein targeting to vacuole (GO:0006623),1/27,0.06412562148920224,1.0,0,0,15.11715797430083,41.52549181706361,AP3M1,up,GO BP
132,negative regulation of gene expression (GO:0010629),4/618,0.06420776771036991,1.0,0,0,2.6418334324020867,7.253499988724246,CTBP2;ZC3H8;DIS3L2;TAF1,up,GO BP
133,hydrogen ion transmembrane transport (GO:1902600),1/28,0.06642160851252993,1.0,0,0,14.57725947521866,39.529633324123054,COX15,up,GO BP
134,nuclear-transcribed mRNA catabolic process (GO:0000956),2/174,0.06783815914716353,1.0,0,0,4.691531785127844,12.623178151909256,RPL7;DIS3L2,up,GO BP
135,semaphorin-plexin signaling pathway (GO:0071526),1/29,0.06871207754428547,1.0,0,0,14.074595355383533,37.68937781813083,ARHGDIA,up,GO BP
136,regulation of myoblast differentiation (GO:0045661),1/29,0.06871207754428547,1.0,0,0,14.074595355383533,37.68937781813083,KLHL41,up,GO BP
137,regulation of actin cytoskeleton reorganization (GO:2000249),1/30,0.07099704156206503,1.0,0,0,13.60544217687075,35.987987359848866,ARHGDIA,up,GO BP
138,protein palmitoylation (GO:0018345),1/30,0.07099704156206503,1.0,0,0,13.60544217687075,35.987987359848866,ZDHHC6,up,GO BP
139,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),1/30,0.07099704156206503,1.0,0,0,13.60544217687075,35.987987359848866,ARHGDIA,up,GO BP
140,regulation of leukocyte chemotaxis (GO:0002688),1/30,0.07099704156206503,1.0,0,0,13.60544217687075,35.987987359848866,MTUS1,up,GO BP
141,protein localization to lysosome (GO:0061462),1/30,0.07099704156206503,1.0,0,0,13.60544217687075,35.987987359848866,AP3M1,up,GO BP
142,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),1/30,0.07099704156206503,1.0,0,0,13.60544217687075,35.987987359848866,CKS1B,up,GO BP
143,regulation of protein polymerization (GO:0032271),1/30,0.07099704156206503,1.0,0,0,13.60544217687075,35.987987359848866,TPPP3,up,GO BP
144,sarcomere organization (GO:0045214),1/31,0.0732765135248936,1.0,0,0,13.166556945358787,34.41099588139884,KLHL41,up,GO BP
145,proton transport (GO:0015992),1/31,0.0732765135248936,1.0,0,0,13.166556945358787,34.41099588139884,COX15,up,GO BP
146,anterograde axonal transport (GO:0008089),1/31,0.0732765135248936,1.0,0,0,13.166556945358787,34.41099588139884,AP3M1,up,GO BP
147,vesicle-mediated transport to the plasma membrane (GO:0098876),1/31,0.0732765135248936,1.0,0,0,13.166556945358787,34.41099588139884,CCDC93,up,GO BP
148,positive regulation of dendrite development (GO:1900006),1/32,0.07555050634212196,1.0,0,0,12.755102040816329,32.94584041079259,PTPRD,up,GO BP
149,aminoglycan catabolic process (GO:0006026),1/32,0.07555050634212196,1.0,0,0,12.755102040816329,32.94584041079259,SGSH,up,GO BP
150,microtubule bundle formation (GO:0001578),1/32,0.07555050634212196,1.0,0,0,12.755102040816329,32.94584041079259,TPPP3,up,GO BP
151,mitochondrial transmembrane transport (GO:1990542),1/32,0.07555050634212196,1.0,0,0,12.755102040816329,32.94584041079259,CPT2,up,GO BP
152,"DNA-templated transcription, initiation (GO:0006352)",2/186,0.07614366001328325,1.0,0,0,4.388852315119597,11.301880446182524,MED13;TAF1,up,GO BP
153,gene expression (GO:0010467),3/411,0.07942955343934288,1.0,0,0,2.9792939073439597,7.5462081645116355,THOC3;MLF1;RPL7,up,GO BP
154,RNA metabolic process (GO:0016070),2/191,0.0796961064847594,1.0,0,0,4.273960893257828,10.811131729951024,PABPC3;DIS3L2,up,GO BP
155,regulation of alcohol biosynthetic process (GO:1902930),1/34,0.08008210609353099,1.0,0,0,12.004801920768307,30.308557556443446,SCAP,up,GO BP
156,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",1/35,0.08233973871315534,1.0,0,0,11.661807580174925,29.118384092278692,DIS3L2,up,GO BP
157,negative regulation of cell-substrate adhesion (GO:0010812),1/35,0.08233973871315534,1.0,0,0,11.661807580174925,29.118384092278692,ADAM15,up,GO BP
158,negative regulation of protein kinase B signaling (GO:0051898),1/35,0.08233973871315534,1.0,0,0,11.661807580174925,29.118384092278692,OTUD3,up,GO BP
159,sulfur compound catabolic process (GO:0044273),1/35,0.08233973871315534,1.0,0,0,11.661807580174925,29.118384092278692,SGSH,up,GO BP
160,regulation of synapse assembly (GO:0051963),1/35,0.08233973871315534,1.0,0,0,11.661807580174925,29.118384092278692,PTPRD,up,GO BP
161,protein acylation (GO:0043543),1/36,0.08459194359992496,1.0,0,0,11.337868480725625,28.00358555804837,ZDHHC6,up,GO BP
162,organophosphate biosynthetic process (GO:0090407),1/36,0.08459194359992496,1.0,0,0,11.337868480725625,28.00358555804837,AGPAT5,up,GO BP
163,mRNA catabolic process (GO:0006402),1/36,0.08459194359992496,1.0,0,0,11.337868480725625,28.00358555804837,DIS3L2,up,GO BP
164,axonal transport (GO:0098930),1/36,0.08459194359992496,1.0,0,0,11.337868480725625,28.00358555804837,AP3M1,up,GO BP
165,sodium ion transmembrane transport (GO:0035725),1/36,0.08459194359992496,1.0,0,0,11.337868480725625,28.00358555804837,SCN9A,up,GO BP
166,regulation of muscle cell differentiation (GO:0051147),1/36,0.08459194359992496,1.0,0,0,11.337868480725625,28.00358555804837,KLHL41,up,GO BP
167,rRNA metabolic process (GO:0016072),2/200,0.08621893825800953,1.0,0,0,4.081632653061225,10.00353234316033,RPL7;DIS3L2,up,GO BP
168,phospholipid biosynthetic process (GO:0008654),1/37,0.08683873349397976,1.0,0,0,11.031439602868176,26.957556739555184,AGPAT5,up,GO BP
169,regulation of osteoclast differentiation (GO:0045670),1/37,0.08683873349397976,1.0,0,0,11.031439602868176,26.957556739555184,TCTA,up,GO BP
170,protein K63-linked ubiquitination (GO:0070534),1/37,0.08683873349397976,1.0,0,0,11.031439602868176,26.957556739555184,UBE2NL,up,GO BP
171,positive regulation of axonogenesis (GO:0050772),1/37,0.08683873349397976,1.0,0,0,11.031439602868176,26.957556739555184,ARHGDIA,up,GO BP
172,positive regulation of receptor activity (GO:2000273),1/37,0.08683873349397976,1.0,0,0,11.031439602868176,26.957556739555184,TAF1,up,GO BP
173,rRNA processing (GO:0006364),2/202,0.08769007674147251,1.0,0,0,4.04122044857547,9.836114512209216,RPL7;DIS3L2,up,GO BP
174,membrane depolarization during action potential (GO:0086010),1/38,0.08908012117667435,1.0,0,0,10.741138560687432,25.97442616843159,SCN9A,up,GO BP
175,retina homeostasis (GO:0001895),1/38,0.08908012117667435,1.0,0,0,10.741138560687432,25.97442616843159,POTEF,up,GO BP
176,skeletal muscle tissue development (GO:0007519),1/39,0.09131611933080344,1.0,0,0,10.465724751439037,25.048958173793586,KLHL41,up,GO BP
177,Golgi to plasma membrane transport (GO:0006893),1/39,0.09131611933080344,1.0,0,0,10.465724751439037,25.048958173793586,CCDC93,up,GO BP
178,DNA replication-independent nucleosome assembly (GO:0006336),1/39,0.09131611933080344,1.0,0,0,10.465724751439037,25.048958173793586,CABIN1,up,GO BP
179,positive regulation of phagocytosis (GO:0050766),1/39,0.09131611933080344,1.0,0,0,10.465724751439037,25.048958173793586,ABCA7,up,GO BP
180,"regulation of transcription, DNA-templated (GO:0006355)",7/1598,0.09300941534909177,1.0,0,0,1.7879492222420883,4.246476936600252,ZNF672;MED13;CTBP2;ZC3H8;MLF1;CKS1B;TAF1,up,GO BP
181,phosphatidic acid biosynthetic process (GO:0006654),1/40,0.0935467406593446,1.0,0,0,10.204081632653065,24.176470076489622,AGPAT5,up,GO BP
182,androgen receptor signaling pathway (GO:0030521),1/40,0.0935467406593446,1.0,0,0,10.204081632653065,24.176470076489622,MED13,up,GO BP
183,regulation of cholesterol biosynthetic process (GO:0045540),1/40,0.0935467406593446,1.0,0,0,10.204081632653065,24.176470076489622,SCAP,up,GO BP
184,regulation of phagocytosis (GO:0050764),1/41,0.09577199782508727,1.0,0,0,9.955201592832255,23.352761921448888,ABCA7,up,GO BP
185,regulation of cholesterol metabolic process (GO:0090181),1/41,0.09577199782508727,1.0,0,0,9.955201592832255,23.352761921448888,SCAP,up,GO BP
186,phosphatidic acid metabolic process (GO:0046473),1/41,0.09577199782508727,1.0,0,0,9.955201592832255,23.352761921448888,AGPAT5,up,GO BP
187,cellular protein modification process (GO:0006464),5/1001,0.0970943934821206,1.0,0,0,2.038777548981631,4.7545753124016015,PTPRD;KBTBD6;ABCA7;KLHL41;TAF1,up,GO BP
188,membrane depolarization (GO:0051899),1/43,0.10020647014004594,1.0,0,0,9.4921689606075,21.836948459042464,SCN9A,up,GO BP
189,nucleobase-containing compound catabolic process (GO:0034655),1/43,0.10020647014004594,1.0,0,0,9.4921689606075,21.836948459042464,DIS3L2,up,GO BP
190,RNA catabolic process (GO:0006401),1/43,0.10020647014004594,1.0,0,0,9.4921689606075,21.836948459042464,DIS3L2,up,GO BP
191,regulation of steroid biosynthetic process (GO:0050810),1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,SCAP,up,GO BP
192,regulation of dendrite morphogenesis (GO:0048814),1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,PTPRD,up,GO BP
193,cholesterol transport (GO:0030301),1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,ABCA7,up,GO BP
194,protein polymerization (GO:0051258),1/45,0.10461963696044026,1.0,0,0,9.0702947845805,20.475501234681968,TPPP3,up,GO BP
195,ribosome biogenesis (GO:0042254),2/226,0.1059089852377372,1.0,0,0,3.6120642947444463,8.109717115898412,RPL7;DIS3L2,up,GO BP
196,ncRNA processing (GO:0034470),2/227,0.10668932040494994,1.0,0,0,3.5961521172345594,8.047592252483152,RPL7;DIS3L2,up,GO BP
197,postreplication repair (GO:0006301),1/47,0.10901159849285977,1.0,0,0,8.684324793747287,19.247077674533823,UBE2NL,up,GO BP
198,myofibril assembly (GO:0030239),1/47,0.10901159849285977,1.0,0,0,8.684324793747287,19.247077674533823,KLHL41,up,GO BP
199,peptide cross-linking (GO:0018149),1/47,0.10901159849285977,1.0,0,0,8.684324793747287,19.247077674533823,ABCA7,up,GO BP
200,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/47,0.10901159849285977,1.0,0,0,8.684324793747287,19.247077674533823,PTPRD,up,GO BP
201,cellular macromolecule catabolic process (GO:0044265),1/48,0.11119965848123284,1.0,0,0,8.503401360544219,18.67710857467947,DIS3L2,up,GO BP
202,negative regulation of protein ubiquitination (GO:0031397),1/50,0.11555999902224065,1.0,0,0,8.16326530612245,17.616044178327805,TAF1,up,GO BP
203,negative regulation of neuron projection development (GO:0010977),1/51,0.11773230434297198,1.0,0,0,8.003201280512204,17.12158334507697,ARHGDIA,up,GO BP
204,positive regulation of nervous system development (GO:0051962),1/52,0.11989938284584432,1.0,0,0,7.849293563579278,16.649155135028106,PTPRD,up,GO BP
205,regulation of cell-matrix adhesion (GO:0001952),1/52,0.11989938284584432,1.0,0,0,7.849293563579278,16.649155135028106,ADAM15,up,GO BP
206,intracellular transport of virus (GO:0075733),1/54,0.12421790857292912,1.0,0,0,7.558578987150415,15.765063707247872,UBAP1,up,GO BP
207,action potential (GO:0001508),1/54,0.12421790857292912,1.0,0,0,7.558578987150415,15.765063707247872,SCN9A,up,GO BP
208,sensory perception (GO:0007600),1/54,0.12421790857292912,1.0,0,0,7.558578987150415,15.765063707247872,SCN9A,up,GO BP
209,transport of virus (GO:0046794),1/54,0.12421790857292912,1.0,0,0,7.558578987150415,15.765063707247872,UBAP1,up,GO BP
210,negative regulation of cellular component organization (GO:0051129),1/54,0.12421790857292912,1.0,0,0,7.558578987150415,15.765063707247872,DNAJA4,up,GO BP
211,cytoplasmic translation (GO:0002181),1/54,0.12421790857292912,1.0,0,0,7.558578987150415,15.765063707247872,RPL7,up,GO BP
212,regulation of axonogenesis (GO:0050770),1/55,0.12636938033824105,1.0,0,0,7.421150278293135,15.350991248791996,ARHGDIA,up,GO BP
213,fat cell differentiation (GO:0045444),1/55,0.12636938033824105,1.0,0,0,7.421150278293135,15.350991248791996,CTBP2,up,GO BP
214,protein ubiquitination (GO:0016567),3/506,0.1268223726763333,1.0,0,0,2.419940308139066,4.997098842972685,KBTBD6;KLHL41;TAF1,up,GO BP
215,glycosaminoglycan catabolic process (GO:0006027),1/56,0.1285156743868668,1.0,0,0,7.288629737609329,14.954113720272913,SGSH,up,GO BP
216,regulation of Rho protein signal transduction (GO:0035023),1/57,0.1306568028722364,1.0,0,0,7.16075904045829,14.573442312437122,ARHGDIA,up,GO BP
217,cellular respiration (GO:0045333),1/57,0.1306568028722364,1.0,0,0,7.16075904045829,14.573442312437122,COX15,up,GO BP
218,phospholipid transport (GO:0015914),1/58,0.13279277797234604,1.0,0,0,7.037297677691766,14.208060704834313,ABCA7,up,GO BP
219,sodium ion transport (GO:0006814),1/58,0.13279277797234604,1.0,0,0,7.037297677691766,14.208060704834313,SCN9A,up,GO BP
220,integrin-mediated signaling pathway (GO:0007229),1/58,0.13279277797234604,1.0,0,0,7.037297677691766,14.208060704834313,ADAM15,up,GO BP
221,post-Golgi vesicle-mediated transport (GO:0006892),1/58,0.13279277797234604,1.0,0,0,7.037297677691766,14.208060704834313,CCDC93,up,GO BP
222,positive regulation of protein binding (GO:0032092),1/60,0.13704931664792866,1.0,0,0,6.802721088435375,13.519826138757372,TAF1,up,GO BP
223,nucleosome assembly (GO:0006334),1/60,0.13704931664792866,1.0,0,0,6.802721088435375,13.519826138757372,CABIN1,up,GO BP
224,"positive regulation of transcription, DNA-templated (GO:0045893)",5/1120,0.13785922480355894,1.0,0,0,1.8221574344023324,3.6106454530075065,MED13;CTBP2;ZC3H8;CKS1B;TAF1,up,GO BP
225,glycosaminoglycan metabolic process (GO:0030203),1/61,0.13916990440240695,1.0,0,0,6.691201070592173,13.195448367099164,SGSH,up,GO BP
226,RNA 3'-end processing (GO:0031123),1/61,0.13916990440240695,1.0,0,0,6.691201070592173,13.195448367099164,THOC3,up,GO BP
227,striated muscle contraction (GO:0006941),1/61,0.13916990440240695,1.0,0,0,6.691201070592173,13.195448367099164,KLHL41,up,GO BP
228,protein targeting to membrane (GO:0006612),1/61,0.13916990440240695,1.0,0,0,6.691201070592173,13.195448367099164,ZDHHC6,up,GO BP
229,ribosomal large subunit biogenesis (GO:0042273),1/63,0.14339577707005752,1.0,0,0,6.478781988986071,12.582745706868382,RPL7,up,GO BP
230,positive regulation of protein polymerization (GO:0032273),1/64,0.145501086009976,1.0,0,0,6.3775510204081645,12.293187043446148,TPPP3,up,GO BP
231,positive regulation of endocytosis (GO:0045807),1/64,0.145501086009976,1.0,0,0,6.3775510204081645,12.293187043446148,ABCA7,up,GO BP
232,negative regulation of cell adhesion (GO:0007162),1/65,0.1476013260006852,1.0,0,0,6.2794348508634235,12.01406833979051,ARHGDIA,up,GO BP
233,regulation of myeloid cell differentiation (GO:0045637),1/65,0.1476013260006852,1.0,0,0,6.2794348508634235,12.01406833979051,PURB,up,GO BP
234,cellular response to light stimulus (GO:0071482),1/66,0.1496965090156283,1.0,0,0,6.184291898577612,11.744868940614404,TAF1,up,GO BP
235,intracellular steroid hormone receptor signaling pathway (GO:0030518),1/66,0.1496965090156283,1.0,0,0,6.184291898577612,11.744868940614404,MED13,up,GO BP
236,negative regulation of protein binding (GO:0032091),1/67,0.1517866469464216,1.0,0,0,6.091989034419737,11.485101326040615,ADAM15,up,GO BP
237,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/67,0.1517866469464216,1.0,0,0,6.091989034419737,11.485101326040615,CKS1B,up,GO BP
238,cellular response to UV (GO:0034644),1/67,0.1517866469464216,1.0,0,0,6.091989034419737,11.485101326040615,TAF1,up,GO BP
239,protein polyubiquitination (GO:0000209),2/283,0.15259053285427396,1.0,0,0,2.8845460445662363,5.422938489995224,UBE2NL;TAF1,up,GO BP
240,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),4/848,0.15310858414391207,1.0,0,0,1.9252984212552944,3.61303024455305,MED13;CTBP2;SCAP;TAF1,up,GO BP
241,termination of RNA polymerase II transcription (GO:0006369),1/68,0.15387175170898196,1.0,0,0,6.002400960384153,11.234308551223542,THOC3,up,GO BP
242,peptidyl-threonine phosphorylation (GO:0018107),1/68,0.15387175170898196,1.0,0,0,6.002400960384153,11.234308551223542,TAF1,up,GO BP
243,snRNA transcription from RNA polymerase II promoter (GO:0042795),1/70,0.1580269091413692,1.0,0,0,5.830903790087462,10.757958888834528,ZC3H8,up,GO BP
244,phospholipid metabolic process (GO:0006644),1/70,0.1580269091413692,1.0,0,0,5.830903790087462,10.757958888834528,AGPAT5,up,GO BP
245,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/70,0.1580269091413692,1.0,0,0,5.830903790087462,10.757958888834528,TAF1,up,GO BP
246,snRNA transcription (GO:0009301),1/70,0.1580269091413692,1.0,0,0,5.830903790087462,10.757958888834528,ZC3H8,up,GO BP
247,actomyosin structure organization (GO:0031032),1/71,0.16009698547444592,1.0,0,0,5.748778384593273,10.531621087515461,KLHL41,up,GO BP
248,lysosomal transport (GO:0007041),1/72,0.1621620759393262,1.0,0,0,5.6689342403628125,10.312692602742626,AP3M1,up,GO BP
249,lipid biosynthetic process (GO:0008610),1/72,0.1621620759393262,1.0,0,0,5.6689342403628125,10.312692602742626,AGPAT5,up,GO BP
250,positive regulation of proteasomal protein catabolic process (GO:1901800),1/73,0.16422219226923945,1.0,0,0,5.5912776069331835,10.100838340526812,TAF1,up,GO BP
251,mRNA 3'-end processing (GO:0031124),1/74,0.1662773462428849,1.0,0,0,5.515719801434088,9.895742549883874,THOC3,up,GO BP
252,negative regulation of cellular amide metabolic process (GO:0034249),1/75,0.1683275495268852,1.0,0,0,5.442176870748299,9.697107473259354,ABCA7,up,GO BP
253,regulation of actin cytoskeleton organization (GO:0032956),1/75,0.1683275495268852,1.0,0,0,5.442176870748299,9.697107473259354,ARHGDIA,up,GO BP
254,nucleic acid-templated transcription (GO:0097659),1/76,0.1703728138367953,1.0,0,0,5.370569280343716,9.5046520973501,MLF1,up,GO BP
255,extracellular matrix disassembly (GO:0022617),1/78,0.17444857199702626,1.0,0,0,5.232862375719519,9.137233370625186,ADAM15,up,GO BP
256,RNA transport (GO:0050658),1/80,0.17850471366148835,1.0,0,0,5.102040816326531,8.791531995122154,THOC3,up,GO BP
257,positive regulation of binding (GO:0051099),1/81,0.18052545718087712,1.0,0,0,5.039052658100277,8.626270970727218,TAF1,up,GO BP
258,positive regulation of cell cycle (GO:0045787),1/82,0.18254133123122268,1.0,0,0,4.977600796416128,8.465797208067526,CKS1B,up,GO BP
259,mitotic sister chromatid segregation (GO:0000070),1/82,0.18254133123122268,1.0,0,0,4.977600796416128,8.465797208067526,DIS3L2,up,GO BP
260,establishment of protein localization to membrane (GO:0090150),1/83,0.1845523472379876,1.0,0,0,4.917629702483403,8.309919502713068,ZDHHC6,up,GO BP
261,regulation of nucleic acid-templated transcription (GO:1903506),3/607,0.18574968159628846,1.0,0,0,2.0172813771307534,3.395801317024409,ZNF672;MLF1;TAF1,up,GO BP
262,mitochondrial ATP synthesis coupled electron transport (GO:0042775),1/85,0.18855985110556656,1.0,0,0,4.8019207683073235,8.01123558220467,COX15,up,GO BP
263,organic substance transport (GO:0071702),1/87,0.19254806017668188,1.0,0,0,4.691531785127844,7.728874000279107,ABCA7,up,GO BP
264,positive regulation of cellular component biogenesis (GO:0044089),1/87,0.19254806017668188,1.0,0,0,4.691531785127844,7.728874000279107,PTPRD,up,GO BP
265,positive regulation of protein complex assembly (GO:0031334),1/88,0.1945349576029131,1.0,0,0,4.63821892393321,7.593429505876667,TPPP3,up,GO BP
266,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/88,0.1945349576029131,1.0,0,0,4.63821892393321,7.593429505876667,TAF1,up,GO BP
267,peptidyl-threonine modification (GO:0018210),1/89,0.1965170653943892,1.0,0,0,4.586104104563174,7.4616189160880575,TAF1,up,GO BP
268,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),1/89,0.1965170653943892,1.0,0,0,4.586104104563174,7.4616189160880575,RPL7,up,GO BP
269,cell-matrix adhesion (GO:0007160),1/90,0.19849439487603893,1.0,0,0,4.5351473922902485,7.333308012035746,ADAM15,up,GO BP
270,regulation of Ras protein signal transduction (GO:0046578),1/90,0.19849439487603893,1.0,0,0,4.5351473922902485,7.333308012035746,ARHGDIA,up,GO BP
271,lipid transport (GO:0006869),1/91,0.20046695733149195,1.0,0,0,4.485310607759588,7.208368904040989,ABCA7,up,GO BP
272,regulation of cellular macromolecule biosynthetic process (GO:2000112),3/631,0.20072269772702955,1.0,0,0,1.9405543516931336,3.1162022124209248,ZNF672;MLF1;TAF1,up,GO BP
273,nuclear export (GO:0051168),1/92,0.20243476399124585,1.0,0,0,4.436557231588288,7.08667966933301,THOC3,up,GO BP
274,ubiquitin-dependent protein catabolic process (GO:0006511),2/341,0.20339566214404872,1.0,0,0,2.393919444610689,3.8125611881513435,UBAP1;TAF1,up,GO BP
275,cotranslational protein targeting to membrane (GO:0006613),1/93,0.20439782611070498,1.0,0,0,4.388852315119597,6.96812401218066,RPL7,up,GO BP
276,respiratory electron transport chain (GO:0022904),1/94,0.20635615488224895,1.0,0,0,4.3421623968736425,6.852590950224973,COX15,up,GO BP
277,transcription elongation from RNA polymerase II promoter (GO:0006368),1/95,0.20830976144800376,1.0,0,0,4.296455424274973,6.739974519290273,TAF1,up,GO BP
278,protein localization to nucleus (GO:0034504),1/96,0.21025865699508986,1.0,0,0,4.2517006802721085,6.630173495783064,ABCA7,up,GO BP
279,positive regulation of protein metabolic process (GO:0051247),1/96,0.21025865699508986,1.0,0,0,4.2517006802721085,6.630173495783064,SCAP,up,GO BP
280,negative regulation of cell motility (GO:2000146),1/97,0.21220285264448208,1.0,0,0,4.207868714496108,6.5230911411936345,ADAM15,up,GO BP
281,protein localization to organelle (GO:0033365),1/97,0.21220285264448208,1.0,0,0,4.207868714496108,6.5230911411936345,ABCA7,up,GO BP
282,protein targeting to ER (GO:0045047),1/97,0.21220285264448208,1.0,0,0,4.207868714496108,6.5230911411936345,RPL7,up,GO BP
283,cellular response to organonitrogen compound (GO:0071417),1/97,0.21220285264448208,1.0,0,0,4.207868714496108,6.5230911411936345,TAF1,up,GO BP
284,positive regulation of neuron projection development (GO:0010976),1/97,0.21220285264448208,1.0,0,0,4.207868714496108,6.5230911411936345,ARHGDIA,up,GO BP
285,response to UV (GO:0009411),1/98,0.21414235950352406,1.0,0,0,4.164931278633904,6.418634959615513,TAF1,up,GO BP
286,"transcription, DNA-templated (GO:0006351)",2/356,0.2168645278895235,1.0,0,0,2.293052052281587,3.5048897405072297,MLF1;TAF1,up,GO BP
287,post-translational protein modification (GO:0043687),2/357,0.21776573038621624,1.0,0,0,2.2866289372892017,3.4855894935782583,KBTBD6;KLHL41,up,GO BP
288,regulation of lipid metabolic process (GO:0019216),1/100,0.21800735103248006,1.0,0,0,4.081632653061225,6.217251005833013,CPT2,up,GO BP
289,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),1/100,0.21800735103248006,1.0,0,0,4.081632653061225,6.217251005833013,THOC3,up,GO BP
290,metal ion transport (GO:0030001),1/101,0.21993285781620825,1.0,0,0,4.04122044857547,6.120157490219282,SCN9A,up,GO BP
291,negative regulation of cell proliferation (GO:0008285),2/363,0.2231804512559396,1.0,0,0,2.2488334176645868,3.37274332105346,CTBP2;DIS3L2,up,GO BP
292,monovalent inorganic cation transport (GO:0015672),1/104,0.2256815539658193,1.0,0,0,3.9246467817896393,5.842348220594505,SCN9A,up,GO BP
293,mRNA transport (GO:0051028),1/104,0.2256815539658193,1.0,0,0,3.9246467817896393,5.842348220594505,THOC3,up,GO BP
294,cellular macromolecule biosynthetic process (GO:0034645),2/367,0.2267969049375615,1.0,0,0,2.22432297169549,3.300228780251212,MLF1;RPL7,up,GO BP
295,mRNA export from nucleus (GO:0006406),1/105,0.22758854778675144,1.0,0,0,3.887269193391643,5.7539976492801825,THOC3,up,GO BP
296,"DNA-templated transcription, termination (GO:0006353)",1/106,0.2294909406653387,1.0,0,0,3.8505968425105888,5.667661626822366,THOC3,up,GO BP
297,positive regulation of cellular component organization (GO:0051130),1/106,0.2294909406653387,1.0,0,0,3.8505968425105888,5.667661626822366,PTPRD,up,GO BP
298,"DNA-templated transcription, elongation (GO:0006354)",1/108,0.2332819671059828,1.0,0,0,3.779289493575208,5.500783816386177,TAF1,up,GO BP
299,viral gene expression (GO:0019080),1/110,0.2370547198597219,1.0,0,0,3.710575139146568,5.3412403673948,RPL7,up,GO BP
300,regulation of protein binding (GO:0043393),1/111,0.2389342705931525,1.0,0,0,3.677146534289392,5.264080835866244,TAF1,up,GO BP
301,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",1/112,0.24080928525036116,1.0,0,0,3.6443148688046647,5.188593317350888,RPL7,up,GO BP
302,viral transcription (GO:0019083),1/113,0.2426797745527419,1.0,0,0,3.6120642947444463,5.114728209854892,RPL7,up,GO BP
303,negative regulation of cell growth (GO:0030308),1/115,0.2464072197465133,1.0,0,0,3.5492457852706303,4.971676120080727,ADAM15,up,GO BP
304,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/118,0.2519647137871081,1.0,0,0,3.4590107229332414,4.768129456691159,CKS1B,up,GO BP
305,RNA export from nucleus (GO:0006405),1/119,0.2538082745383733,1.0,0,0,3.4299434059338014,4.703056496790394,THOC3,up,GO BP
306,protein modification by small protein conjugation (GO:0032446),2/398,0.2549554239750257,1.0,0,0,2.051071684955389,2.8031310779314444,KBTBD6;KLHL41,up,GO BP
307,enzyme linked receptor protein signaling pathway (GO:0007167),1/120,0.2556473842905439,1.0,0,0,3.4013605442176877,4.639306765687263,PTPRD,up,GO BP
308,negative regulation of growth (GO:0045926),1/120,0.2556473842905439,1.0,0,0,3.4013605442176877,4.639306765687263,ADAM15,up,GO BP
309,negative regulation of cell migration (GO:0030336),1/121,0.257482053509444,1.0,0,0,3.37325012649688,4.576843502837304,ADAM15,up,GO BP
310,negative regulation of macromolecule metabolic process (GO:0010605),1/124,0.26295952305137155,1.0,0,0,3.2916392363396967,4.3968241059794595,TAF1,up,GO BP
311,dephosphorylation (GO:0016311),1/124,0.26295952305137155,1.0,0,0,3.2916392363396967,4.3968241059794595,PTPRD,up,GO BP
312,protein dephosphorylation (GO:0006470),1/125,0.26477653500882337,1.0,0,0,3.26530612244898,4.339164319545324,PTPRD,up,GO BP
313,protein lipidation (GO:0006497),1/127,0.2683974045277928,1.0,0,0,3.2138839787883664,4.227178351586288,ZDHHC6,up,GO BP
314,regulation of cell proliferation (GO:0042127),3/740,0.2717972095396405,1.0,0,0,1.6547159404302263,2.1555968735447357,CTBP2;KLHL41;DIS3L2,up,GO BP
315,generation of neurons (GO:0048699),1/130,0.2737959781604629,1.0,0,0,3.1397174254317117,4.067102214141391,PTPRD,up,GO BP
316,regulation of intracellular signal transduction (GO:1902531),2/422,0.2768350054637457,1.0,0,0,1.9344230583228557,2.484444527341046,ARHGDIA;TAF1,up,GO BP
317,protein targeting (GO:0006605),1/133,0.2791555222256205,1.0,0,0,3.0688967316249807,3.9158699559113153,ZDHHC6,up,GO BP
318,cellular response to organic cyclic compound (GO:0071407),1/135,0.2827070050205103,1.0,0,0,3.0234315948601664,3.8196348770958566,TAF1,up,GO BP
319,muscle contraction (GO:0006936),1/137,0.28624134560631603,1.0,0,0,2.9792939073439597,3.7268582102203514,KLHL41,up,GO BP
320,regulation of signal transduction by p53 class mediator (GO:1901796),1/138,0.2880021129069961,1.0,0,0,2.9577048210588583,3.6817138787059385,TAF1,up,GO BP
321,regulation of primary metabolic process (GO:0080090),1/139,0.2897586249714423,1.0,0,0,2.936426369108795,3.6373719872656314,CPT2,up,GO BP
322,neuron differentiation (GO:0030182),1/139,0.2897586249714423,1.0,0,0,2.936426369108795,3.6373719872656314,PTPRD,up,GO BP
323,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),1/140,0.2915108919386749,1.0,0,0,2.915451895043732,3.5938131450390602,TAF1,up,GO BP
324,regulation of small GTPase mediated signal transduction (GO:0051056),1/140,0.2915108919386749,1.0,0,0,2.915451895043732,3.5938131450390602,ARHGDIA,up,GO BP
325,modification-dependent protein catabolic process (GO:0019941),1/141,0.29325892381433954,1.0,0,0,2.894774931249096,3.551018558900339,TAF1,up,GO BP
326,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/142,0.2950027306318848,1.0,0,0,2.8743891922966367,3.5089700095024057,PTPRD,up,GO BP
327,negative regulation of nucleic acid-templated transcription (GO:1903507),2/444,0.2968792849897903,1.0,0,0,1.838573267144696,2.2328179272799704,CTBP2;ZC3H8,up,GO BP
328,peptidyl-serine phosphorylation (GO:0018105),1/145,0.3002089005513339,1.0,0,0,2.8149190710767065,3.3871265629378464,TAF1,up,GO BP
329,negative regulation of intracellular signal transduction (GO:1902532),1/161,0.3273454602523001,1.0,0,0,2.535175560907593,2.8311299591027383,OTUD3,up,GO BP
330,regulation of protein kinase B signaling (GO:0051896),1/163,0.33066419041532485,1.0,0,0,2.5040691123075,2.7711329637078905,OTUD3,up,GO BP
331,glycerophospholipid biosynthetic process (GO:0046474),1/164,0.3323175352602721,1.0,0,0,2.488800398208064,2.7418226372523447,AGPAT5,up,GO BP
332,cellular protein metabolic process (GO:0044267),2/484,0.33312023240930105,1.0,0,0,1.68662506324844,1.854025629754363,GGA1;RPL7,up,GO BP
333,regulation of mitotic cell cycle (GO:0007346),1/165,0.33396687924295043,1.0,0,0,2.473716759431045,2.7129584535949727,CKS1B,up,GO BP
334,peptidyl-serine modification (GO:0018209),1/170,0.34215391769017306,1.0,0,0,2.4009603841536613,2.575017026258781,TAF1,up,GO BP
335,peptide biosynthetic process (GO:0043043),1/174,0.34863249456533457,1.0,0,0,2.345765892563922,2.4718201636577093,RPL7,up,GO BP
336,positive regulation of nucleic acid-templated transcription (GO:1903508),2/502,0.34928322914714266,1.0,0,0,1.6261484673550697,1.7105002700543863,MED13;CKS1B,up,GO BP
337,protein autophosphorylation (GO:0046777),1/175,0.35024234803788656,1.0,0,0,2.332361516034985,2.4469503000523978,TAF1,up,GO BP
338,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/512,0.3582115001591163,1.0,0,0,1.5943877551020411,1.6368489866986475,CTBP2;ZC3H8,up,GO BP
339,phosphate-containing compound metabolic process (GO:0006796),1/183,0.3629816298960361,1.0,0,0,2.2304003568640574,2.2602945295970533,PTPRD,up,GO BP
340,positive regulation of ERK1 and ERK2 cascade (GO:0070374),1/201,0.39075708304605,1.0,0,0,2.030663011473246,1.908151453035896,ABCA7,up,GO BP
341,regulation of cell growth (GO:0001558),1/201,0.39075708304605,1.0,0,0,2.030663011473246,1.908151453035896,ADAM15,up,GO BP
342,positive regulation of multicellular organismal process (GO:0051240),1/202,0.3922648788623522,1.0,0,0,2.020610224287735,1.8909233299621584,ABCA7,up,GO BP
343,positive regulation of signal transduction (GO:0009967),1/206,0.39825959238173575,1.0,0,0,1.9813750743015648,1.8241554272835507,CTBP2,up,GO BP
344,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),1/215,0.411536700451846,1.0,0,0,1.8984337921215,1.6855378753463046,TAF1,up,GO BP
345,regulation of cell cycle (GO:0051726),1/215,0.411536700451846,1.0,0,0,1.8984337921215,1.6855378753463046,CKS1B,up,GO BP
346,endosomal transport (GO:0016197),1/229,0.4316215589800439,1.0,0,0,1.7823723375813207,1.4975601025721104,UBAP1,up,GO BP
347,extracellular matrix organization (GO:0030198),1/229,0.4316215589800439,1.0,0,0,1.7823723375813207,1.4975601025721104,ADAM15,up,GO BP
348,translation (GO:0006412),1/232,0.4358372673709556,1.0,0,0,1.7593244194229416,1.4610949072472752,RPL7,up,GO BP
349,regulation of ERK1 and ERK2 cascade (GO:0070372),1/247,0.456460624171487,1.0,0,0,1.6524828554903743,1.2959643701390278,ABCA7,up,GO BP
350,protein deubiquitination (GO:0016579),1/257,0.4697973134041093,1.0,0,0,1.5881839116969745,1.199799770298722,OTUD3,up,GO BP
351,regulation of gene expression (GO:0010468),3/1037,0.4703810034731523,1.0,0,0,1.1808001889280304,0.8905739873491749,ZNF672;MLF1;TAF1,up,GO BP
352,protein modification by small protein removal (GO:0070646),1/261,0.4750417597272074,1.0,0,0,1.5638439283759484,1.1640512371516747,OTUD3,up,GO BP
353,cellular response to oxygen-containing compound (GO:1901701),1/274,0.4917376802124648,1.0,0,0,1.4896469536719796,1.0573661179435772,TAF1,up,GO BP
354,regulation of transcription from RNA polymerase II promoter (GO:0006357),4/1478,0.4944496249304196,1.0,0,0,1.1046367126011434,0.7780066872780013,MED13;CTBP2;ZC3H8;TAF1,up,GO BP
355,mRNA processing (GO:0006397),1/283,0.5029905183138399,1.0,0,0,1.4422730222831182,0.9911068858884582,THOC3,up,GO BP
356,DNA repair (GO:0006281),1/288,0.5091362579400526,1.0,0,0,1.4172335600907031,0.9566887768253304,UBE2NL,up,GO BP
357,positive regulation of MAPK cascade (GO:0043410),1/289,0.510356441841124,1.0,0,0,1.4123296377374481,0.9499977287108174,ABCA7,up,GO BP
358,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/291,0.5127879026587183,1.0,0,0,1.402622904832036,0.9368019698619438,TAF1,up,GO BP
359,regulation of cell migration (GO:0030334),1/316,0.5422011037023227,1.0,0,0,1.291655902867476,0.7906462236110033,ADAM15,up,GO BP
360,protein transport (GO:0015031),1/326,0.5534729385978511,1.0,0,0,1.2520345561537498,0.7406315505831976,GGA1,up,GO BP
361,cellular protein localization (GO:0034613),1/327,0.5545850544289485,1.0,0,0,1.2482057043000687,0.7358610678932513,GGA1,up,GO BP
362,cellular response to DNA damage stimulus (GO:0006974),1/329,0.5568011522469258,1.0,0,0,1.2406178276781838,0.7264401718938999,TAF1,up,GO BP
363,positive regulation of gene expression (GO:0010628),2/771,0.5683987794389564,1.0,0,0,1.0587892744646497,0.5981439742971982,MED13;CKS1B,up,GO BP
364,intracellular protein transport (GO:0006886),1/347,0.576266079691405,1.0,0,0,1.1762630124095748,0.6483394472043721,GGA1,up,GO BP
365,"negative regulation of transcription, DNA-templated (GO:0045892)",2/813,0.5976997418300833,1.0,0,0,1.004091673569797,0.5167726034500412,CTBP2;ZC3H8,up,GO BP
366,organelle assembly (GO:0070925),1/376,0.6058784056171705,1.0,0,0,1.0855405992184108,0.543938302043677,KLHL41,up,GO BP
367,transmembrane transport (GO:0055085),1/378,0.607844190073138,1.0,0,0,1.0797969981643452,0.5375625701164798,ABCA7,up,GO BP
368,phosphorylation (GO:0016310),1/386,0.6156117285417131,1.0,0,0,1.0574177857671567,0.512994422107322,TAF1,up,GO BP
369,negative regulation of programmed cell death (GO:0043069),1/408,0.6362036156415435,1.0,0,0,1.0004001600640255,0.45241758353284,ARHGDIA,up,GO BP
370,protein phosphorylation (GO:0006468),1/470,0.6885948155529351,1.0,0,0,0.8684324793747287,0.32401411817075204,TAF1,up,GO BP
371,negative regulation of apoptotic process (GO:0043066),1/485,0.700114766090204,1.0,0,0,0.8415737428992216,0.3000303015526076,ARHGDIA,up,GO BP
372,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),1/565,0.7548504432290065,1.0,0,0,0.7224128589488893,0.20316824113680354,TAF1,up,GO BP
373,regulation of apoptotic process (GO:0042981),1/815,0.8701098235613699,1.0,0,0,0.5008138224615,0.06968115253374718,ARHGDIA,up,GO BP
0,regulation of hydrogen peroxide metabolic process (GO:0010310),1/6,0.0032958256764104637,1.0,0,0,303.030303030303,1731.8480478097515,NOXA1,down,GO BP
1,regulation of respiratory burst (GO:0060263),1/10,0.005487567669022947,1.0,0,0,181.8181818181818,946.4127580312836,NOXA1,down,GO BP
2,spliceosomal tri-snRNP complex assembly (GO:0000244),1/12,0.0065817961978748354,1.0,0,0,151.5151515151515,761.1284231055006,PRPF19,down,GO BP
3,signal transduction involved in DNA damage checkpoint (GO:0072422),1/13,0.007128500182420091,1.0,0,0,139.86013986013987,691.4201985706308,PRPF19,down,GO BP
4,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),1/17,0.009312583434128836,1.0,0,0,106.951871657754,500.1485279087759,IGFBP2,down,GO BP
5,positive regulation of activated T cell proliferation (GO:0042104),1/19,0.010402987018789436,1.0,0,0,95.6937799043062,436.90548332320844,IGFBP2,down,GO BP
6,regulation of sprouting angiogenesis (GO:1903670),1/19,0.010402987018789436,1.0,0,0,95.6937799043062,436.90548332320844,EPN1,down,GO BP
7,innate immune response in mucosa (GO:0002227),1/19,0.010402987018789436,1.0,0,0,95.6937799043062,436.90548332320844,HIST2H2BE,down,GO BP
8,negative regulation of sprouting angiogenesis (GO:1903671),1/22,0.012036547438812549,1.0,0,0,82.64462809917354,365.27335849570125,EPN1,down,GO BP
9,regulation of AMPA receptor activity (GO:2000311),1/24,0.013124225781325726,1.0,0,0,75.75757575757575,328.27995911619576,CNIH2,down,GO BP
10,mucosal immune response (GO:0002385),1/24,0.013124225781325726,1.0,0,0,75.75757575757575,328.27995911619576,HIST2H2BE,down,GO BP
11,signal transduction in response to DNA damage (GO:0042770),1/25,0.013667656724254872,1.0,0,0,72.72727272727272,312.19804075139365,PRPF19,down,GO BP
12,synaptic vesicle endocytosis (GO:0048488),1/29,0.015838661771675533,1.0,0,0,62.69592476489028,259.8935034655946,SYT5,down,GO BP
13,regulation of activated T cell proliferation (GO:0046006),1/29,0.015838661771675533,1.0,0,0,62.69592476489028,259.8935034655946,IGFBP2,down,GO BP
14,synaptic vesicle recycling (GO:0036465),1/29,0.015838661771675533,1.0,0,0,62.69592476489028,259.8935034655946,SYT5,down,GO BP
15,superoxide metabolic process (GO:0006801),1/29,0.015838661771675533,1.0,0,0,62.69592476489028,259.8935034655946,NOXA1,down,GO BP
16,regulation of glutamate receptor signaling pathway (GO:1900449),1/32,0.017464064240814415,1.0,0,0,56.81818181818181,229.97783984491127,CNIH2,down,GO BP
17,regulation of neurotransmitter receptor activity (GO:0099601),1/33,0.01800532259639319,1.0,0,0,55.09641873278236,221.32715509624904,CNIH2,down,GO BP
18,antibacterial humoral response (GO:0019731),1/35,0.01908702632439229,1.0,0,0,51.94805194805194,205.64916492239948,HIST2H2BE,down,GO BP
19,regulation of cyclin-dependent protein kinase activity (GO:1904029),1/35,0.01908702632439229,1.0,0,0,51.94805194805194,205.64916492239948,CDK5R2,down,GO BP
20,vesicle-mediated transport in synapse (GO:0099003),1/36,0.01962747193991364,1.0,0,0,50.5050505050505,198.52651841030726,SYT5,down,GO BP
21,protein K63-linked ubiquitination (GO:0070534),1/37,0.020167646885642116,1.0,0,0,49.14004914004914,191.82681070737445,PRPF19,down,GO BP
22,spliceosomal snRNP assembly (GO:0000387),1/37,0.020167646885642116,1.0,0,0,49.14004914004914,191.82681070737445,PRPF19,down,GO BP
23,regulation of regulated secretory pathway (GO:1903305),1/37,0.020167646885642116,1.0,0,0,49.14004914004914,191.82681070737445,SYT5,down,GO BP
24,DNA damage checkpoint (GO:0000077),1/38,0.020707551273270317,1.0,0,0,47.84688995215311,185.5146817905487,PRPF19,down,GO BP
25,clathrin-dependent endocytosis (GO:0072583),1/39,0.021247185233602552,1.0,0,0,46.620046620046615,179.55854787787558,SYT5,down,GO BP
26,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/40,0.02178654888216798,1.0,0,0,45.45454545454545,173.93011469901603,EPN1,down,GO BP
27,spliceosomal complex assembly (GO:0000245),1/41,0.022325642342211446,1.0,0,0,44.345898004434595,168.603963649933,PRPF19,down,GO BP
28,negative regulation of ERBB signaling pathway (GO:1901185),1/43,0.02340301917551725,1.0,0,0,42.283298097251574,158.76914335503946,EPN1,down,GO BP
29,non-recombinational repair (GO:0000726),1/49,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157845,PRPF19,down,GO BP
30,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/49,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157845,HIST2H2BE,down,GO BP
31,regulation of reactive oxygen species metabolic process (GO:2000377),1/49,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157845,NOXA1,down,GO BP
32,double-strand break repair via nonhomologous end joining (GO:0006303),1/50,0.0271653448579924,1.0,0,0,36.36363636363636,131.12048014986075,PRPF19,down,GO BP
33,regulation of calcium ion-dependent exocytosis (GO:0017158),1/53,0.028773732993623582,1.0,0,0,34.30531732418525,121.72529526045805,SYT5,down,GO BP
34,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),1/58,0.031449009079719786,1.0,0,0,31.34796238244514,108.44475875019188,EPN1,down,GO BP
35,nucleosome assembly (GO:0006334),1/60,0.032517242545820016,1.0,0,0,30.3030303030303,103.81772092307816,HIST2H2BE,down,GO BP
36,positive regulation of T cell proliferation (GO:0042102),1/61,0.03305095755598113,1.0,0,0,29.806259314456035,101.63054367077929,IGFBP2,down,GO BP
37,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/63,0.034117584722214066,1.0,0,0,28.860028860028855,97.4875136105938,CNIH2,down,GO BP
38,vesicle coating (GO:0006901),1/63,0.034117584722214066,1.0,0,0,28.860028860028855,97.4875136105938,CNIH2,down,GO BP
39,COPII vesicle coating (GO:0048208),1/63,0.034117584722214066,1.0,0,0,28.860028860028855,97.4875136105938,CNIH2,down,GO BP
40,defense response to Gram-positive bacterium (GO:0050830),1/65,0.035183142220876845,1.0,0,0,27.97202797202797,93.62764266499985,HIST2H2BE,down,GO BP
41,chromatin assembly (GO:0031497),1/65,0.035183142220876845,1.0,0,0,27.97202797202797,93.62764266499985,HIST2H2BE,down,GO BP
42,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/67,0.03624763101785663,1.0,0,0,27.137042062415194,90.02391454677013,CDK5R2,down,GO BP
43,COPII-coated vesicle budding (GO:0090114),1/68,0.0367794749552908,1.0,0,0,26.7379679144385,88.31057045950347,CNIH2,down,GO BP
44,negative regulation of angiogenesis (GO:0016525),1/69,0.03731105207809084,1.0,0,0,26.350461133069828,86.65258745347978,EPN1,down,GO BP
45,regulation of cation channel activity (GO:2001257),1/71,0.03837340635379309,1.0,0,0,25.60819462227913,83.49271708519889,CNIH2,down,GO BP
46,organelle membrane fusion (GO:0090174),1/71,0.03837340635379309,1.0,0,0,25.60819462227913,83.49271708519889,SYT5,down,GO BP
47,transcription-coupled nucleotide-excision repair (GO:0006283),1/73,0.03943469482153839,1.0,0,0,24.906600249066,80.52576017269782,PRPF19,down,GO BP
48,nucleosome organization (GO:0034728),1/79,0.04261217490903927,1.0,0,0,23.014959723820482,72.62635835562412,HIST2H2BE,down,GO BP
49,regulation of protein serine/threonine kinase activity (GO:0071900),1/80,0.04314082499469826,1.0,0,0,22.72727272727273,71.43830714872377,CDK5R2,down,GO BP
50,protein catabolic process (GO:0030163),1/81,0.043669209702019214,1.0,0,0,22.446689113355774,70.28309783824933,PRPF19,down,GO BP
51,protein-DNA complex assembly (GO:0065004),1/91,0.048938487444328285,1.0,0,0,19.980019980019986,60.28353901643958,HIST2H2BE,down,GO BP
52,proteolysis involved in cellular protein catabolic process (GO:0051603),1/93,0.049989170431872655,1.0,0,0,19.550342130987293,58.57182577469862,PRPF19,down,GO BP
53,vesicle fusion (GO:0006906),1/94,0.05051411613720297,1.0,0,0,19.342359767891683,57.7466625588391,SYT5,down,GO BP
54,nucleotide-excision repair (GO:0006289),1/108,0.057835721217223385,1.0,0,0,16.835016835016837,47.98230101106203,PRPF19,down,GO BP
55,vesicle organization (GO:0016050),1/127,0.0676900970783306,1.0,0,0,14.316392269148176,38.551401378698,SYT5,down,GO BP
56,double-strand break repair (GO:0006302),1/141,0.0748911573283546,1.0,0,0,12.894906511927788,33.41998007904706,PRPF19,down,GO BP
57,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/148,0.07847269291023612,1.0,0,0,12.285012285012286,31.26541247822547,IGFBP2,down,GO BP
58,ribonucleoprotein complex assembly (GO:0022618),1/156,0.08255043847948365,1.0,0,0,11.655011655011654,29.071629335040523,PRPF19,down,GO BP
59,negative regulation of Wnt signaling pathway (GO:0030178),1/174,0.0916654573897091,1.0,0,0,10.449320794148381,24.96979793294625,IGFBP2,down,GO BP
60,ER to Golgi vesicle-mediated transport (GO:0006888),1/180,0.09468545262186537,1.0,0,0,10.1010101010101,23.81004955542997,CNIH2,down,GO BP
61,protein complex assembly (GO:0006461),1/189,0.0991983332467464,1.0,0,0,9.620009620009617,22.228321950751177,CNIH2,down,GO BP
62,regulation of canonical Wnt signaling pathway (GO:0060828),1/213,0.11113288082569198,1.0,0,0,8.536064874093043,18.753979249648008,IGFBP2,down,GO BP
63,regulation of signal transduction (GO:0009966),1/233,0.12096833412743813,1.0,0,0,7.803355442840421,16.482453913861264,IGFBP2,down,GO BP
64,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",1/236,0.1224350881991886,1.0,0,0,7.704160246533128,16.18007921179808,PRPF19,down,GO BP
65,proteasomal protein catabolic process (GO:0010498),1/237,0.12292351156490608,1.0,0,0,7.671653241273494,16.08126562515525,PRPF19,down,GO BP
66,anterograde trans-synaptic signaling (GO:0098916),1/240,0.12438729930510922,1.0,0,0,7.575757575757575,15.790569693236845,SYT5,down,GO BP
67,defense response to bacterium (GO:0042742),1/241,0.1248747347838204,1.0,0,0,7.544322897019992,15.695542556536891,HIST2H2BE,down,GO BP
68,"mRNA splicing, via spliceosome (GO:0000398)",1/261,0.1345717890784102,1.0,0,0,6.966213862765587,13.971838903086455,PRPF19,down,GO BP
69,Golgi vesicle transport (GO:0048193),1/271,0.13938359277392362,1.0,0,0,6.709158000670914,13.22056683313375,CNIH2,down,GO BP
70,mRNA processing (GO:0006397),1/283,0.14512564631064567,1.0,0,0,6.424670735624798,12.400612820420196,PRPF19,down,GO BP
71,protein polyubiquitination (GO:0000209),1/283,0.14512564631064567,1.0,0,0,6.424670735624798,12.400612820420196,PRPF19,down,GO BP
72,chemical synaptic transmission (GO:0007268),1/289,0.1479835926195893,1.0,0,0,6.291286568103177,12.020471041471984,SYT5,down,GO BP
73,cellular protein localization (GO:0034613),1/327,0.16588313247512798,1.0,0,0,5.5601890464275785,9.988722601051368,PRPF19,down,GO BP
74,vesicle-mediated transport (GO:0016192),1/410,0.20379652334942885,1.0,0,0,4.434589800443459,7.05380584243201,SYT5,down,GO BP
75,cellular protein metabolic process (GO:0044267),1/484,0.2362704804875858,1.0,0,0,3.7565740045078884,5.4199024285165045,IGFBP2,down,GO BP
76,protein ubiquitination (GO:0016567),1/506,0.24568997785912786,1.0,0,0,3.5932446999640666,5.043782933672597,PRPF19,down,GO BP
0,cullin-RING ubiquitin ligase complex (GO:0031461),3/181,0.009899359026938006,1.0,0,0,6.765136994024129,31.22303710919852,KBTBD6;KLHL41;CKS1B,up,GO CC
1,Cul3-RING ubiquitin ligase complex (GO:0031463),2/70,0.012771842039635313,1.0,0,0,11.661807580174925,50.851456232232465,KBTBD6;KLHL41,up,GO CC
2,THO complex part of transcription export complex (GO:0000445),1/6,0.014611943812165882,1.0,0,0,68.02721088435375,287.4772799576697,THOC3,up,GO CC
3,ATP-binding cassette (ABC) transporter complex (GO:0043190),1/8,0.019435974184612268,1.0,0,0,51.020408163265316,201.05253013595427,ABCA7,up,GO CC
4,cytoplasmic exosome (RNase complex) (GO:0000177),1/15,0.03613860922017235,1.0,0,0,27.2108843537415,90.3508429299313,DIS3L2,up,GO CC
5,transcriptionally active chromatin (GO:0035327),1/22,0.052562460131218174,1.0,0,0,18.55287569573284,54.652191090011996,ZC3H8,up,GO CC
6,MLL1 complex (GO:0071339),1/27,0.06412562148920224,1.0,0,0,15.11715797430083,41.52549181706361,TAF1,up,GO CC
7,MLL1/2 complex (GO:0044665),1/27,0.06412562148920224,1.0,0,0,15.11715797430083,41.52549181706361,TAF1,up,GO CC
8,lytic vacuole (GO:0000323),2/183,0.0740376032488283,1.0,0,0,4.460800713728115,11.612276849926555,AP3M1;SGSH,up,GO CC
9,Cajal body (GO:0015030),1/34,0.08008210609353099,1.0,0,0,12.004801920768307,30.308557556443446,ZC3H8,up,GO CC
10,transcription factor TFIID complex (GO:0005669),1/35,0.08233973871315534,1.0,0,0,11.661807580174925,29.118384092278692,TAF1,up,GO CC
11,nucleolus (GO:0005730),4/676,0.0831381784847287,1.0,0,0,2.4151672503320856,6.0071277729979835,CPT2;MTUS1;RPL7;TAF1,up,GO CC
12,aggresome (GO:0016235),1/41,0.09577199782508727,1.0,0,0,9.955201592832255,23.352761921448888,CABIN1,up,GO CC
13,ruffle membrane (GO:0032587),1/53,0.122061246826909,1.0,0,0,7.7011936850211775,16.197399592213856,ABCA7,up,GO CC
14,SCF ubiquitin ligase complex (GO:0019005),1/54,0.12421790857292912,1.0,0,0,7.558578987150415,15.765063707247872,CKS1B,up,GO CC
15,cytoskeleton (GO:0005856),3/520,0.13452984561226022,1.0,0,0,2.354788069073784,4.723632348729062,ARHGDIA;MTUS1;KLHL41,up,GO CC
16,polysome (GO:0005844),1/63,0.14339577707005752,1.0,0,0,6.478781988986071,12.582745706868382,DIS3L2,up,GO CC
17,P-body (GO:0000932),1/68,0.15387175170898196,1.0,0,0,6.002400960384153,11.234308551223542,DIS3L2,up,GO CC
18,cytosolic large ribosomal subunit (GO:0022625),1/69,0.1559518351617717,1.0,0,0,5.915409642117718,10.992061924687226,RPL7,up,GO CC
19,large ribosomal subunit (GO:0015934),1/72,0.1621620759393262,1.0,0,0,5.6689342403628125,10.312692602742626,RPL7,up,GO CC
20,chromatin (GO:0000785),2/296,0.16375313757849214,1.0,0,0,2.757859900717044,4.990058587605231,ZC3H8;TAF1,up,GO CC
21,early endosome membrane (GO:0031901),1/73,0.16422219226923945,1.0,0,0,5.5912776069331835,10.100838340526812,GGA1,up,GO CC
22,lysosomal lumen (GO:0043202),1/86,0.19055636178365606,1.0,0,0,4.7460844803037485,7.868093335513186,SGSH,up,GO CC
23,"DNA-directed RNA polymerase II, holoenzyme (GO:0016591)",1/90,0.19849439487603893,1.0,0,0,4.5351473922902485,7.333308012035746,TAF1,up,GO CC
24,mitochondrial inner membrane (GO:0005743),2/341,0.20339566214404872,1.0,0,0,2.393919444610689,3.8125611881513435,CPT2;COX15,up,GO CC
25,"nuclear chromosome, telomeric region (GO:0000784)",1/107,0.2313887434989261,1.0,0,0,3.8146099561319855,5.5832771718997884,THOC3,up,GO CC
26,microtubule cytoskeleton (GO:0015630),2/388,0.2458522720516027,1.0,0,0,2.103934357248054,2.9518713308429096,TPPP3;MTUS1,up,GO CC
27,mitochondrial outer membrane (GO:0005741),1/115,0.2464072197465133,1.0,0,0,3.5492457852706303,4.971676120080727,AGPAT5,up,GO CC
28,nuclear chromosome part (GO:0044454),2/392,0.2494918936199796,1.0,0,0,2.0824656393169514,2.8911471362338097,THOC3;TAF1,up,GO CC
29,"chromosome, telomeric region (GO:0000781)",1/124,0.26295952305137155,1.0,0,0,3.2916392363396967,4.3968241059794595,THOC3,up,GO CC
30,cytosolic ribosome (GO:0022626),1/124,0.26295952305137155,1.0,0,0,3.2916392363396967,4.3968241059794595,RPL7,up,GO CC
31,nucleoplasm part (GO:0044451),2/407,0.263157412308478,1.0,0,0,2.005716291430577,2.677637065560455,ZC3H8;TAF1,up,GO CC
32,lysosome (GO:0005764),2/422,0.2768350054637457,1.0,0,0,1.9344230583228557,2.484444527341046,AP3M1;SGSH,up,GO CC
33,RNA polymerase II transcription factor complex (GO:0090575),1/147,0.3036587378991768,1.0,0,0,2.7766208524226017,3.309317731036141,TAF1,up,GO CC
34,cytosolic part (GO:0044445),1/159,0.32401061243337953,1.0,0,0,2.5670645616737264,2.893027876529872,RPL7,up,GO CC
35,vacuolar lumen (GO:0005775),1/161,0.3273454602523001,1.0,0,0,2.535175560907593,2.8311299591027383,SGSH,up,GO CC
36,cytoplasmic ribonucleoprotein granule (GO:0036464),1/170,0.34215391769017306,1.0,0,0,2.4009603841536613,2.575017026258781,DIS3L2,up,GO CC
37,microtubule (GO:0005874),1/210,0.4041963688398145,1.0,0,0,1.9436345966958213,1.76065006341286,TPPP3,up,GO CC
38,polymeric cytoskeletal fiber (GO:0099513),1/221,0.4202282253075736,1.0,0,0,1.8468926031951245,1.6011770647337644,TPPP3,up,GO CC
39,early endosome (GO:0005769),1/222,0.421664534596916,1.0,0,0,1.838573267144696,1.5876911615982867,GGA1,up,GO CC
40,lytic vacuole membrane (GO:0098852),1/233,0.4372356849478535,1.0,0,0,1.7517736708417273,1.4492124103467563,AP3M1,up,GO CC
41,mitochondrion (GO:0005739),3/1026,0.4632958206075837,1.0,0,0,1.1934598400763814,0.9182354786019958,AGPAT5;CPT2;COX15,up,GO CC
42,nuclear chromatin (GO:0000790),1/253,0.4645015534354056,1.0,0,0,1.6132935387593772,1.2370579598555995,TAF1,up,GO CC
43,lysosomal membrane (GO:0005765),1/291,0.5127879026587183,1.0,0,0,1.402622904832036,0.9368019698619438,AP3M1,up,GO CC
44,focal adhesion (GO:0005925),1/356,0.5856819748214155,1.0,0,0,1.1465260261407937,0.6133665923019251,RPL7,up,GO CC
45,perinuclear region of cytoplasm (GO:0048471),1/378,0.607844190073138,1.0,0,0,1.0797969981643452,0.5375625701164798,TPPP3,up,GO CC
46,Golgi membrane (GO:0000139),1/442,0.6659196445860133,1.0,0,0,0.9234463015975622,0.3754605868462047,SCAP,up,GO CC
47,Golgi subcompartment (GO:0098791),1/479,0.6955577691854211,1.0,0,0,0.8521153764219674,0.309352997055367,SCAP,up,GO CC
48,integral component of plasma membrane (GO:0005887),3/1463,0.7055213863332834,1.0,0,0,0.8369718358977221,0.29195100458099843,PTPRD;SLC31A1;SCN9A,up,GO CC
49,nuclear body (GO:0016604),1/618,0.7855886943090409,1.0,0,0,0.6604583581005218,0.1593830745656919,ZC3H8,up,GO CC
0,AMPA glutamate receptor complex (GO:0032281),1/18,0.009857921634816495,1.0,0,0,101.010101010101,466.6141333465025,CNIH2,down,GO CC
1,U2-type catalytic step 2 spliceosome (GO:0071007),1/29,0.015838661771675533,1.0,0,0,62.69592476489028,259.8935034655946,PRPF19,down,GO CC
2,site of double-strand break (GO:0035861),1/34,0.018546309917010683,1.0,0,0,53.475935828877,213.23446181945755,PRPF19,down,GO CC
3,site of DNA damage (GO:0090734),1/37,0.020167646885642116,1.0,0,0,49.14004914004914,191.82681070737445,PRPF19,down,GO CC
4,ionotropic glutamate receptor complex (GO:0008328),1/39,0.021247185233602552,1.0,0,0,46.620046620046615,179.55854787787558,CNIH2,down,GO CC
5,endoplasmic reticulum-Golgi intermediate compartment membrane (GO:0033116),1/47,0.025554535876943483,1.0,0,0,38.684719535783366,141.8545628107789,CNIH2,down,GO CC
6,ER to Golgi transport vesicle membrane (GO:0012507),1/54,0.029309324971107782,1.0,0,0,33.670033670033675,118.85015337350148,CNIH2,down,GO CC
7,U2-type spliceosomal complex (GO:0005684),1/60,0.032517242545820016,1.0,0,0,30.3030303030303,103.81772092307816,PRPF19,down,GO CC
8,cation channel complex (GO:0034703),1/65,0.035183142220876845,1.0,0,0,27.97202797202797,93.62764266499985,CNIH2,down,GO CC
9,COPII-coated ER to Golgi transport vesicle (GO:0030134),1/75,0.04049491842710541,1.0,0,0,24.24242424242424,77.73524324066544,CNIH2,down,GO CC
10,endoplasmic reticulum-Golgi intermediate compartment (GO:0005793),1/95,0.051038798139041684,1.0,0,0,19.13875598086124,56.94103708431418,CNIH2,down,GO CC
11,dendrite (GO:0030425),1/215,0.11212090854714336,1.0,0,0,8.456659619450317,18.504671876299977,CNIH2,down,GO CC
12,nuclear speck (GO:0016607),1/296,0.1513068837331026,1.0,0,0,6.142506142506143,11.59978600723729,PRPF19,down,GO CC
13,nuclear body (GO:0016604),1/618,0.2920269333526104,1.0,0,0,2.942041776993233,3.6213864179421393,PRPF19,down,GO CC
0,ubiquitin binding (GO:0043130),2/62,0.010125571527613491,1.0,0,0,13.166556945358787,60.469930485989636,UBAP1;CKS1B,up,GO MF
1,ADP-ribosylation factor binding (GO:0030306),1/6,0.014611943812165882,1.0,0,0,68.02721088435375,287.4772799576697,GGA1,up,GO MF
2,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding (GO:0001162),1/6,0.014611943812165882,1.0,0,0,68.02721088435375,287.4772799576697,ZC3H8,up,GO MF
3,ubiquitin-protein transferase activity (GO:0004842),4/417,0.01887060800213517,1.0,0,0,3.915235158811726,15.544069689431204,KBTBD6;UBE2NL;KLHL41;TAF1,up,GO MF
4,phosphatidylcholine transporter activity (GO:0008525),1/8,0.019435974184612268,1.0,0,0,51.020408163265316,201.05253013595427,ABCA7,up,GO MF
5,intronic transcription regulatory region sequence-specific DNA binding (GO:0001161),1/8,0.019435974184612268,1.0,0,0,51.020408163265316,201.05253013595427,ZC3H8,up,GO MF
6,DNA binding (GO:0003677),6/893,0.021236405146642098,1.0,0,0,2.742418355920196,10.563900668187868,PURB;ZC3H8;AFF1;MLF1;RPL7;TAF1,up,GO MF
7,"transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly (GO:0001075)",1/9,0.021839307484116888,1.0,0,0,45.351473922902485,173.42602436330466,TAF1,up,GO MF
8,double-stranded DNA binding (GO:0003690),2/99,0.024529187812367872,1.0,0,0,8.245722531436819,30.574244743208908,PURB;AFF1,up,GO MF
9,"oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor (GO:0016653)",1/13,0.03139507576319159,1.0,0,0,31.39717425431711,108.66889234518707,COX15,up,GO MF
10,vitamin D receptor binding (GO:0042809),1/14,0.033769693865094014,1.0,0,0,29.15451895043732,98.7810935836037,MED13,up,GO MF
11,poly(A) binding (GO:0008143),1/14,0.033769693865094014,1.0,0,0,29.15451895043732,98.7810935836037,PABPC3,up,GO MF
12,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),1/15,0.03613860922017235,1.0,0,0,27.2108843537415,90.3508429299313,PTPRD,up,GO MF
13,transmembrane receptor protein phosphatase activity (GO:0019198),1/15,0.03613860922017235,1.0,0,0,27.2108843537415,90.3508429299313,PTPRD,up,GO MF
14,poly(U) RNA binding (GO:0008266),1/16,0.03850183520662026,1.0,0,0,25.510204081632647,83.08799416122565,DIS3L2,up,GO MF
15,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),1/18,0.04321127244441888,1.0,0,0,22.67573696145125,71.23931704209987,AGPAT5,up,GO MF
16,phosphatase inhibitor activity (GO:0019212),1/18,0.04321127244441888,1.0,0,0,22.67573696145125,71.23931704209987,CABIN1,up,GO MF
17,lysine-acetylated histone binding (GO:0070577),1/18,0.04321127244441888,1.0,0,0,22.67573696145125,71.23931704209987,TAF1,up,GO MF
18,acetylation-dependent protein binding (GO:0140033),1/18,0.04321127244441888,1.0,0,0,22.67573696145125,71.23931704209987,TAF1,up,GO MF
19,ubiquitin conjugating enzyme activity (GO:0061631),1/20,0.04789811206941787,1.0,0,0,20.40816326530613,62.01386100697238,TAF1,up,GO MF
20,poly-purine tract binding (GO:0070717),1/20,0.04789811206941787,1.0,0,0,20.40816326530613,62.01386100697238,PABPC3,up,GO MF
21,poly-pyrimidine tract binding (GO:0008187),1/20,0.04789811206941787,1.0,0,0,20.40816326530613,62.01386100697238,DIS3L2,up,GO MF
22,phospholipid-translocating ATPase activity (GO:0004012),1/20,0.04789811206941787,1.0,0,0,20.40816326530613,62.01386100697238,ABCA7,up,GO MF
23,"transcription factor activity, RNA polymerase II core promoter sequence-specific (GO:0000983)",1/20,0.04789811206941787,1.0,0,0,20.40816326530613,62.01386100697238,TAF1,up,GO MF
24,lysophosphatidic acid acyltransferase activity (GO:0042171),1/20,0.04789811206941787,1.0,0,0,20.40816326530613,62.01386100697238,AGPAT5,up,GO MF
25,ubiquitin-like protein conjugating enzyme activity (GO:0061650),1/21,0.0502330909367498,1.0,0,0,19.43634596695821,58.135690718027526,TAF1,up,GO MF
26,TBP-class protein binding (GO:0017025),1/21,0.0502330909367498,1.0,0,0,19.43634596695821,58.135690718027526,TAF1,up,GO MF
27,protein phosphatase inhibitor activity (GO:0004864),1/23,0.054886232846338284,1.0,0,0,17.74622892635315,51.50830043904919,CABIN1,up,GO MF
28,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1905030),1/23,0.054886232846338284,1.0,0,0,17.74622892635315,51.50830043904919,SCN9A,up,GO MF
29,voltage-gated sodium channel activity (GO:0005248),1/23,0.054886232846338284,1.0,0,0,17.74622892635315,51.50830043904919,SCN9A,up,GO MF
30,protein-cysteine S-palmitoyltransferase activity (GO:0019706),1/24,0.057204422219257416,1.0,0,0,17.006802721088437,48.658572654069516,ZDHHC6,up,GO MF
31,protein-cysteine S-acyltransferase activity (GO:0019707),1/24,0.057204422219257416,1.0,0,0,17.006802721088437,48.658572654069516,ZDHHC6,up,GO MF
32,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",1/25,0.059517041402020875,1.0,0,0,16.3265306122449,46.06518526236904,DIS3L2,up,GO MF
33,thyroid hormone receptor binding (GO:0046966),1/26,0.06182410346022105,1.0,0,0,15.698587127158554,43.69642020297904,MED13,up,GO MF
34,carboxy-lyase activity (GO:0016831),1/26,0.06182410346022105,1.0,0,0,15.698587127158554,43.69642020297904,AMD1,up,GO MF
35,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),1/27,0.06412562148920224,1.0,0,0,15.11715797430083,41.52549181706361,CKS1B,up,GO MF
36,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),1/27,0.06412562148920224,1.0,0,0,15.11715797430083,41.52549181706361,TAF1,up,GO MF
37,palmitoyltransferase activity (GO:0016409),1/28,0.06642160851252993,1.0,0,0,14.57725947521866,39.529633324123054,ZDHHC6,up,GO MF
38,acylglycerol O-acyltransferase activity (GO:0016411),1/28,0.06642160851252993,1.0,0,0,14.57725947521866,39.529633324123054,AGPAT5,up,GO MF
39,mRNA binding (GO:0003729),2/179,0.07125997090554112,1.0,0,0,4.560483411241592,12.046154495909288,PURB;RPL7,up,GO MF
40,sequence-specific DNA binding (GO:0043565),3/394,0.07196252095280897,1.0,0,0,3.1078421216202217,8.17862790163898,PURB;ZC3H8;TAF1,up,GO MF
41,3'-5'-exoribonuclease activity (GO:0000175),1/31,0.0732765135248936,1.0,0,0,13.166556945358787,34.41099588139884,DIS3L2,up,GO MF
42,protein serine/threonine kinase activator activity (GO:0043539),1/31,0.0732765135248936,1.0,0,0,13.166556945358787,34.41099588139884,CKS1B,up,GO MF
43,transition metal ion transmembrane transporter activity (GO:0046915),1/32,0.07555050634212196,1.0,0,0,12.755102040816329,32.94584041079259,SLC31A1,up,GO MF
44,3'-5' exonuclease activity (GO:0008408),1/38,0.08908012117667435,1.0,0,0,10.741138560687432,25.97442616843159,DIS3L2,up,GO MF
45,peptide-lysine-N-acetyltransferase activity (GO:0061733),1/39,0.09131611933080344,1.0,0,0,10.465724751439037,25.048958173793586,TAF1,up,GO MF
46,sodium channel activity (GO:0005272),1/40,0.0935467406593446,1.0,0,0,10.204081632653065,24.176470076489622,SCN9A,up,GO MF
47,histone acetyltransferase activity (GO:0004402),1/41,0.09577199782508727,1.0,0,0,9.955201592832255,23.352761921448888,TAF1,up,GO MF
48,"hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances (GO:0016820)",1/42,0.09799190344985674,1.0,0,0,9.718172983479104,22.574056575152703,ABCA7,up,GO MF
49,RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977),3/460,0.10274155898370348,1.0,0,0,2.6619343389529724,6.05733428568915,PURB;ZC3H8;TAF1,up,GO MF
50,P-P-bond-hydrolysis-driven transmembrane transporter activity (GO:0015405),1/45,0.10461963696044026,1.0,0,0,9.0702947845805,20.475501234681968,ABCA7,up,GO MF
51,"ATPase activity, coupled to transmembrane movement of substances (GO:0042626)",1/45,0.10461963696044026,1.0,0,0,9.0702947845805,20.475501234681968,ABCA7,up,GO MF
52,protein phosphatase regulator activity (GO:0019888),1/47,0.10901159849285977,1.0,0,0,8.684324793747287,19.247077674533823,CABIN1,up,GO MF
53,ribonuclease activity (GO:0004540),1/49,0.11338245452043423,1.0,0,0,8.329862557267807,18.134016007506887,DIS3L2,up,GO MF
54,RNA binding (GO:0003723),6/1387,0.1215696666002297,1.0,0,0,1.7656666127157423,3.720732385920362,PURB;RBM12B;NBPF10;ZC3H8;GPATCH4;RPL7,up,GO MF
55,methylated histone binding (GO:0035064),1/55,0.12636938033824105,1.0,0,0,7.421150278293135,15.350991248791996,TAF1,up,GO MF
56,SH3 domain binding (GO:0017124),1/55,0.12636938033824105,1.0,0,0,7.421150278293135,15.350991248791996,ADAM15,up,GO MF
57,"ATPase activity, coupled to movement of substances (GO:0043492)",1/56,0.1285156743868668,1.0,0,0,7.288629737609329,14.954113720272913,ABCA7,up,GO MF
58,"transferase activity, transferring acyl groups other than amino-acyl groups (GO:0016747)",1/56,0.1285156743868668,1.0,0,0,7.288629737609329,14.954113720272913,ZDHHC6,up,GO MF
59,nuclear hormone receptor binding (GO:0035257),1/56,0.1285156743868668,1.0,0,0,7.288629737609329,14.954113720272913,MED13,up,GO MF
60,tubulin binding (GO:0015631),2/255,0.1291411867660454,1.0,0,0,3.2012805122048817,6.552537821729147,TPPP3;MTUS1,up,GO MF
61,nuclease activity (GO:0004518),1/59,0.1349236118713764,1.0,0,0,6.918021445866482,13.857118634937684,DIS3L2,up,GO MF
62,protein heterodimerization activity (GO:0046982),2/265,0.13741365721745422,1.0,0,0,3.0804774740084717,6.114006951487249,GGA1;TAF1,up,GO MF
63,protein tyrosine phosphatase activity (GO:0004725),1/62,0.14128538719624215,1.0,0,0,6.583278472679393,12.883300931598015,PTPRD,up,GO MF
64,small GTPase binding (GO:0031267),1/63,0.14339577707005752,1.0,0,0,6.478781988986071,12.582745706868382,GGA1,up,GO MF
65,ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374),1/65,0.1476013260006852,1.0,0,0,6.2794348508634235,12.01406833979051,MED13,up,GO MF
66,metalloendopeptidase activity (GO:0004222),1/65,0.1476013260006852,1.0,0,0,6.2794348508634235,12.01406833979051,ADAM15,up,GO MF
67,transcription coactivator activity (GO:0003713),2/291,0.15944149349257508,1.0,0,0,2.805245809664072,5.1506507777767805,MED13;TAF1,up,GO MF
68,core promoter sequence-specific DNA binding (GO:0001046),1/73,0.16422219226923945,1.0,0,0,5.5912776069331835,10.100838340526812,TAF1,up,GO MF
69,ubiquitin-like protein-specific protease activity (GO:0019783),1/74,0.1662773462428849,1.0,0,0,5.515719801434088,9.895742549883874,OTUD3,up,GO MF
70,thiol-dependent ubiquitin-specific protease activity (GO:0004843),1/76,0.1703728138367953,1.0,0,0,5.370569280343716,9.5046520973501,OTUD3,up,GO MF
71,RNA polymerase II transcription cofactor activity (GO:0001104),1/84,0.1865585167269208,1.0,0,0,4.859086491739553,8.158456396990406,MED13,up,GO MF
72,single-stranded DNA binding (GO:0003697),1/87,0.19254806017668188,1.0,0,0,4.691531785127844,7.728874000279107,PURB,up,GO MF
73,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",1/88,0.1945349576029131,1.0,0,0,4.63821892393321,7.593429505876667,CTBP2,up,GO MF
74,thiol-dependent ubiquitinyl hydrolase activity (GO:0036459),1/92,0.20243476399124585,1.0,0,0,4.436557231588288,7.08667966933301,OTUD3,up,GO MF
75,ion channel activity (GO:0005216),1/93,0.20439782611070498,1.0,0,0,4.388852315119597,6.96812401218066,SCN9A,up,GO MF
76,integrin binding (GO:0005178),1/94,0.20635615488224895,1.0,0,0,4.3421623968736425,6.852590950224973,ADAM15,up,GO MF
77,cation transmembrane transporter activity (GO:0008324),1/97,0.21220285264448208,1.0,0,0,4.207868714496108,6.5230911411936345,SCN9A,up,GO MF
78,metallopeptidase activity (GO:0008237),1/102,0.2218537199073844,1.0,0,0,4.001600640256102,6.0253582778260055,ADAM15,up,GO MF
79,transcription regulatory region DNA binding (GO:0044212),2/374,0.2331369970381504,1.0,0,0,2.1826912583215106,3.178280100583489,PURB;TAF1,up,GO MF
80,sequence-specific double-stranded DNA binding (GO:1990837),1/112,0.24080928525036116,1.0,0,0,3.6443148688046647,5.188593317350888,PURB,up,GO MF
81,RNA polymerase II transcription factor binding (GO:0001085),1/121,0.257482053509444,1.0,0,0,3.37325012649688,4.576843502837304,TAF1,up,GO MF
82,magnesium ion binding (GO:0000287),1/127,0.2683974045277928,1.0,0,0,3.2138839787883664,4.227178351586288,DIS3L2,up,GO MF
83,kinase binding (GO:0019900),2/418,0.2731875259076744,1.0,0,0,1.9529342837613517,2.534121299724316,CTBP2;CKS1B,up,GO MF
84,Rab GTPase binding (GO:0017137),1/130,0.2737959781604629,1.0,0,0,3.1397174254317117,4.067102214141391,AP3M1,up,GO MF
85,cation channel activity (GO:0005261),1/146,0.301935906875971,1.0,0,0,2.7956388034665918,3.3478907269178584,SCN9A,up,GO MF
86,"transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding (GO:0001227)",1/159,0.32401061243337953,1.0,0,0,2.5670645616737264,2.893027876529872,PURB,up,GO MF
87,protein kinase binding (GO:0019901),2/495,0.3430109098953936,1.0,0,0,1.6491445062873635,1.7645731190217897,CTBP2;CKS1B,up,GO MF
88,Ras GTPase binding (GO:0017016),1/184,0.3645567344401913,1.0,0,0,2.218278615794144,2.2384052564417884,AP3M1,up,GO MF
89,"peptidase activity, acting on L-amino acid peptides (GO:0070011)",1/185,0.3661280236109952,1.0,0,0,2.2062879205736348,2.216816801889925,ADAM15,up,GO MF
90,ubiquitin-like protein ligase activity (GO:0061659),1/186,0.3676955064724341,1.0,0,0,2.1944261575597985,2.1955236150642783,UBE2NL,up,GO MF
91,ubiquitin protein ligase activity (GO:0061630),1/192,0.3770209754460539,1.0,0,0,2.1258503401360542,2.0736701855737865,UBE2NL,up,GO MF
92,microtubule binding (GO:0008017),1/195,0.3816330514858885,1.0,0,0,2.093144950287808,2.0163175934069586,MTUS1,up,GO MF
93,RNA polymerase II regulatory region DNA binding (GO:0001012),1/201,0.39075708304605,1.0,0,0,2.030663011473246,1.908151453035896,PURB,up,GO MF
94,transcription corepressor activity (GO:0003714),1/203,0.3937690190040998,1.0,0,0,2.0106564793405046,1.873913316127828,CTBP2,up,GO MF
95,ATPase activity (GO:0016887),1/203,0.3937690190040998,1.0,0,0,2.0106564793405046,1.873913316127828,ABCA7,up,GO MF
96,regulatory region DNA binding (GO:0000975),1/224,0.4245267040312901,1.0,0,0,1.8221574344023324,1.5611887175405181,TAF1,up,GO MF
97,protein homodimerization activity (GO:0042803),2/664,0.4873020345206853,1.0,0,0,1.2294074256208507,0.8837855348571068,CTBP2;RPL7,up,GO MF
98,kinase activity (GO:0016301),1/280,0.4992669609297039,1.0,0,0,1.4577259475218658,1.0125573388405829,TAF1,up,GO MF
99,ubiquitin protein ligase binding (GO:0031625),1/284,0.5042256660474921,1.0,0,0,1.4371945961483186,0.9840922118808566,UBE2NL,up,GO MF
100,transcription regulatory region sequence-specific DNA binding (GO:0000976),1/292,0.5139991937339735,1.0,0,0,1.3978194017332959,0.9302957536191624,PURB,up,GO MF
101,ubiquitin-like protein ligase binding (GO:0044389),1/297,0.5200115368245155,1.0,0,0,1.374287088572803,0.8986522111616613,UBE2NL,up,GO MF
102,endopeptidase activity (GO:0004175),1/354,0.5836074304796434,1.0,0,0,1.1530035743110805,0.6209232448632143,ADAM15,up,GO MF
103,protein serine/threonine kinase activity (GO:0004674),1/368,0.5979182831384894,1.0,0,0,1.109139307897072,0.5704316599812431,TAF1,up,GO MF
104,nucleoside-triphosphatase activity (GO:0017111),1/424,0.6504968233712418,1.0,0,0,0.9626492106276472,0.4139573203756573,ABCA7,up,GO MF
105,metal ion binding (GO:0046872),1/442,0.6659196445860133,1.0,0,0,0.9234463015975622,0.3754605868462047,DIS3L2,up,GO MF
106,protein kinase activity (GO:0004672),1/513,0.7205123579213936,1.0,0,0,0.7956398933842542,0.26080495828536304,TAF1,up,GO MF
0,insulin-like growth factor II binding (GO:0031995),1/7,0.00384417200458596,1.0,0,0,259.7402597402597,1444.4667643181622,IGFBP2,down,GO MF
1,superoxide-generating NADPH oxidase activator activity (GO:0016176),1/9,0.0049400429229450454,1.0,0,0,202.020202020202,1072.8042947403599,NOXA1,down,GO MF
2,ubiquitin-ubiquitin ligase activity (GO:0034450),1/13,0.007128500182420091,1.0,0,0,139.86013986013987,691.4201985706308,PRPF19,down,GO MF
3,insulin-like growth factor I binding (GO:0031994),1/13,0.007128500182420091,1.0,0,0,139.86013986013987,691.4201985706308,IGFBP2,down,GO MF
4,insulin-like growth factor binding (GO:0005520),1/14,0.007674930787541143,1.0,0,0,129.87012987012986,632.4410394103227,IGFBP2,down,GO MF
5,protein serine/threonine kinase activator activity (GO:0043539),1/31,0.016922534733463997,1.0,0,0,58.65102639296187,239.24393718954147,CDK5R2,down,GO MF
6,Rac GTPase binding (GO:0048365),1/43,0.02340301917551725,1.0,0,0,42.283298097251574,158.76914335503946,NOXA1,down,GO MF
7,calcium-dependent phospholipid binding (GO:0005544),1/47,0.025554535876943483,1.0,0,0,38.684719535783366,141.8545628107789,SYT5,down,GO MF
8,SH3 domain binding (GO:0017124),1/55,0.029844648447595826,1.0,0,0,33.057851239669425,116.09090038690742,NOXA1,down,GO MF
9,Rho GTPase binding (GO:0017048),1/72,0.03890418375818435,1.0,0,0,25.25252525252525,81.98619905345255,NOXA1,down,GO MF
10,syntaxin binding (GO:0019905),1/77,0.0415540781399269,1.0,0,0,23.612750885478157,75.10648435226321,SYT5,down,GO MF
11,ubiquitin-like protein ligase activity (GO:0061659),1/186,0.0976963172043407,1.0,0,0,9.775171065493646,22.735986467097653,PRPF19,down,GO MF
12,ubiquitin protein ligase activity (GO:0061630),1/192,0.1006980759679046,1.0,0,0,9.469696969696967,21.738907064536768,PRPF19,down,GO MF
13,calcium ion binding (GO:0005509),1/284,0.14560257506488405,1.0,0,0,6.402048655569782,12.335944030030424,SYT5,down,GO MF
14,ubiquitin-protein transferase activity (GO:0004842),1/417,0.20692126889930912,1.0,0,0,4.360148245040331,6.86905123848831,PRPF19,down,GO MF
15,metal ion binding (GO:0046872),1/442,0.21799028511186305,1.0,0,0,4.113533525298231,6.266165285450803,SYT5,down,GO MF
16,DNA binding (GO:0003677),1/893,0.3950323435681387,1.0,0,0,2.0360378703043875,1.8910467982942398,HIST2H2BE,down,GO MF
0,Lysosome,3/123,0.003402738900445428,1.0,0,0,9.955201592832255,56.57714895663468,GGA1;AP3M1;SGSH,up,KEGG
1,Glycosaminoglycan degradation,1/19,0.045557510321821836,1.0,0,0,21.482277121374864,66.35402337351628,SGSH,up,KEGG
2,RNA transport,2/165,0.06182511643006713,1.0,0,0,4.94743351886209,13.770911972079565,PABPC3;THOC3,up,KEGG
3,Transcriptional misregulation in cancer,2/186,0.07614366001328325,1.0,0,0,4.388852315119597,11.301880446182524,AFF1;MLF1,up,KEGG
4,Porphyrin and chlorophyll metabolism,1/42,0.09799190344985674,1.0,0,0,9.718172983479104,22.574056575152703,COX15,up,KEGG
5,Fatty acid degradation,1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,CPT2,up,KEGG
6,Vasopressin-regulated water reabsorption,1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,ARHGDIA,up,KEGG
7,ABC transporters,1/45,0.10461963696044026,1.0,0,0,9.0702947845805,20.475501234681968,ABCA7,up,KEGG
8,Basal transcription factors,1/45,0.10461963696044026,1.0,0,0,9.0702947845805,20.475501234681968,TAF1,up,KEGG
9,Cysteine and methionine metabolism,1/47,0.10901159849285977,1.0,0,0,8.684324793747287,19.247077674533823,AMD1,up,KEGG
10,Thermogenesis,2/231,0.10982643836999696,1.0,0,0,3.533881084901493,7.80582734262446,CPT2;COX15,up,KEGG
11,Notch signaling pathway,1/48,0.11119965848123284,1.0,0,0,8.503401360544219,18.67710857467947,CTBP2,up,KEGG
12,Arginine and proline metabolism,1/49,0.11338245452043423,1.0,0,0,8.329862557267807,18.134016007506887,AMD1,up,KEGG
13,Mineral absorption,1/51,0.11773230434297198,1.0,0,0,8.003201280512204,17.12158334507697,SLC31A1,up,KEGG
14,Glycerolipid metabolism,1/61,0.13916990440240695,1.0,0,0,6.691201070592173,13.195448367099164,AGPAT5,up,KEGG
15,PPAR signaling pathway,1/74,0.1662773462428849,1.0,0,0,5.515719801434088,9.895742549883874,CPT2,up,KEGG
16,Chronic myeloid leukemia,1/76,0.1703728138367953,1.0,0,0,5.370569280343716,9.5046520973501,CTBP2,up,KEGG
17,RNA degradation,1/79,0.1764790891137693,1.0,0,0,5.1666236114699045,8.961781890486334,PABPC3,up,KEGG
18,Taste transduction,1/83,0.1845523472379876,1.0,0,0,4.917629702483403,8.309919502713068,SCN9A,up,KEGG
19,mRNA surveillance pathway,1/91,0.20046695733149195,1.0,0,0,4.485310607759588,7.208368904040989,PABPC3,up,KEGG
20,Small cell lung cancer,1/93,0.20439782611070498,1.0,0,0,4.388852315119597,6.96812401218066,CKS1B,up,KEGG
21,Glycerophospholipid metabolism,1/97,0.21220285264448208,1.0,0,0,4.207868714496108,6.5230911411936345,AGPAT5,up,KEGG
22,Thyroid hormone signaling pathway,1/116,0.24826419695837745,1.0,0,0,3.518648838845883,4.902398977978437,MED13,up,KEGG
23,Neurotrophin signaling pathway,1/119,0.2538082745383733,1.0,0,0,3.4299434059338014,4.703056496790394,ARHGDIA,up,KEGG
24,Oxidative phosphorylation,1/133,0.2791555222256205,1.0,0,0,3.0688967316249807,3.9158699559113153,COX15,up,KEGG
25,Spliceosome,1/134,0.28093341146581,1.0,0,0,3.0459945172098686,3.867309191601433,THOC3,up,KEGG
26,Ubiquitin mediated proteolysis,1/137,0.28624134560631603,1.0,0,0,2.9792939073439597,3.7268582102203514,UBE2NL,up,KEGG
27,Phospholipase D signaling pathway,1/148,0.3053774035133981,1.0,0,0,2.757859900717044,3.2713923848331303,AGPAT5,up,KEGG
28,Ribosome,1/153,0.3139085948171959,1.0,0,0,2.667733760170735,3.0909788842465113,RPL7,up,KEGG
29,Wnt signaling pathway,1/158,0.3223371204330746,1.0,0,0,2.583311805734952,2.924715379098926,CTBP2,up,KEGG
30,Pathways in cancer,2/530,0.374177063372468,1.0,0,0,1.5402387370042356,1.5140949743915917,CTBP2;CKS1B,up,KEGG
0,Systemic lupus erythematosus,1/133,0.0707824821112975,1.0,0,0,13.67053998632946,36.201554842164114,HIST2H2BE,down,KEGG
1,Spliceosome,1/134,0.07129697211276262,1.0,0,0,13.568521031207595,35.83312644946137,PRPF19,down,KEGG
2,Ubiquitin mediated proteolysis,1/137,0.07283888870776588,1.0,0,0,13.271400132714,34.76450273204473,PRPF19,down,KEGG
3,Alcoholism,1/180,0.09468545262186537,1.0,0,0,10.1010101010101,23.81004955542997,HIST2H2BE,down,KEGG
4,Viral carcinogenesis,1/201,0.10518369495092053,1.0,0,0,9.045680687471732,20.37129788920578,HIST2H2BE,down,KEGG
5,Endocytosis,1/244,0.12633556158899392,1.0,0,0,7.451564828614009,15.41589958879108,EPN1,down,KEGG
0,"Fatty acid, triacylglycerol, and ketone body metabolism Homo sapiens R-HSA-535734",3/217,0.0160912469066545,1.0,0,0,5.642810119439481,23.30187054581879,AGPAT5;MED13;CPT2,up,Reactome
1,Axonal growth inhibition (RHOA activation) Homo sapiens R-HSA-193634,1/8,0.019435974184612268,1.0,0,0,51.020408163265316,201.05253013595427,ARHGDIA,up,Reactome
2,p75NTR regulates axonogenesis Homo sapiens R-HSA-193697,1/9,0.021839307484116888,1.0,0,0,45.351473922902485,173.42602436330466,ARHGDIA,up,Reactome
3,Import of palmitoyl-CoA into the mitochondrial matrix Homo sapiens R-HSA-200425,1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,CPT2,up,Reactome
4,Heme biosynthesis Homo sapiens R-HSA-189451,1/11,0.02662867767591582,1.0,0,0,37.10575139146568,134.53679168157848,COX15,up,Reactome
5,PPARA activates gene expression Homo sapiens R-HSA-1989781,2/113,0.03131455034104185,1.0,0,0,7.224128589488893,25.022014970759184,MED13;CPT2,up,Reactome
6,Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) Homo sapiens R-HSA-400206,2/116,0.03285489913796097,1.0,0,0,7.037297677691766,24.036976837096837,MED13;CPT2,up,Reactome
7,Repression of WNT target genes Homo sapiens R-HSA-4641265,1/14,0.033769693865094014,1.0,0,0,29.15451895043732,98.7810935836037,CTBP2,up,Reactome
8,RNA Polymerase II Transcription Homo sapiens R-HSA-73857,2/124,0.037104657144108814,1.0,0,0,6.583278472679393,21.685403474365447,THOC3;TAF1,up,Reactome
9,ABC transporters in lipid homeostasis Homo sapiens R-HSA-1369062,1/17,0.04085938516720612,1.0,0,0,24.009603841536613,76.77355911185376,ABCA7,up,Reactome
10,Formation of Senescence-Associated Heterochromatin Foci (SAHF) Homo sapiens R-HSA-2559584,1/17,0.04085938516720612,1.0,0,0,24.009603841536613,76.77355911185376,CABIN1,up,Reactome
11,Metabolism of porphyrins Homo sapiens R-HSA-189445,1/17,0.04085938516720612,1.0,0,0,24.009603841536613,76.77355911185376,COX15,up,Reactome
12,Regulation of TP53 Activity through Methylation Homo sapiens R-HSA-6804760,1/19,0.045557510321821836,1.0,0,0,21.482277121374864,66.35402337351628,SETD8,up,Reactome
13,HS-GAG degradation Homo sapiens R-HSA-2024096,1/21,0.0502330909367498,1.0,0,0,19.43634596695821,58.135690718027526,SGSH,up,Reactome
14,SALM protein interactions at the synapse Homo sapiens R-HSA-8849932,1/22,0.052562460131218174,1.0,0,0,18.55287569573284,54.652191090011996,PTPRD,up,Reactome
15,Regulation of TP53 Activity Homo sapiens R-HSA-5633007,2/151,0.0528680221477525,1.0,0,0,5.406135964319502,15.893805212386429,SETD8;TAF1,up,Reactome
16,Metal ion SLC transporters Homo sapiens R-HSA-425410,1/25,0.059517041402020875,1.0,0,0,16.3265306122449,46.06518526236904,SLC31A1,up,Reactome
17,Synthesis of PA Homo sapiens R-HSA-1483166,1/28,0.06642160851252993,1.0,0,0,14.57725947521866,39.529633324123054,AGPAT5,up,Reactome
18,Interaction between L1 and Ankyrins Homo sapiens R-HSA-445095,1/29,0.06871207754428547,1.0,0,0,14.074595355383533,37.68937781813083,SCN9A,up,Reactome
19,Metabolism of lipids and lipoproteins Homo sapiens R-HSA-556833,4/659,0.07732672078127363,1.0,0,0,2.4774705026168284,6.341620158628928,AGPAT5;MED13;CPT2;SCAP,up,Reactome
20,Signaling by WNT in cancer Homo sapiens R-HSA-4791275,1/34,0.08008210609353099,1.0,0,0,12.004801920768307,30.308557556443446,CTBP2,up,Reactome
21,G1 Phase Homo sapiens R-HSA-69236,1/38,0.08908012117667435,1.0,0,0,10.741138560687432,25.97442616843159,CKS1B,up,Reactome
22,Cyclin D associated events in G1 Homo sapiens R-HSA-69231,1/38,0.08908012117667435,1.0,0,0,10.741138560687432,25.97442616843159,CKS1B,up,Reactome
23,Metabolism Homo sapiens R-HSA-1430728,8/1908,0.09077571042697502,1.0,0,0,1.7113763744491508,4.106214068321453,AGPAT5;MED13;CPT2;COX15;AMD1;SCAP;RPL7;SGSH,up,Reactome
24,Association of TriC/CCT with target proteins during biosynthesis Homo sapiens R-HSA-390471,1/39,0.09131611933080344,1.0,0,0,10.465724751439037,25.048958173793586,AP3M1,up,Reactome
25,PKMTs methylate histone lysines Homo sapiens R-HSA-3214841,1/40,0.0935467406593446,1.0,0,0,10.204081632653065,24.176470076489622,SETD8,up,Reactome
26,Condensation of Prophase Chromosomes Homo sapiens R-HSA-2299718,1/41,0.09577199782508727,1.0,0,0,9.955201592832255,23.352761921448888,SETD8,up,Reactome
27,Phase 0 - rapid depolarisation Homo sapiens R-HSA-5576892,1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,SCN9A,up,Reactome
28,RNA Polymerase II HIV Promoter Escape Homo sapiens R-HSA-167162,1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,TAF1,up,Reactome
29,RNA Polymerase II Promoter Escape Homo sapiens R-HSA-73776,1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,TAF1,up,Reactome
30,RNA Polymerase II Transcription Initiation And Promoter Clearance Homo sapiens R-HSA-76042,1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,TAF1,up,Reactome
31,RNA Polymerase II Transcription Initiation Homo sapiens R-HSA-75953,1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,TAF1,up,Reactome
32,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening Homo sapiens R-HSA-73779,1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,TAF1,up,Reactome
33,HIV Transcription Initiation Homo sapiens R-HSA-167161,1/44,0.10241571046432067,1.0,0,0,9.27643784786642,21.13835951430081,TAF1,up,Reactome
34,ABC-family proteins mediated transport Homo sapiens R-HSA-382556,1/45,0.10461963696044026,1.0,0,0,9.0702947845805,20.475501234681968,ABCA7,up,Reactome
35,mRNA 3'-end processing Homo sapiens R-HSA-72187,1/51,0.11773230434297198,1.0,0,0,8.003201280512204,17.12158334507697,THOC3,up,Reactome
36,Post-Elongation Processing of Intron-Containing pre-mRNA Homo sapiens R-HSA-112296,1/51,0.11773230434297198,1.0,0,0,8.003201280512204,17.12158334507697,THOC3,up,Reactome
37,Heparan sulfate/heparin (HS-GAG) metabolism Homo sapiens R-HSA-1638091,1/54,0.12421790857292912,1.0,0,0,7.558578987150415,15.765063707247872,SGSH,up,Reactome
38,Regulation of cholesterol biosynthesis by SREBP (SREBF) Homo sapiens R-HSA-1655829,1/55,0.12636938033824105,1.0,0,0,7.421150278293135,15.350991248791996,SCAP,up,Reactome
39,SCF(Skp2)-mediated degradation of p27/p21 Homo sapiens R-HSA-187577,1/59,0.1349236118713764,1.0,0,0,6.918021445866482,13.857118634937684,CKS1B,up,Reactome
40,DNA Damage/Telomere Stress Induced Senescence Homo sapiens R-HSA-2559586,1/59,0.1349236118713764,1.0,0,0,6.918021445866482,13.857118634937684,CABIN1,up,Reactome
41,Cleavage of Growing Transcript in the Termination Region Homo sapiens R-HSA-109688,1/60,0.13704931664792866,1.0,0,0,6.802721088435375,13.519826138757372,THOC3,up,Reactome
42,RNA Polymerase II Transcription Termination Homo sapiens R-HSA-73856,1/60,0.13704931664792866,1.0,0,0,6.802721088435375,13.519826138757372,THOC3,up,Reactome
43,Post-Elongation Processing of the Transcript Homo sapiens R-HSA-76044,1/60,0.13704931664792866,1.0,0,0,6.802721088435375,13.519826138757372,THOC3,up,Reactome
44,RNA Polymerase II Pre-transcription Events Homo sapiens R-HSA-674695,1/64,0.145501086009976,1.0,0,0,6.3775510204081645,12.293187043446148,TAF1,up,Reactome
45,Triglyceride Biosynthesis Homo sapiens R-HSA-75109,1/66,0.1496965090156283,1.0,0,0,6.184291898577612,11.744868940614404,AGPAT5,up,Reactome
46,Transcription of the HIV genome Homo sapiens R-HSA-167172,1/67,0.1517866469464216,1.0,0,0,6.091989034419737,11.485101326040615,TAF1,up,Reactome
47,Cyclin E associated events during G1/S transition Homo sapiens R-HSA-69202,1/68,0.15387175170898196,1.0,0,0,6.002400960384153,11.234308551223542,CKS1B,up,Reactome
48,Transport of Mature mRNA derived from an Intron-Containing Transcript Homo sapiens R-HSA-159236,1/68,0.15387175170898196,1.0,0,0,6.002400960384153,11.234308551223542,THOC3,up,Reactome
49,Amyloid fiber formation Homo sapiens R-HSA-977225,1/68,0.15387175170898196,1.0,0,0,6.002400960384153,11.234308551223542,GGA1,up,Reactome
50,Cyclin A:Cdk2-associated events at S phase entry Homo sapiens R-HSA-69656,1/69,0.1559518351617717,1.0,0,0,5.915409642117718,10.992061924687226,CKS1B,up,Reactome
51,Transport of Mature Transcript to Cytoplasm Homo sapiens R-HSA-72202,1/74,0.1662773462428849,1.0,0,0,5.515719801434088,9.895742549883874,THOC3,up,Reactome
52,RNA polymerase II transcribes snRNA genes Homo sapiens R-HSA-6807505,1/77,0.17241315077194586,1.0,0,0,5.30082162735224,9.318111015542156,ZC3H8,up,Reactome
53,Transcriptional regulation of white adipocyte differentiation Homo sapiens R-HSA-381340,1/79,0.1764790891137693,1.0,0,0,5.1666236114699045,8.961781890486334,MED13,up,Reactome
54,Degradation of beta-catenin by the destruction complex Homo sapiens R-HSA-195253,1/82,0.18254133123122268,1.0,0,0,4.977600796416128,8.465797208067526,CTBP2,up,Reactome
55,p75 NTR receptor-mediated signalling Homo sapiens R-HSA-193704,1/83,0.1845523472379876,1.0,0,0,4.917629702483403,8.309919502713068,ARHGDIA,up,Reactome
56,Metabolism of polyamines Homo sapiens R-HSA-351202,1/84,0.1865585167269208,1.0,0,0,4.859086491739553,8.158456396990406,AMD1,up,Reactome
57,Viral mRNA Translation Homo sapiens R-HSA-192823,1/84,0.1865585167269208,1.0,0,0,4.859086491739553,8.158456396990406,RPL7,up,Reactome
58,Peptide chain elongation Homo sapiens R-HSA-156902,1/84,0.1865585167269208,1.0,0,0,4.859086491739553,8.158456396990406,RPL7,up,Reactome
59,Selenocysteine synthesis Homo sapiens R-HSA-2408557,1/87,0.19254806017668188,1.0,0,0,4.691531785127844,7.728874000279107,RPL7,up,Reactome
60,Eukaryotic Translation Termination Homo sapiens R-HSA-72764,1/87,0.19254806017668188,1.0,0,0,4.691531785127844,7.728874000279107,RPL7,up,Reactome
61,Regulation of TP53 Activity through Phosphorylation Homo sapiens R-HSA-6804756,1/89,0.1965170653943892,1.0,0,0,4.586104104563174,7.4616189160880575,TAF1,up,Reactome
62,Eukaryotic Translation Elongation Homo sapiens R-HSA-156842,1/89,0.1965170653943892,1.0,0,0,4.586104104563174,7.4616189160880575,RPL7,up,Reactome
63,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) Homo sapiens R-HSA-975956,1/89,0.1965170653943892,1.0,0,0,4.586104104563174,7.4616189160880575,RPL7,up,Reactome
64,Metabolism of amino acids and derivatives Homo sapiens R-HSA-71291,2/335,0.19803733107938745,1.0,0,0,2.436795613767895,3.9459024678749888,AMD1;RPL7,up,Reactome
65,Gene Expression Homo sapiens R-HSA-74160,6/1631,0.2071192392323853,1.0,0,0,1.5015202892929091,2.364084560550781,MED13;SETD8;ZC3H8;THOC3;RPL7;TAF1,up,Reactome
66,Chaperonin-mediated protein folding Homo sapiens R-HSA-390466,1/95,0.20830976144800376,1.0,0,0,4.296455424274973,6.739974519290273,AP3M1,up,Reactome
67,Transcriptional Regulation by TP53 Homo sapiens R-HSA-3700989,2/348,0.20966904995853705,1.0,0,0,2.345765892563922,3.664613990059969,SETD8;TAF1,up,Reactome
68,Infectious disease Homo sapiens R-HSA-5663205,2/348,0.20966904995853705,1.0,0,0,2.345765892563922,3.664613990059969,RPL7;TAF1,up,Reactome
69,Formation of a pool of free 40S subunits Homo sapiens R-HSA-72689,1/96,0.21025865699508986,1.0,0,0,4.2517006802721085,6.630173495783064,RPL7,up,Reactome
70,L1CAM interactions Homo sapiens R-HSA-373760,1/96,0.21025865699508986,1.0,0,0,4.2517006802721085,6.630173495783064,SCN9A,up,Reactome
71,"Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds Homo sapiens R-HSA-425366",1/101,0.21993285781620825,1.0,0,0,4.04122044857547,6.120157490219282,SLC31A1,up,Reactome
72,Protein folding Homo sapiens R-HSA-391251,1/101,0.21993285781620825,1.0,0,0,4.04122044857547,6.120157490219282,AP3M1,up,Reactome
73,Glycerophospholipid biosynthesis Homo sapiens R-HSA-1483206,1/102,0.2218537199073844,1.0,0,0,4.001600640256102,6.0253582778260055,AGPAT5,up,Reactome
74,Degradation of the extracellular matrix Homo sapiens R-HSA-1474228,1/106,0.2294909406653387,1.0,0,0,3.8505968425105888,5.667661626822366,ADAM15,up,Reactome
75,Nonsense-Mediated Decay (NMD) Homo sapiens R-HSA-927802,1/106,0.2294909406653387,1.0,0,0,3.8505968425105888,5.667661626822366,RPL7,up,Reactome
76,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) Homo sapiens R-HSA-975957,1/106,0.2294909406653387,1.0,0,0,3.8505968425105888,5.667661626822366,RPL7,up,Reactome
77,L13a-mediated translational silencing of Ceruloplasmin expression Homo sapiens R-HSA-156827,1/106,0.2294909406653387,1.0,0,0,3.8505968425105888,5.667661626822366,RPL7,up,Reactome
78,3' -UTR-mediated translational regulation Homo sapiens R-HSA-157279,1/106,0.2294909406653387,1.0,0,0,3.8505968425105888,5.667661626822366,RPL7,up,Reactome
79,Mitotic Prophase Homo sapiens R-HSA-68875,1/107,0.2313887434989261,1.0,0,0,3.8146099561319855,5.5832771718997884,SETD8,up,Reactome
80,SRP-dependent cotranslational protein targeting to membrane Homo sapiens R-HSA-1799339,1/107,0.2313887434989261,1.0,0,0,3.8146099561319855,5.5832771718997884,RPL7,up,Reactome
81,GTP hydrolysis and joining of the 60S ribosomal subunit Homo sapiens R-HSA-72706,1/107,0.2313887434989261,1.0,0,0,3.8146099561319855,5.5832771718997884,RPL7,up,Reactome
82,Selenoamino acid metabolism Homo sapiens R-HSA-2408522,1/111,0.2389342705931525,1.0,0,0,3.677146534289392,5.264080835866244,RPL7,up,Reactome
83,G1/S Transition Homo sapiens R-HSA-69206,1/112,0.24080928525036116,1.0,0,0,3.6443148688046647,5.188593317350888,CKS1B,up,Reactome
84,Cap-dependent Translation Initiation Homo sapiens R-HSA-72737,1/114,0.24454574915763636,1.0,0,0,3.5803795202291444,5.042437788942069,RPL7,up,Reactome
85,Eukaryotic Translation Initiation Homo sapiens R-HSA-72613,1/114,0.24454574915763636,1.0,0,0,3.5803795202291444,5.042437788942069,RPL7,up,Reactome
86,Glycosaminoglycan metabolism Homo sapiens R-HSA-1630316,1/121,0.257482053509444,1.0,0,0,3.37325012649688,4.576843502837304,SGSH,up,Reactome
87,Rho GTPase cycle Homo sapiens R-HSA-194840,1/122,0.259312292735852,1.0,0,0,3.3456005352960867,4.515631248486648,ARHGDIA,up,Reactome
88,Disease Homo sapiens R-HSA-1643685,3/725,0.26179267761844033,1.0,0,0,1.6889514426460241,2.2635367689278647,CTBP2;RPL7;TAF1,up,Reactome
89,S Phase Homo sapiens R-HSA-69242,1/124,0.26295952305137155,1.0,0,0,3.2916392363396967,4.3968241059794595,CKS1B,up,Reactome
90,Late Phase of HIV Life Cycle Homo sapiens R-HSA-162599,1/128,0.2702012828540778,1.0,0,0,3.1887755102040822,4.172793704313759,TAF1,up,Reactome
91,Influenza Viral RNA Transcription and Replication Homo sapiens R-HSA-168273,1/128,0.2702012828540778,1.0,0,0,3.1887755102040822,4.172793704313759,RPL7,up,Reactome
92,Cardiac conduction Homo sapiens R-HSA-5576891,1/135,0.2827070050205103,1.0,0,0,3.0234315948601664,3.8196348770958566,SCN9A,up,Reactome
93,Mitotic G1-G1/S phases Homo sapiens R-HSA-453279,1/136,0.2844763130304335,1.0,0,0,3.0012004801920766,3.772824991365301,CKS1B,up,Reactome
94,Influenza Life Cycle Homo sapiens R-HSA-168255,1/136,0.2844763130304335,1.0,0,0,3.0012004801920766,3.772824991365301,RPL7,up,Reactome
95,HIV Life Cycle Homo sapiens R-HSA-162587,1/141,0.29325892381433954,1.0,0,0,2.894774931249096,3.551018558900339,TAF1,up,Reactome
96,Influenza Infection Homo sapiens R-HSA-168254,1/147,0.3036587378991768,1.0,0,0,2.7766208524226017,3.309317731036141,RPL7,up,Reactome
97,Translation Homo sapiens R-HSA-72766,1/151,0.31050850642228905,1.0,0,0,2.703067982159751,3.161356891739086,RPL7,up,Reactome
98,"Cell Cycle, Mitotic Homo sapiens R-HSA-69278",2/462,0.3132320846787084,1.0,0,0,1.7669405424507465,2.051083803532752,SETD8;CKS1B,up,Reactome
99,Generic Transcription Pathway Homo sapiens R-HSA-212436,3/812,0.3203371236861411,1.0,0,0,1.5079923595053786,1.7166703421478575,MED13;SETD8;TAF1,up,Reactome
100,Phospholipid metabolism Homo sapiens R-HSA-1483257,1/161,0.3273454602523001,1.0,0,0,2.535175560907593,2.8311299591027383,AGPAT5,up,Reactome
101,Cellular Senescence Homo sapiens R-HSA-2559583,1/161,0.3273454602523001,1.0,0,0,2.535175560907593,2.8311299591027383,CABIN1,up,Reactome
102,Major pathway of rRNA processing in the nucleolus Homo sapiens R-HSA-6791226,1/166,0.3356122319023523,1.0,0,0,2.4588148512417014,2.6845312446316583,RPL7,up,Reactome
103,rRNA processing Homo sapiens R-HSA-72312,1/180,0.358233333402858,1.0,0,0,2.2675736961451247,2.327824797299462,RPL7,up,Reactome
104,Processing of Capped Intron-Containing Pre-mRNA Homo sapiens R-HSA-72203,1/193,0.3785620658271017,1.0,0,0,2.114835571534313,2.05429891327162,THOC3,up,Reactome
105,Muscle contraction Homo sapiens R-HSA-397014,1/196,0.3831629644986655,1.0,0,0,2.0824656393169514,1.9976986370765084,SCN9A,up,Reactome
106,Cell Cycle Homo sapiens R-HSA-1640170,2/566,0.4056385126152308,1.0,0,0,1.4422730222831182,1.3013526775880329,SETD8;CKS1B,up,Reactome
107,HIV Infection Homo sapiens R-HSA-162906,1/222,0.421664534596916,1.0,0,0,1.838573267144696,1.5876911615982867,TAF1,up,Reactome
108,Chromatin organization Homo sapiens R-HSA-4839726,1/226,0.4273749962880352,1.0,0,0,1.8060321473722232,1.535296080383186,SETD8,up,Reactome
109,Chromatin modifying enzymes Homo sapiens R-HSA-3247509,1/226,0.4273749962880352,1.0,0,0,1.8060321473722232,1.535296080383186,SETD8,up,Reactome
110,Transmembrane transport of small molecules Homo sapiens R-HSA-382551,2/594,0.4296098368045768,1.0,0,0,1.374287088572803,1.161104704816644,SLC31A1;ABCA7,up,Reactome
111,SLC-mediated transmembrane transport Homo sapiens R-HSA-425407,1/268,0.4840975294665612,1.0,0,0,1.5229972586049343,1.1048871236719922,SLC31A1,up,Reactome
112,M Phase Homo sapiens R-HSA-68886,1/268,0.4840975294665612,1.0,0,0,1.5229972586049343,1.1048871236719922,SETD8,up,Reactome
113,Metabolism of proteins Homo sapiens R-HSA-392499,3/1074,0.4939204933758078,1.0,0,0,1.140120852810398,0.8042192672791801,GGA1;AP3M1;RPL7,up,Reactome
114,Metabolism of carbohydrates Homo sapiens R-HSA-71387,1/282,0.5017523563861601,1.0,0,0,1.4473874656245478,0.998188732061905,SGSH,up,Reactome
115,Extracellular matrix organization Homo sapiens R-HSA-1474244,1/283,0.5029905183138399,1.0,0,0,1.4422730222831182,0.9911068858884582,ADAM15,up,Reactome
116,Diseases of signal transduction Homo sapiens R-HSA-5663202,1/288,0.5091362579400526,1.0,0,0,1.4172335600907031,0.9566887768253304,CTBP2,up,Reactome
117,Signaling by Wnt Homo sapiens R-HSA-195721,1/295,0.5176153939128149,1.0,0,0,1.3836042891732965,0.9111349640862152,CTBP2,up,Reactome
118,Neuronal System Homo sapiens R-HSA-112316,1/301,0.5247688961664531,1.0,0,0,1.3560241372296429,0.8743607174509217,PTPRD,up,Reactome
119,Developmental Biology Homo sapiens R-HSA-1266738,2/786,0.5790308916362434,1.0,0,0,1.0385833722802098,0.5674813827718889,MED13;SCN9A,up,Reactome
120,Signaling by Rho GTPases Homo sapiens R-HSA-194315,1/367,0.5969122607405265,1.0,0,0,1.112161485847745,0.5738588036746087,ARHGDIA,up,Reactome
121,Cellular responses to stress Homo sapiens R-HSA-2262752,1/367,0.5969122607405265,1.0,0,0,1.112161485847745,0.5738588036746087,CABIN1,up,Reactome
122,Signalling by NGF Homo sapiens R-HSA-166520,1/450,0.6725583292828072,1.0,0,0,0.90702947845805,0.3597881508157669,ARHGDIA,up,Reactome
123,Axon guidance Homo sapiens R-HSA-422475,1/515,0.7219161613644761,1.0,0,0,0.7925500297206262,0.2582494684569524,SCN9A,up,Reactome
124,Signal Transduction Homo sapiens R-HSA-162582,2/2465,0.9875427419688112,1.0,0,0,0.3311669495384361,0.004151343341359089,CTBP2;ARHGDIA,up,Reactome
0,RHO GTPases Activate NADPH Oxidases Homo sapiens R-HSA-5668599,1/13,0.007128500182420091,1.0,0,0,139.86013986013987,691.4201985706308,NOXA1,down,Reactome
1,RHO GTPase Effectors Homo sapiens R-HSA-195258,2/255,0.008255133559476517,1.0,0,0,14.2602495543672,68.40527661346253,NOXA1;HIST2H2BE,down,Reactome
2,DNA Repair Homo sapiens R-HSA-73894,2/285,0.01022362811243465,1.0,0,0,12.759170653907494,58.47596498868139,PRPF19;HIST2H2BE,down,Reactome
3,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) Homo sapiens R-HSA-381426,1/21,0.011492299803033998,1.0,0,0,86.58008658008656,386.6734242621798,IGFBP2,down,Reactome
4,EGFR downregulation Homo sapiens R-HSA-182971,1/27,0.014753702756032041,1.0,0,0,67.34006734006735,283.92331268638986,EPN1,down,Reactome
5,RNA Polymerase I Promoter Opening Homo sapiens R-HSA-73728,1/30,0.01638073395054089,1.0,0,0,60.6060606060606,249.19087235367996,HIST2H2BE,down,Reactome
6,Signaling by Rho GTPases Homo sapiens R-HSA-194315,2/367,0.016554153973110292,1.0,0,0,9.908347783007182,40.63530555659185,NOXA1;HIST2H2BE,down,Reactome
7,Packaging Of Telomere Ends Homo sapiens R-HSA-171306,1/31,0.016922534733463997,1.0,0,0,58.65102639296187,239.24393718954147,HIST2H2BE,down,Reactome
8,DNA methylation Homo sapiens R-HSA-5334118,1/32,0.017464064240814415,1.0,0,0,56.81818181818181,229.97783984491127,HIST2H2BE,down,Reactome
9,Cargo concentration in the ER Homo sapiens R-HSA-5694530,1/33,0.01800532259639319,1.0,0,0,55.09641873278236,221.32715509624904,CNIH2,down,Reactome
10,Metabolism of proteins Homo sapiens R-HSA-392499,3/1074,0.01841786782205083,1.0,0,0,5.078720162519045,20.286612535664577,IGFBP2;CNIH2;HIST2H2BE,down,Reactome
11,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 Homo sapiens R-HSA-5625886,1/34,0.018546309917010683,1.0,0,0,53.475935828877,213.23446181945755,HIST2H2BE,down,Reactome
12,SIRT1 negatively regulates rRNA Expression Homo sapiens R-HSA-427359,1/35,0.01908702632439229,1.0,0,0,51.94805194805194,205.64916492239948,HIST2H2BE,down,Reactome
13,PRC2 methylates histones and DNA Homo sapiens R-HSA-212300,1/40,0.02178654888216798,1.0,0,0,45.45454545454545,173.93011469901603,HIST2H2BE,down,Reactome
14,Condensation of Prophase Chromosomes Homo sapiens R-HSA-2299718,1/41,0.022325642342211446,1.0,0,0,44.345898004434595,168.603963649933,HIST2H2BE,down,Reactome
15,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression Homo sapiens R-HSA-427389,1/43,0.02340301917551725,1.0,0,0,42.283298097251574,158.76914335503946,HIST2H2BE,down,Reactome
16,Nonhomologous End-Joining (NHEJ) Homo sapiens R-HSA-5693571,1/52,0.028237872395663863,1.0,0,0,34.96503496503497,124.72346885637036,HIST2H2BE,down,Reactome
17,Deposition of new CENPA-containing nucleosomes at the centromere Homo sapiens R-HSA-606279,1/52,0.028237872395663863,1.0,0,0,34.96503496503497,124.72346885637036,HIST2H2BE,down,Reactome
18,Nucleosome assembly Homo sapiens R-HSA-774815,1/52,0.028237872395663863,1.0,0,0,34.96503496503497,124.72346885637036,HIST2H2BE,down,Reactome
19,Formation of TC-NER Pre-Incision Complex Homo sapiens R-HSA-6781823,1/53,0.028773732993623582,1.0,0,0,34.30531732418525,121.72529526045805,PRPF19,down,Reactome
20,Meiotic recombination Homo sapiens R-HSA-912446,1/54,0.029309324971107782,1.0,0,0,33.670033670033675,118.85015337350148,HIST2H2BE,down,Reactome
21,Meiotic synapsis Homo sapiens R-HSA-1221632,1/57,0.03091449038178541,1.0,0,0,31.897926634768734,110.89410719630452,HIST2H2BE,down,Reactome
22,RNA Polymerase I Chain Elongation Homo sapiens R-HSA-73777,1/57,0.03091449038178541,1.0,0,0,31.897926634768734,110.89410719630452,HIST2H2BE,down,Reactome
23,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Homo sapiens R-HSA-5693565,1/58,0.031449009079719786,1.0,0,0,31.34796238244514,108.44475875019188,HIST2H2BE,down,Reactome
24,Formation of the beta-catenin:TCF transactivating complex Homo sapiens R-HSA-201722,1/58,0.031449009079719786,1.0,0,0,31.34796238244514,108.44475875019188,HIST2H2BE,down,Reactome
25,B-WICH complex positively regulates rRNA expression Homo sapiens R-HSA-5250924,1/58,0.031449009079719786,1.0,0,0,31.34796238244514,108.44475875019188,HIST2H2BE,down,Reactome
26,DNA Double Strand Break Response Homo sapiens R-HSA-5693606,1/59,0.031983259760384464,1.0,0,0,30.816640986132512,106.08760078742485,HIST2H2BE,down,Reactome
27,DNA Damage/Telomere Stress Induced Senescence Homo sapiens R-HSA-2559586,1/59,0.031983259760384464,1.0,0,0,30.816640986132512,106.08760078742485,HIST2H2BE,down,Reactome
28,Telomere Maintenance Homo sapiens R-HSA-157579,1/59,0.031983259760384464,1.0,0,0,30.816640986132512,106.08760078742485,HIST2H2BE,down,Reactome
29,RHO GTPases activate PKNs Homo sapiens R-HSA-5625740,1/60,0.032517242545820016,1.0,0,0,30.3030303030303,103.81772092307816,HIST2H2BE,down,Reactome
30,HDACs deacetylate histones Homo sapiens R-HSA-3214815,1/60,0.032517242545820016,1.0,0,0,30.3030303030303,103.81772092307816,HIST2H2BE,down,Reactome
31,Gap-filling DNA repair synthesis and ligation in TC-NER Homo sapiens R-HSA-6782210,1/62,0.03358440490598319,1.0,0,0,29.325513196480934,99.52180233026488,PRPF19,down,Reactome
32,Dual incision in TC-NER Homo sapiens R-HSA-6782135,1/63,0.034117584722214066,1.0,0,0,28.860028860028855,97.4875136105938,PRPF19,down,Reactome
33,COPII (Coat Protein 2) Mediated Vesicle Transport Homo sapiens R-HSA-204005,1/68,0.0367794749552908,1.0,0,0,26.7379679144385,88.31057045950347,CNIH2,down,Reactome
34,Amyloid fiber formation Homo sapiens R-HSA-977225,1/68,0.0367794749552908,1.0,0,0,26.7379679144385,88.31057045950347,HIST2H2BE,down,Reactome
35,Transcriptional regulation by small RNAs Homo sapiens R-HSA-5578749,1/72,0.03890418375818435,1.0,0,0,25.25252525252525,81.98619905345255,HIST2H2BE,down,Reactome
36,Positive epigenetic regulation of rRNA expression Homo sapiens R-HSA-5250913,1/73,0.03943469482153839,1.0,0,0,24.906600249066,80.52576017269782,HIST2H2BE,down,Reactome
37,NoRC negatively regulates rRNA expression Homo sapiens R-HSA-427413,1/73,0.03943469482153839,1.0,0,0,24.906600249066,80.52576017269782,HIST2H2BE,down,Reactome
38,Transcription-Coupled Nucleotide Excision Repair (TC-NER) Homo sapiens R-HSA-6781827,1/76,0.041024631208246766,1.0,0,0,23.923444976076556,76.40149836090508,PRPF19,down,Reactome
39,Negative epigenetic regulation of rRNA expression Homo sapiens R-HSA-5250941,1/76,0.041024631208246766,1.0,0,0,23.923444976076556,76.40149836090508,HIST2H2BE,down,Reactome
40,RNA Polymerase I Promoter Clearance Homo sapiens R-HSA-73854,1/76,0.041024631208246766,1.0,0,0,23.923444976076556,76.40149836090508,HIST2H2BE,down,Reactome
41,Senescence-Associated Secretory Phenotype (SASP) Homo sapiens R-HSA-2559582,1/77,0.0415540781399269,1.0,0,0,23.612750885478157,75.10648435226321,HIST2H2BE,down,Reactome
42,G2/M DNA damage checkpoint Homo sapiens R-HSA-69473,1/78,0.04208325933054256,1.0,0,0,23.310023310023308,73.84860741208578,HIST2H2BE,down,Reactome
43,RNA Polymerase I Transcription Homo sapiens R-HSA-73864,1/79,0.04261217490903927,1.0,0,0,23.014959723820482,72.62635835562412,HIST2H2BE,down,Reactome
44,Regulation of insulin secretion Homo sapiens R-HSA-422356,1/80,0.04314082499469826,1.0,0,0,22.72727272727273,71.43830714872377,SYT5,down,Reactome
45,Processing of DNA double-strand break ends Homo sapiens R-HSA-5693607,1/81,0.043669209702019214,1.0,0,0,22.446689113355774,70.28309783824933,HIST2H2BE,down,Reactome
46,Meiosis Homo sapiens R-HSA-1500620,1/85,0.0457800971719973,1.0,0,0,21.390374331550802,65.96590036093572,HIST2H2BE,down,Reactome
47,Chromosome Maintenance Homo sapiens R-HSA-73886,1/86,0.04630715680061324,1.0,0,0,21.141649048625787,64.95684472110096,HIST2H2BE,down,Reactome
48,Activation of anterior HOX genes in hindbrain development during early embryogenesis Homo sapiens R-HSA-5617472,1/89,0.04788674820170976,1.0,0,0,20.42900919305413,62.082052468603145,HIST2H2BE,down,Reactome
49,Activation of HOX genes during differentiation Homo sapiens R-HSA-5619507,1/89,0.04788674820170976,1.0,0,0,20.42900919305413,62.082052468603145,HIST2H2BE,down,Reactome
50,Oxidative Stress Induced Senescence Homo sapiens R-HSA-2559580,1/91,0.048938487444328285,1.0,0,0,19.980019980019986,60.28353901643958,HIST2H2BE,down,Reactome
51,Gene Silencing by RNA Homo sapiens R-HSA-211000,1/101,0.05418135902506024,1.0,0,0,18.001800180018,52.48277874204786,HIST2H2BE,down,Reactome
52,HATs acetylate histones Homo sapiens R-HSA-3214847,1/107,0.05731445654280469,1.0,0,0,16.992353440951568,48.5845775938267,HIST2H2BE,down,Reactome
53,Mitotic Prophase Homo sapiens R-HSA-68875,1/107,0.05731445654280469,1.0,0,0,16.992353440951568,48.5845775938267,HIST2H2BE,down,Reactome
54,Nucleotide Excision Repair Homo sapiens R-HSA-5696398,1/108,0.057835721217223385,1.0,0,0,16.835016835016837,47.98230101106203,PRPF19,down,Reactome
55,Integration of energy metabolism Homo sapiens R-HSA-163685,1/110,0.05887746455604018,1.0,0,0,16.528925619834713,46.814824242929475,SYT5,down,Reactome
56,HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA) Homo sapiens R-HSA-5693567,1/112,0.05991816068709738,1.0,0,0,16.233766233766232,45.69440968161597,HIST2H2BE,down,Reactome
57,Epigenetic regulation of gene expression Homo sapiens R-HSA-212165,1/115,0.06147724341022344,1.0,0,0,15.810276679841895,44.09625610270589,HIST2H2BE,down,Reactome
58,"RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription Homo sapiens R-HSA-504046",1/116,0.06199641507314463,1.0,0,0,15.67398119122257,43.584305909242325,HIST2H2BE,down,Reactome
59,Homology Directed Repair Homo sapiens R-HSA-5693538,1/118,0.06303397522541687,1.0,0,0,15.408320493066256,42.58985221359758,HIST2H2BE,down,Reactome
60,ER to Golgi Anterograde Transport Homo sapiens R-HSA-199977,1/131,0.0697527247352707,1.0,0,0,13.879250520471894,36.95765155778898,CNIH2,down,Reactome
61,mRNA Splicing - Major Pathway Homo sapiens R-HSA-72163,1/134,0.07129697211276262,1.0,0,0,13.568521031207595,35.83312644946137,PRPF19,down,Reactome
62,mRNA Splicing Homo sapiens R-HSA-72172,1/144,0.07642764774151524,1.0,0,0,12.626262626262625,32.46730766211502,PRPF19,down,Reactome
63,DNA Double-Strand Break Repair Homo sapiens R-HSA-5693532,1/145,0.0769392954545684,1.0,0,0,12.539184952978056,32.159730893742555,HIST2H2BE,down,Reactome
64,G2/M Checkpoints Homo sapiens R-HSA-69481,1/150,0.07949367100398377,1.0,0,0,12.12121212121212,30.691852975802163,HIST2H2BE,down,Reactome
65,Cellular Senescence Homo sapiens R-HSA-2559583,1/161,0.08509069246445834,1.0,0,0,11.293054771315642,27.826511814001456,HIST2H2BE,down,Reactome
66,Transport to the Golgi and subsequent modification Homo sapiens R-HSA-948021,1/162,0.08559797531574136,1.0,0,0,11.223344556677887,27.588031974945704,CNIH2,down,Reactome
67,Cell Cycle Checkpoints Homo sapiens R-HSA-69620,1/182,0.09569008743413483,1.0,0,0,9.990009990009993,23.442962691993827,HIST2H2BE,down,Reactome
68,Processing of Capped Intron-Containing Pre-mRNA Homo sapiens R-HSA-72203,1/193,0.101197485556128,1.0,0,0,9.420631182289213,21.579664330859785,PRPF19,down,Reactome
69,TCF dependent signaling in response to WNT Homo sapiens R-HSA-201681,1/199,0.10418865221778634,1.0,0,0,9.136592051164914,20.66287856969705,HIST2H2BE,down,Reactome
70,Chromatin organization Homo sapiens R-HSA-4839726,1/226,0.117537237046427,1.0,0,0,8.045052292839904,17.224457639341892,HIST2H2BE,down,Reactome
71,Chromatin modifying enzymes Homo sapiens R-HSA-3247509,1/226,0.117537237046427,1.0,0,0,8.045052292839904,17.224457639341892,HIST2H2BE,down,Reactome
72,Asparagine N-linked glycosylation Homo sapiens R-HSA-446203,1/259,0.13360649851899148,1.0,0,0,7.020007020007019,14.130265899988336,CNIH2,down,Reactome
73,M Phase Homo sapiens R-HSA-68886,1/268,0.1379426117806564,1.0,0,0,6.784260515603799,13.439060630795142,HIST2H2BE,down,Reactome
74,Signal Transduction Homo sapiens R-HSA-162582,3/2465,0.1450285484897144,1.0,0,0,2.212797344643186,4.272523702316355,NOXA1;EPN1;HIST2H2BE,down,Reactome
75,Signaling by Wnt Homo sapiens R-HSA-195721,1/295,0.1508328504724236,1.0,0,0,6.163328197226503,11.65844687706126,HIST2H2BE,down,Reactome
76,Signaling by EGFR Homo sapiens R-HSA-177929,1/355,0.17885276479325368,1.0,0,0,5.1216389244558265,8.815325760153588,EPN1,down,Reactome
77,Cellular responses to stress Homo sapiens R-HSA-2262752,1/367,0.18435484026174914,1.0,0,0,4.954173891503591,8.376977452660071,HIST2H2BE,down,Reactome
78,Membrane Trafficking Homo sapiens R-HSA-199991,1/420,0.20825702947155306,1.0,0,0,4.329004329004329,6.792130924413117,CNIH2,down,Reactome
79,Gene Expression Homo sapiens R-HSA-74160,2/1631,0.2245343818746232,1.0,0,0,2.2295301265258343,3.3303080873170243,PRPF19;HIST2H2BE,down,Reactome
80,"Cell Cycle, Mitotic Homo sapiens R-HSA-69278",1/462,0.2267441708902177,1.0,0,0,3.9354584809130264,5.839956306678281,HIST2H2BE,down,Reactome
81,Vesicle-mediated transport Homo sapiens R-HSA-5653656,1/492,0.2397080537363025,1.0,0,0,3.695491500369549,5.278394452596469,CNIH2,down,Reactome
82,Post-translational protein modification Homo sapiens R-HSA-597592,1/521,0.25205167542219986,1.0,0,0,3.489792357354737,4.809356661293601,CNIH2,down,Reactome
83,Cell Cycle Homo sapiens R-HSA-1640170,1/566,0.2708452362996239,1.0,0,0,3.2123353678124,4.19597720847448,HIST2H2BE,down,Reactome
84,Developmental Biology Homo sapiens R-HSA-1266738,1/786,0.3566946137536628,1.0,0,0,2.313208420078649,2.384629393812885,HIST2H2BE,down,Reactome
85,Metabolism Homo sapiens R-HSA-1430728,1/1908,0.6681838834716249,1.0,0,0,0.952925481227368,0.3842118054778799,SYT5,down,Reactome
